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Summary 
The increasing demand for milligrams of recombinant proteins (r-proteins) to be used for 
therapeutics and structural studies justifies the need for a rapid and scalable expression system. 
Transient transfection of mammalian cells is a powerful technology for the fast production of 
large amounts of these r-proteins. This system depends on a multitude of different factors 
including the cell line, its physiological state, the type of expression vector and the medium 
formulation. Moreover, monitoring bioprocess parameters, and control of the bioprocess at its 
optimal state, enable the reduction of production costs, increase the yield and maintain the 
quality of the desired product. Off-line and on-line monitoring methods have been used to 
characterize and to optimize the transient transfection process using HEK293 cells and 
polyethylenimine (PEI) as transfection mediator. As an off-line method the intracellular 
nucleotide analysis was used, which has been considered as a reliable tool reflecting the 
metabolic status, the growth potential, and the overall physiological condition of the cell. As an 
on-line and non-invasive method a completely new technology, the electronic nose, was applied 
for bioprocess monitoring and the identification of characteristic process states.  
 
HEK293 cells were cultured in suspension (HEK293s) using a completely new medium, 
totally free of proteins or animal-origin components, which facilitates the transfection process 
by allowing growth and transfection of the cells without medium exchange. This is a central 
prerequisite for scaling the technology up to large volume cultivation processes. A special 
bicistronic plasmid was constructed under control of the cytomegalovirus promoter. The 
plasmid DNA was combined with PEI using an efficient minimum amount of DNA at a 
DNA:PEI ratio of 0.50:1.50 (µg:µg) showing 70-80 % of GFP positive cells under serum-
containing as well as serum-free culture conditions. Specific cells taken from an early (from 40 
to 77) and a late (from 89 to 150) passage number were compared as hosts for transient 
transfection. 
 
The combined NucleotideTriPhosphate ratio expressed as NTP/U = [ATP+GTP] [UDP-
GNAc] / [UTP+CTP] [UTP] was calculated in parallel during cultivation and transient 
transfection under serum-containing and serum-free culture conditions for process monitoring 
and characterization. The results showed that nucleotide ratios can be used to distinguish 
between: 
o HEK293s cells from early and late passage numbers. 
o Cells cultured under serum-containing conditions from those under protein/serum-
free medium conditions. 
o Transfected and untransfected cells in culture. 
o DNA:PEI complex uptake (transfection procedure) from PEI uptake alone. 
 
The BioNose was connected to the off-gas line of the bioreactor cultivation. The data were 
collected using the NST Senstool software and evaluated applying multivariate methods such as 
Principal Component Analysis (PCA). The results showed, that the BioNose can generate 
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characteristic pattern specific for a particular process being an easily accessible tool to monitor 
cell cultivations as well as to distinguish between different culture conditions. 
 
In conclusion, a transient transfection procedure easy to perform, cost-effective, for a large-
scale application using the mammalian cell line HEK293s cultivated in a medium totally free of 
proteins or components of animal origin was developed. In addition, the characterization of the 
transfection procedure using an off-line method such as intracellular nucleotide patterns, and an 
on-line method such as the electronic nose, has shown the applicability of both methods as 
appropriate and even excellent tools for process optimization. 
 
 
 
 
1 1.  Introduction  
1. Introduction 
1.1 Animal cell culture: historical outline 
Nearly 100 years of progress and drawbacks have elapsed from the beginning of animal 
cell “cultivation” to the mass production of cells and products. Animal cell cultivation 
began in the last decade of the nineteenth century with the first tentative experiments to 
maintain pieces of tissue in plasma or ascites fluid over several days or even weeks. The 
success of those experiments was limited by the quality of the nutrient fluid and the 
sterility of the experimental set up. In 1907, Ross Harrison was the first to record the 
maintenance and growth of nerve cells in a hanging drop over a period of up to 30 days. 
Harrison and his successors observed that strict aseptic conditions were crucial for the 
success of such experiments. These experiments (Harrison 1907) showed that normal 
cell functions can continue in vitro. Therefore the year 1907 is commonly regarded as 
marking the beginning of cell cultivation (Kretzmer 2002).  
During the next four decades, the progress of cell cultivation was limited due to the 
stringent sterility controls necessary. The development of antibiotics in the late 1940s 
was another milestone. The addition of antibiotics eased the handling of complex 
undefined culture media. At the same time, the development of sterility techniques took 
place. During the following decade, great progress was made towards mass cultivation 
of animal cells and production processes. Maitland and Maitland (1928) had developed 
a simple method for virus propagation in tissue culture, but it took the findings of 
Enders and his co-workers, who showed that poliomyelitis virus could be cultured in 
HeLa cells and used as a vaccine, to indicate a great milestone towards production 
processes (Enders et al. 1949).  
 
The most important breakthrough towards large-scale cultivation was achieved by 
Earle and Eagle, who made an extensive analysis of the requirements of cells in vitro. In 
1955, Eagle reported a chemically defined medium known as EMEM (Eagle´s 
Minimum Essential Medium), which could replace the biological fluids used thus far 
(Eagle 1955). However, the cellular requirements for growth were not found to be 
satisfied until a 5 % to 10 % addition of blood serum was made (Butler 1986).  
Serum from young or unborn animals was found to be particularly efficacious. It 
contains undefined materials essential for cell proliferation. However, blood serum is of 
undefined composition and varies between batches. This leads to many difficulties in 
reproducing experiments on a small-scale and in maintaining consistent yields of cell or 
their products on the large-scale. Consequently, numerous attempts have been made to 
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develop media suitable for the growth of cells in vitro in the absence of serum (Higuchi 
1973). 
 
The first permanent animal cell lines were established in the fifties and sixties 
(Capstick et al. 1962; Stoker and Macpherson 1964). Furthermore, in the beginning of 
the eighties the development of the hybridoma technique and expression of recombinant 
proteins in cultured animal cells contributed to their technological and commercial 
exploitation. 
 
The development of a chemically defined medium, together with the development of 
permanent cell lines that can be sub-cultured indefinitely and which have the possibility 
to grow in suspension, had an enormous impact on large-scale cultivation of animal 
cells.  
1.2 Animal cell culture: importance in protein production   
The progress in gene manipulation and cell fusion has made it possible to produce large 
amounts of physiologically active proteins through cell cultivation. In the production of 
pharmaceuticals, microorganisms such as Escherichia coli have been chosen first as 
host cells due to their relative simple cultivation. The production of proteins by these 
microorganisms, however, revealed that some products fail to manifest their biological 
properties sufficiently. One particular reason for this was a deficiency of the products in 
their tertiary or quaternary structure. Yeasts also have the capacity to perform post-
translational modifications in their synthesized proteins, but these were found to differ 
from their natural form (Andersen and Krummen 2002). Consequently, the production 
of recombinant proteins (r-proteins) has been briskly investigated using animal cells as 
hosts because these cells can perform the post-translational modification in an authentic 
manner. 
 
Recombinant proteins can also be produced using transgenic plants and animals, as 
well as plant tissue cultures (Doran 2000; Giddings et al. 2000; Larrick and Thomas 
2001). For example, more than 50 recombinant proteins have already been obtained 
from the milk of transgenic animals (Houdebine 1997) but the recombinant proteins 
obtained in this milk do not always have their normal biochemical structure. They may 
be underglycosylated, not fully γ-carboxylated or cleaved. In addition, limits in 
glycosylation and the problem of proteolysis have been cited as one challenge for 
recombinant production in plant culture. 
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Insect cells have been used in a variety of protein expression applications (Jäger 
1996), particularly related to high-throughput expression of sequences for functional 
screening. However, some limitations had appeared to generate corrected glycosylated 
proteins (Andersen and Krummen 2002). 
 
Due to the ability to carry out post-translational modifications as well as protein 
folding in an authentic manner (Hauser 1997), mammalian cells are the most common 
choice of production host for recently approved protein therapeutics (Chu and Robinson 
2001). Over the past seven to eight years there has been considerable progress in fine-
tuning mammalian expression systems for high-level recombinant gene expression 
(Andersen and Krummen 2002). 
 
Some properties of host cell lines for recombinant protein production are listed 
below (Hauser 1997): 
o Efficient expression of foreign genes. 
o Post-translational modifications. 
o Stability of transgenic expression. 
o Cultivation requirements. 
o Optimal production under controlled fermentation conditions. 
 
Mammalian cells are classified on the basis of their proliferation mode into 
anchorage-dependent cells and anchorage-independent cells. Anchorage-dependent cells 
attach to solid surfaces and proliferate, while the others proliferate in suspension and do 
not need attaching surfaces (Tokashiki and Yokoyama 1997). The development of 
bioreactors has been made mainly on the basis of the techniques utilizing these 
properties. Bioreactors for suspension cells are classified by two types: Stirred tank 
bioreactor (Griffiths 1988) and Airlift or bubble column (Birch et al. 1985; Griffiths 
1988). Nowadays, a large number of cultivation processes is existing to cover the 
cellular demand such as batch and fed-batch culture, and continuous culture, that 
includes chemostat and perfusion culture (Tokashiki and Yokoyama 1997). The process 
type and the scale chosen for the considered product depend on the aim of the study, the 
amount required, the market price and the feasibility of the process. 
In the present, the ability to adapt many cell types to suspension culture and the use 
of polymeric additives to reduce shear effects led to widespread applications of 
suspension cell cultures (Chu and Robinson 2001). 
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1.3 Gene expression in mammalian cells 
Developments in molecular biology over the past two decades have led to the cloning of 
numerous mammalian genes. The study of mammalian gene structure and function has 
been greatly enhanced by the use of eukaryotic expression vector systems. These vector 
systems facilitate the introduction of specific genes into the mammalian cells, the 
transcription of these genes and the subsequent production of proteins that are 
appropriately modified to reflect native molecular structure and biological function.  
These mammalian expression vector systems have advantages that include but are not 
limited to the ability to (Colosimo et al. 2000): 
o Express constitutive and inducible proteins. 
o Produce a large quantity of protein that is post-translationally modified and 
appropriately folded. 
o Characterize the impact of specific mutations on cell metabolism. 
Nowadays, a wide variety of techniques and reagents are used to deliver 
macromolecules into eukaryotic cells. Currently, the following two approaches are used 
to deliver specifically nucleic acid into these cells (Guide to eukaryotic transfections 
with cationic lipid reagents, Life Technologies, 1999): 
 
o Transfection: process in which the gene of interest is introduced into eukaryotic 
cells by biochemical or physical methods. 
 
o Infection: viral mediated process where target cells are infected with a virus 
carrying the cloned sequence of interest in its genome. 
 
DNA delivery by infection is more complicated than transfection. Generally, 
infection requires more steps and more time than does transfection, in addition biosafety 
issues also may arise, depending on the virus being used. While viral infection 
efficiencies are high in permissible cell lines, efficiencies are low or non-existent in cell 
lines lacking the receptor for the virus. DNA delivery by transfection, however, is faster 
and requires only a few reagents including plasmid DNA containing the gene of interest 
under the control of a strong promoter. Its simplicity and the numerous advances that 
have increased its level of efficiency have made transfection a far more popular method 
for nucleic acid delivery (Guide to eukaryotic transfections with cationic lipid reagents, 
Life Technology, 1999).  
 
When the cells take up DNA, they express it transiently over a period of several 
days to several weeks and eventually the DNA is lost from the population.The ability to 
express this DNA over a short period of time is called “transient expression” (Kaufman 
5 1.  Introduction  
1997). The DNA is transferred into the nucleus of the cell but does not integrate into the 
chromosomes. Whilst when the transfected DNA is either integrated into the 
chromosomal DNA or maintained as an episome, the transfection is called “stable 
transfection” (The QIAGEN transfection resource book, QIAGEN, 1999) (See below 
under 1.3.1).  
 
Many transfection techniques have been developed. Desirable features include high 
efficiency transfer of DNA to the nucleus, minimal interference with normal cell 
physiology, low toxicity, ease of use, reproducibility, successful generation of stable 
transfectans, and in vivo efficacy (Transfection guide, Promega, 1999). The techniques 
developed for gene transfer can be broadly classified as either chemical reagents 
(calcium phosphate, cationic polymers, liposomes, molecular conjugates) or physical 
methods (electroporation, biolistic, microinjection) (Colosimo et al. 2000). 
The selection of DNA transfer method depends on numerous factors including the 
efficiency required, whether the transfection is in vitro or in vivo and whether the 
expression is stable or transient. The use of any strategy depends on the goals of the 
experiment and study. Once the endpoints are defined, it is possible to design the most 
effective strategy to achieve a desired outcome. 
1.3.1 Transient transfection versus stable transfection 
Transient transfection 
Following DNA transfection, expression of the transgene may be detected transiently 
for 1 to 4 days. The optimal time interval depends upon the cell type, the doubling time 
of the cells and the specific characteristics of expression for the transferred gene 
(Colosimo et al. 2000). The DNA delivered to the cells is transported to the nucleus for 
transcription without integration into the chromosomes. This means, that many copies 
of the gene of interest are present, leading to high levels of expressed protein. Transient 
transfection is most efficient when supercoiled plasmid DNA is used (The QIAGEN 
transfection resource book, QIAGEN, 1999). Within a few days most of the foreign 
DNA is degraded by nucleases or diluted by cell division; and after a week, it can no 
longer be detected. Transient expression assays detect gene expression from 
unrearranged plasmid DNA. Thus, the level of expression is position independent and 
not influenced by surrounding chromosomal elements. Less time and labor are required 
to assay transient transfection than stable expression but as the efficiency of DNA 
uptake and level of expression can variable from one assay to the next, experiments 
must be carefully controlled.  
Transient expression systems are extremely useful for studying elements that 
regulate gene expression or when it is important to have experimental results within a 
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short time frame (Colosimo et al. 2000). This system offers a convenient means to 
compare different vectors and ensures that an expression plasmid is functional before 
using the expression plasmid to establish a stable transfected expression cell line 
(Kaufman 1997). More recently, this method has demonstrated its ability to produce 
large amounts of recombinant proteins in large-scale (see under 1.3.2) (Durocher et al. 
2002; Girard et al. 2002; Jordan et al. 1996; Meissner et al. 2001; Pham et al. 2003; Pick 
et al. 2002; Schlaeger and Christensen 1999; Wurm and Bernard 1999). 
Transient expression system can be evaluated in terms of the protein products 
synthesized in the transfected cell, such as the activity of a reporter gene that is not 
endogenously expressed in the cell type used. The most common reporter gene systems 
include bacterial chloramphenicol acetyltransferase (CAT), β-galactosidase (β-gal), 
firefly luciferase (Luc), human placental alkaline phosphatase (AP), β-glucuronidase 
(GUS) and green fluorescent protein (GFP) (Transfection guide, Promega, 1999; Guide 
to eukaryotic transfections with cationic lipid reagents, Life Technologies, 1999; The 
QIAGEN transfection resource book, QIAGEN, 1999; Alam and Cook 1990). 
Presently, GFP is widely used to estimate DNA uptake efficiencies in mammalian cells 
because it can be detected with high sensitivity and minimal invasive treatment in live 
cells (Pick et al. 2002). Moreover, the GFP variant, the enhanced GFP (EGFP), includes 
chromophore mutations that make it 30 – 35 times brighter than wild-type GFP. It can 
be detected by a variety of methods such as spectrofluorimetry, microscopy and flow 
cytometry (www.bdbiosciences.com/clontech).  
 
Stable transfection 
In order to achieve stable transfection, the transgene must be able to replicate in 
synchrony with the cell. This occurs as a result of spontaneous integration of the 
transfected plasmid into the host genome. In a small fraction of transfected cells, the 
added DNA is incorporated into the cell’s genome by recombination. Although linear 
DNA results in lower DNA uptake, it yields optimal integration of DNA into the host 
genome (The QIAGEN transfection resource book, QIAGEN, 1999). Cells containing 
integrated DNA are rare and must be amplified by selection for drug resistance or 
identified as a result of phenotypic alteration. Stable gene expression experiments 
require several weeks to perform and longer if it is necessary to verify protein yield. 
However, the resulting cell line could be a stable source for protein production or used 
to develop transgenic animals (Guide to eukaryotic transfections with cationic lipid 
reagents, Life Technologies, 1999). 
These systems are particularly useful when large quantities of protein are required. 
Stable transfection technologies have delivered kilograms of complex proteins from 
mammalian cells (Colosimo et al. 2000; Wurm 1990). 
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Typically, cells are maintained in non-selective medium for 1 – 2 days post-
transfection, then cultivated in selective medium containing the drug. The use of the 
selective medium is continued for 2 – 3 weeks, with frequent changes of medium to 
eliminate dead cells and debris, until distinct colonies can be visualized. Individual 
colonies are sub-cloned to multi-well plates for further propagation in the presence of 
selective medium. 
A typical vector used to enrich successfully transfected cells will carry a gene 
essential for the survival of a given cell line that is either defective in the gene or void 
of the gene. Classic selectable markers such as thymidine kinase (tk), dihydrofolate 
reductase (dhfr), hypoxanthine guanine phosphoribosyl transferase (hprt) and adenyl 
phosphoribosyl transferase (aprt) genes can only be used in cells deficient in TK, 
DHFR, HPRT and APRT, respectively. Alternatively, genes that confer resistance to 
cytotoxic drugs are quite effective in situations when the cell line is not defective in one 
of the endogenous genes mentioned earlier. For example, the most common selection 
marker is the aminoglycoside phosphotransferase (aph) gene that confers resistance to 
antibiotics such as kanamycin, neomycin and geneticin (Transfection guide, Promega, 
1999; Guide to eukaryotic transfections with cationic lipid reagents, Life Technologies, 
1999; The QIAGEN transfection resource book, QIAGEN, 1999).  
An additional approach to select or enrich transfected cells relies on the 
fluorescence-activated cell sorting (FACS) analysis. Cell selection is based on 
expression of cell surface proteins that bind specific antibodies, (for example, human 
and murine CD24), that will facilitate FACS identification of cells carrying the 
expression vector (Colosimo et al. 2000). 
1.3.2 Large-scale transient transfection 
The great advances made in genomics and proteomics during the past decade have 
positioned r-proteins as major therapeutic biomolecules and drug targets (Chu and 
Robinson 2001; Kelley 2001). The increasing demand for milligrams of r-proteins to be 
used in pre-clinical, biochemical, and biophysical studies justifies the need for a rapid 
and scalable expression system. As was discussed above, mammalian expression 
systems are more appropriate for providing soluble and fully processed r-proteins. 
Widely used stable expression systems require considerable investment in time, human 
resource and bioreactor equipment, therefore this technology is not readily amenable to 
high-throughput mode, while transient transfection technology has demonstrated to 
produce large amounts of r-proteins within a few days (Bernard 2000; Durocher et al. 
2002; Girard et al. 2002; Jordan et al. 1998; Meissner et al. 2001; Pham et al. 2003; Pick 
et al. 2002; Schlaeger and Christensen 1999; Wright et al. 2003; Wurm and Bernard 
1999; Wurm and Bernard 2001). 
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Transient gene expression in mammalian cell lines was reviewed by Wurm and 
Bernard (1999) and they described the key features of most transient expression 
systems, of which some have been mentioned above (1.3.1): 
o Simplicity, particularly in the construction of expression vectors. 
o Extremely short time frame for the generation of product (days). 
o Intrinsic genetic stability and consistency due to extremely short time frame 
between generation of a vector and the product recovered. 
o Applicability to a wide range of host cell lines. 
o Suitability for multiple processing, allowing studies of many genes or mutants at 
the same time. 
 
For an optimal large-scale transient transfection and r-protein expression in 
mammalian cells, some key aspects need to be taken into account such as the cell line, 
the expression vector, the transfection vehicle, and the culture medium. 
 
Cell line 
Three cell types dominate the field: human embryonic kidney 293 (HEK293), COS and 
baby hamster kidney (BHK) (Wurm and Bernard 1999). Recently, Chinese hamster 
ovary (CHO) cell line was used by Genentech (Wurm and Bernard 2001). 
HEK293, is widely used for r-protein production as it offers many advantages such 
as high transfection yields with most gene transfer vehicles, simple adaptation to growth 
in suspension culture, and adaptation to serum free-media (Garnier et al. 1994; Graham 
1987). Moreover, the cells can be efficiently transfected in suspension using low-cost 
vehicles such as polyethylenimine (Durocher et al. 2002; Pham et al. 2003; Schlaeger 
and Christensen 1999; Schlaeger et al. 1998a; Schlaeger et al. 1998b) or calcium-
phosphate (Girard et al. 2002; Jordan et al. 1998; Jordan et al. 1996; Jordan and Wurm 
2004; Meissner et al. 2001; Pick et al. 2002; Wright et al. 2003).  
Several different cell lines have been derived from the HEK293 parent. The two 
most popular variants for transient expression are HEK293T, expressing the SV-40 
large T antigen (Kim et al. 1997) and HEK293-EBNA, expressing the nuclear antigen 
from Epstein-Barr virus EBNA (Cachianes et al. 1993), that allow episomal 
amplification of plasmids containing the viral SV40 (293T) or EBV (293E) origins of 
replication (Van Craenenbroeck et al. 2000). 
HEK293 cells are also used for virus production, cell cycle research, gene 
expression, metabolism, receptor binding, and other studies. This epithelial cell line was 
derived from primary human embryonic kidney cells that were transformed using 
shared DNA from adenovirus type 5 (Graham et al. 1977).  
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The expression vector 
For high level r-protein expression it is important to use vectors with promoters that are 
highly active in the host cell line, such as the human cytomegalovirus (CMV) or SV40 
promoters. One non-viral promoter, the elongation factor (EF)-1 promoter, has also 
been used because it appears to be as strong as some of the viral promoters (Wurm and 
Bernard 1999). The CMV promoter is particularly powerful in HEK293 cells, where it 
has been shown to be strongly transactivated by the constitutively expressed adenovirus 
E1a protein (Gorman et al. 1989).  
 
The transfection vehicle 
Even though many highly effective gene transfer reagents are commercially available, 
only a few are relatively cheap and are considered for large-scale transfections, namely 
calcium phosphate, polyethylenimine (PEI) and electroporation (Wurm and Bernard 
1999).  
Especially the cationic polymer, PEI, exhibits several properties which are 
extremely important for high efficient gene delivery (Boussif et al. 1995; Boussif et al. 
1996). For example, PEI-mediated transfection methods are highly efficient in a broad 
range of different cell lines and the cationic agent shows a low level of cell toxicity, it is 
simple to use and is effective in suspension cultures. Moreover, it is cheap and therefore 
useful for scale up experiments (Durocher et al. 2002; Pham et al. 2003; Schlaeger and 
Christensen 1999; Wurm and Bernard 1999). This polymer is available in both, linear 
and branched isoforms with a wide range of molecular weights and polydispersities 
(Godbey et al. 1999). Boussif et al, (1995 and 1996) described PEI with a high cationic-
charged-density potential. This cationic charge density is due to the presence of a 
potentially protonable amino nitrogen at every third atom which may participate in 
DNA condensation. These protonable amino groups may also play a protective role in 
preventing DNA degradation in cytoplasmic endosomes as it has a high pH-buffer 
capacity. The so-called proton sponge effect was postulated to cause an early escape of 
DNA:PEI complexes from lysosomes, thus avoiding lysosomal degradation (Fig. 
1.3.2a). 
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The culture medium 
Some gene transfer reagents work only in serum-free medium whereas others are 
insensitive to the presence of serum, moreover, serum significantly increases the 
expression of r-proteins (Durocher et al. 2002). Also, the presence of cellular by-
products in conditioned medium is associated with poor transfection yield. Hence, it is 
often necessary to perform a complete medium exchange prior to transfection 
(Schlaeger and Christensen 1999). However, this step does not satisfy the need for a 
robust large-scale transient transfection process. Additionally, in the production of 
secreted proteins, serum greatly interferes with their subsequent purification.  
Moreover, numerous problems are associated with the presence of serum in culture. 
These are possible contaminations by infectious microorganisms which may be present 
in the serum, or by serum proteins, as well as the high cost and the batch-to-batch 
variability (Broad et al. 1991; Butler 1986). 
Many commercially available serum-free media have been developed for HEK293 
cells; however many of them do not support good transfection when using PEI and their 
cost-effectiveness is rather questionable (Pham et al. 2003). In addition, serum-free 
media offer the advantage of lowering the burden on purification of the r-proteins.  
1.4 Monitoring of cultivation process 
Monitoring and control of the cellular physiology is one of the great challenges in 
bioprocess engineering today. Unexpected variations in cell behavior often accompany 
fermentation processes due to unknown reasons. These variations strongly influence 
Fig. 1.3.2a: Mechanism of gene transfer into eukaryotic cells by PEI:DNA complexes (taken from: 
www.qbiogen.com, modified). 
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process efficiency and therefore require adequate monitoring and control. Controlling 
the bioprocess at its optimal state enables the reduction of production costs, increases 
the yield and at the same time maintains the quality of the desired product. In general, 
bioprocesses are difficult to control. The main problem results from the inability to 
properly influence the cells internal environment by manipulation of their external 
environment. Several other factors further contribute to the control problem, such as the 
non-linear behavior of the cell, the highly complex metabolic network and that reliable 
methods for process state characterization are rarely available. 
The particular control concept has been referred to as physiological state control, 
which was first proposed by Konstantinov and Yoshida (1989). Here, the physiological 
state of the cell culture is quantified by process variables that provide information about 
the status of the cells. Normally, these variables are specific metabolic rates or 
metabolic rate ratios. Despite the fact that today many of those variables can be 
measured on-line with commercially available sensors, this control strategy has not yet 
been implemented as a standard in industrial bioprocesses.  
There are many aspects which contribute to the term “cell physiology”, as was 
defined by Grammatikos et al (1999). This term should mean the balance of all 
intracellular metabolic, growth-promoting and growth-inhibiting events, which result in 
cell growth and viability (or in growth arrest and/or cell death). Without cells in good 
physiological state, rapid growth without lags cannot be achieved, resulting in 
excessively long and, hence, costly pre-production scale-up steps. Cells in poor 
physiological state may not respond favorably to stress. Therefore, cell physiology 
should play the central role in a successful process development. Intracellular 
nucleotides were found to present one of the most valuable targets as they reflect the 
exact physiological state of a culture (Ryll and Wagner 1992). Therefore, nucleotides as 
a tool of monitoring bioprocess off-line will be discussed in detail later (see under 1.4. 
1). 
On the other hand, on-line monitoring of the physiological state of a cell culture is 
the method of choice but difficult to realize. For resolving the physiological state of a 
cell culture, one would have to incorporate several different sensors in the monitoring 
set up. However, a typical production scale set up often includes dissolved oxygen, pH 
and temperature sensors, and eventually a mass spectrometer (Heinzle 1992). Sensors 
for the determination of nutrient, metabolite and product concentrations, like biosensors, 
gas chromatography, HPLC, flow-injection and others, require sophisticated sterile 
liquid sampling systems and are therefore difficult to integrate into an existing reactor 
set up (Bachinger 1999). In the last years, the use of an electronic nose device, a 
combination of gas sensor arrays and pattern recognition techniques to simulate the 
human olfactory sense, has been used for bioprocess monitoring (Mandenius et al. 
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1997) solving some of these problems discussed above. The use of an electronic nose in 
bioprocesses monitoring will be discussed in detail under section 1.4.2.   
1.4.1 Nucleotides and bioprocess control 
Although only a small number of different cell lines are used regularly by the 
biotechnology industry, it is extremely important to realize that every recombinant cell 
is different. Every cell line has specific demands on the nutrient composition and the 
process control has to involve the measurement of several parameters with different 
uptake and secretion rates (Ryll and Wagner 1992). Moreover, the expression vectors, 
the transfection, cloning, and selection process, and the recombinant product of interest 
itself lead to as many different phenotypes as there are recombinant proteins. Because 
of this, universal culture conditions and universal production processes does not exist. 
For every new cell and product, often extensive process development has to be done for 
achieving maximum productivity and minimum costs (Grammatikos et al. 1999). The 
development and optimization of bioprocesses and the control of cellular growth is 
generally performed by the determination of specific nutrients such as glucose, 
glutamine, and sometimes other essential amino acids as well as secreted waste 
products, especially lactate and ammonia. The information provided is useful but often 
incomplete because it gives rare information about the state of the cells at the time of 
sampling and allows no reliable prediction. Cell counting allows only a post factor 
assessment of the cell state because the extent of cell proliferation measured at any 
given time point reflects the outcome of the respective pre-existing physiological 
condition. Due of these limitations, an exact reliable prediction of the growth behavior 
of a culture based on cell concentration measurement is not yet possible. The cellular 
viability, the most valuable parameter at present, is only an end result of intracellular 
physiological processes; a viability of x % does not reveal anything about the state of 
the remaining viable cells (Grammatikos et al. 1999). 
Nucleotides have shown to be one of the most important substances for cell 
metabolism. They are involved in a number of cellular processes and have widespread 
regulatory potential. They participate as substrates, products, effectors, or energy 
donators in many cellular reactions. Additionally, fluctuations of pool size could affect 
alterations in transport processes, macromolecular synthesis, and cell growth (Hauschka 
1973). Some evidence had been found supporting the idea that the pool size of ATP, the 
adenylate energy charge (AEC) or the pool size of UTP are, either influenced by or 
depended on the cell cycle (Rapaport et al. 1979), the stimulation of cells by serum or 
hypoxanthine (Grummt et al. 1977) or colchicine (Chou et al. 1984). Additionally, in 
plant cells a specific variation of the intracellular concentrations of nucleotides has been 
shown to be dependent on the growth cycle (Wylegalla et al. 1985). 
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 Ryll and Wagner (1992) described the sensitivity of certain ratios of nucleotide 
triphosphates in responding to physiological changes of BHK and hybridoma cells and 
showed these parameters being useful in monitoring and control of production 
processes. In particularly, three combinations gave characteristic responses: the ratio of 
the sum of purine trinucleotides and pyrimidine trinucleotides (PurTP/PyrTP = NTP = 
[ATP + GTP]/[UTP + CTP]), the U ratio expressed as the quotient of UTP and UDP-
GNAc (UDP-GNAc = sum of N-acetylated UDP-activated sugars) (UDP-GlcNAc + 
UDP-GalNAc) and the combination of both parameters NTP ratio/U ratio. The NTP 
ratio can be thought of as a measure of metabolic energy (represented by ATP + GTP) 
versus growth potential (represented by UTP + CTP) and is found to increase as a 
culture progresses, mainly due to notable decreases in UTP and CTP as cells enter the 
reduced exponential and eventually the stationary phase (Grammatikos et al. 1999; Ryll 
and Wagner 1992). The U ratio can be regarded as an argument of the growth energy 
versus the accumulation of ammonia which contributes UTP to the formation of UDP-
GNAc (Ryll et al. 1994). Furthermore, when the U ratio decreases culture conditions get 
worse, mainly due to decreasing UTP concentrations and further due to an increase of 
the UDP-GNAc pool (due to accumulation of ammonia). Finally, the NTP/U ratio 
amplifies the NTP and U ratios and is, therefore, a very sensitive parameter which 
increases dramatically, compared to the increase of the NTP and the decrease of the U 
value. Increase in the NTP/U ratio can be taken to identify a worsening in cellular 
physiology and growth potential. These intracellular parameters have many 
applications, not only in the monitoring and the control of production processes but also 
in the development of efficient cell culture processes (Grammatikos et al. 1999).  
1.4.2 Electronic nose and bioprocess control 
Monitoring bioprocess parameters on-line is a method of choice. Apart from 
continuously being able to sample data by automatically programmed procedures, it is 
not necessary to take a sample manually which is time-consuming on the one hand and 
brings the necessary information about the process with time-shifting on the other hand.     
The concept of the electronic nose, the combination of gas sensor arrays and pattern 
recognition techniques to model the human olfactory sense, was first proposed by 
Persaud and Dodd in 1982. Since then, this concept has been applied to a variety of 
applications with the main focus on the classification of the flavor of beverages or 
foodstuffs (Gardner and Bartlett 1994). Other examples of its applications are the 
analysis of medication off-odors (Schiffman et al. 1997), diabetes diagnosis (Ping et al. 
1997) and the identification of microorganisms (Gardner et al. 1998; Gibson et al. 
1997). 
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The use of the electronic nose for bioprocess monitoring was first evaluated by 
Mandenius et al., 1997 and Namdev et al., 1998. Mandenius et al. used a metal oxide 
sensor based electronic nose to explore the possibility of monitoring ethanol and 
biomass on-line in production scale baker’s yeast fermentations. Namdev et al., applied 
a polymer sensor based instrument to detect abnormalities like variability in media 
composition in bioprocess. The potential of non-invasive chemical sensor arrays has 
been also shown in key process variables such as biomass and specific growth rate in 
Escherichia coli, as well as ethanol and glucose concentrations in Saccharomyces 
cerevisiae batch cultivations, which were estimated on-line with high accuracy 
(Bachinger et al. 1998b; Bachinger et al. 1998a). This technology had been applied for 
on-line monitoring of state transitions in perfusion culture of a CHO cell line producing 
recombinant human blood coagulation factor VIII in which it was possible to identify 
characteristic process states and visualize transitions related to product and lactate 
formation (Bachinger et al. 2000a; Bachinger et al. 2000c) and identify early 
contamination (Bachinger et al. 2002). 
One limitation to on-line monitoring is often the need of instruments that endure 
heat sterilization still maintaining their sensor stability, reliability and sensitivity. For 
this reason it is most commonly found that parameters important for describing the 
cellular state are related to off-line sampling and off-line analysis and hence information 
is only obtained with a low sampling frequency (Bachinger and Mandenius 2000b). 
An electronic nose prototype called BioNose (EU BioNose Project QLK3-CT-1999-
00435) has been built according to a similar principle as the human nose. The nose uses 
an array of non-specific sensors that give a different pattern when exposed to different 
odors or gaseous emissions. The broad and overlapping sensitivities of the sensors in the 
array produce a flow of signals very rich in information. The signal pattern is the unique 
"fingerprint" of the emission produced by the measured object that is analyzed by the 
pattern recognition system. The system is trained to recognize a given emission with the 
help of a pattern recognition algorithm or other types of advanced mathematical 
algorithms. These methods together with unique combinations of sensors constitute the 
strength of the electronic nose technique.  
An array of chemical gas sensors – including typically conducting polymers, metal 
oxide semiconductors (MOS), metal oxide semiconductor field efficient transistors 
(MOSFET) or quartz microbalance sensors – are combined (Dickinson et al. 1998; 
Mandenius 1999). Every sensor is by itself more or less unspecific to the measured gas 
mixture and the information is instead revealed by studying the complex total response 
pattern from the whole array.  
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MOS sensors: The device is based on the properties of semiconducting metal oxides. 
Thin films of materials, like tin oxide and copper oxide, change their conductivity in the 
presence of reducing or oxidizing gases.The selectivity and sensitivity of the surface are 
modulated by oxide composition, amounts of trace elements, e.g. palladium, platinum, 
gold or rhodium, and by operating temperatures, usually in the range between 100 and 
400 °C. Oxygen in the air is adsorbed onto the sensor surface, removing electrons from 
the conduction band of the semiconductor, thereby increasing its electrical resistance 
and leading to a decreased conductivity of the device. The interaction of reducing gases 
with the surface-adsorbed oxygen decreases this electron trapping, leading to 
characteristic increases in electrical conductance of the sensor (Fig. 1.4.2a). 
The MOS sensors exhibit varying sensitivity towards organic compounds and the 
analyte affinity to the surface is more or less affected by its chemical properties. 
Examples of typical analytes to which selectivity can be attained are hydrogen, carbon 
monoxide, ammonia, hydrogen sulfide, nitrogen oxide, sulfurous compounds, alcohols, 
and hydrocarbons (Bachinger 1999; Dickinson et al. 1998; Mandenius 1999; Persaud 
and Dodd 1982).  
 
 
 
 
MOSFET sensor: These metal oxide semiconductor field effect transistor devices can 
be built as capacitors and transistors. The semiconductor is normally silicon and the 
insulator silicon dioxide. A number of organic and inorganic compounds can be 
catalytically decomposed on such a surface resulting in dipoles that cause shifts in the 
capacitance of the semiconductor device. The working principle relies on the fact that 
the charge distribution at the insulator-semiconductor interface can be controlled by a 
Fig. 1.4.2a: Design and principle of a MOS-sensor (from Nordic Sensor Technology (NST) Senstool 
manual, 2000). 
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potential on the metal gate. As metal gates, continuous layers of palladium, or thin 
discontinuous layers of catalytic metals like platinum, iridium, rhodium and palladium 
are used. A schematic illustration of a MOSFET sensor is shown in figure 1.4.2b.  
The principle of operation is that hydrogen atoms from dissociated hydrogen 
molecules on the catalytic metal surface, diffuse through the gate and adsorb at the 
metal-insulator interface where they give rise to a dipole layer or electrical polarization. 
Devices with thick continuous metal gates are merely sensitive to hydrogen atoms, 
whereas devices with discontinuous gates are sensitive to e.g. ammonia, ethanol, 
hydrogen, sulfurous hydrogen and unsaturated hydrocarbons.  
The selectivity of the MOSFET sensors is modulated by using different catalytic 
metals, e.g. palladium, iridium, platinum and by the operating temperature (< 250 °C). 
Different compositions of the metals, different thickness and different working 
temperatures result in a large number of different selectivity patterns towards given gas 
mixtures. This sensor type is therefore of great interest in sensor arrays used to analyze 
complex gas mixture or odors (Bachinger 1999; Dickinson et al. 1998; Mandenius 
1999; Winquist et al. 1993).  
 
 
 
Typical sizes of a sensor array for electronic noses are 20 to 40 sensors. A set of 
different signal types (response, on/off derivative, on/off integral) can be obtained with 
these arrays. Using multivariate methods such as principal component analysis (PCA), 
partial least squares (PLS) and/or artificial neural networks (ANN) it is possible to 
analyze the signal pattern and identify important sensor responses. Furthermore, these 
methods can be used to build predictive models for various substances (Mandenius 
1999).  
Fig. 1.4.2b: Structure of a MOSFET-sensor.
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The principle of monitoring a bioprocess using an electronic nose is illustrated in 
figure 1.4.2c. The gaseous emissions from the culture in the bioreactor are sampled 
continuously (on-line) from the gas exit of the bioreactor and are exposed to the sensor 
array of the electronic nose without violating the sterile barrier. The signal response 
generated by the array is analyzed by pattern recognition and correlations are sought 
that have significance for the bioactivity of the culture. These correlations include 
metabolite concentrations, cell viability, contaminating species and other relevant 
process variables. The pattern-recognition methods used have a key role in electronic-
nose technology. For example, in the main static pattern-analysis techniques, PCA 
(1.4.3.1), PLS, cluster analysis and ANN are used today (Bachinger and Mandenius 
2000b). 
 
Fig. 1.4.2c: Process monitoring the electronic nose. Sample-containing emissions from cells or the 
medium in the bioreactor are withdrawn from the headspace volume of the bioreactor and transferred 
to the gas-sensor array of the electronic nose. Signals are generated in the array, which are analysed 
by pattern recognition using, for example, an artificial neural network (ANN) model. An ANN can 
quantify or qualify important culture variables, such as metabolic activity, biomass and nutrient 
concentrations (Bachinger and Mandenius 2000b). 
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1.4.3 Multivariate analysis 
When the human brain is confronted with large data sets, for example more than 20 
variables from various numbers of measurements, it has at first great difficulty just 
getting an overview of all the presented information followed by problems in filtering 
out what parts are really essential and informative (Unscrambler user Manual, 1998). 
Multivariate analysis simplifies the problem such that data can be viewed in a better 
way (NST Senstool manual, 2000).  
1.4.3.1 Principal component analysis (PCA) 
PCA can be seen as the basis of multivariate analysis. It is a method for 
approximating or reorganizing large data sets in a way that the most important 
information is compressed and can be presented in few very informative plots without 
loosing important information on the way. Mathematically PCA can be seen as a 
method for reducing the dimensions of the original problem. PCA operates by finding 
directions in the sensor space where a data set has maximal variation. These directions 
are called principal components (PCs). The PCs are calculated in order of importance. 
The first PC explains as much of the variance in the data set as possible. The second PC 
is orthogonal to the first and explains as much as possible of the variance that is not 
explained by the first PC. This continues until no variance remains in the data set (NST 
Senstool manual, 2000).  
In other words, having K measured variables and N measured samples, this can be 
seen as a K-dimensional room with N data points. The PCA will rearrange this K-
dimensional space into a new vector room build p of new variables called principal 
components (PCs). These PCs are linear combinations of the original variables and 
chosen in such a way that they create favorable mathematical properties, which in turn 
have shown to be very informative as well. The strength of the method is that most of 
the original information can be captured using only a few PCs and the remaining 
variation described by higher PCs will originate from non-systemic variations or noise 
(Wold 1987). 
Figure 1.4.3.1a; A, B and C, illustrate the computation principles for a principal 
component analysis with two PCs (PC1 and PC2) based on three sensors signals (from 
NST Senstool manual, 2000). 
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Fig. 1.4.3.1a; A, B and C: Illustration of the computation principles for a principal component 
analysis with two principal components (PC1 and PC2) based on three sensors signals. The first PC 
explains as much of the variance in the data set as possible. The second PC is orthogonal to the first 
and explains as much as possible of the variance that is not explained by PC1 (from NST Senstool 
manual, 2000). 
A
B
20 1.  Introduction  
 
The results obtained from PCA are usually visualized in so called score and loading 
plots. The scores are the original data points, the measuring points, projected onto the 
new PCs while the loading plots describe the contribution the original variable has to 
the new PC. These PCs are obtained by projection of these original variables onto the 
new PC coordinate system. A score plot shows a condensed view of all measurement 
points in a data set, which is much easier to interpret than a whole collection of raw data 
bar charts. Since the scores contain information on the measurements, the score plot can 
be used to explore the relationships between different measurements, such as 
grouping/spreading of measurements on samples with similar/ different properties, 
outliers, and systematic errors including drifts (Fig. 1.4.3.1b; A). The loading plot 
contains information about the influence of the original variables on each PC, thus it can 
be used to explore the relationships between different variables. One important property 
is that variables arranged along the same direction in a loading plot give similar 
information. Another is that variables close to the origin give very little information 
(Fig. 1.4.3.1b; B) (NST Senstool manual, 2000).  
 
 
     
 
C
Fig. 1.4.3.1a. (Continued)
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Fig. 1.4.3.1b: Illustration of a score plot (A) and loading plot interpretation (B) (from NST Senstool 
manual, 2000). 
 B 
A
22 1.  Introduction  
1.5 Problems in production of large amounts of r-proteins- Aims of 
the work 
The development of industrial cell culture processes for the production of commercially 
relevant recombinant proteins is governed by constraints that pertain to issues such as 
cost, human resources, competitiveness, and the meeting of project timelines. Usually, 
the time allowed for proper process development is rather short, and in this time culture 
conditions and scale-up protocols have to be defined in such a way to maximize cell 
productivity and to minimize process length and overall cost. Due to high demand, the 
need for faster and cheaper approaches for the production of recombinant products is 
evident (Grammatikos et al. 1999; Wurm and Bernard 1999). The consideration of 
transient system for production of milligram to gram quantities of protein is rather new 
and it is now generating great interest because of its demonstrated ability to produce 
large amounts of r-proteins within a few days (Durocher et al. 2002; Girard et al. 2002; 
Jordan et al. 1998; Meissner et al. 2001; Pham et al. 2003; Schlaeger and Christensen 
1999). However, there remains a high demand for simplification or reduction of 
handling steps, and reduction in the amount of DNA especially for large-scale 
transfection and the complete elimination of serum, proteins and undefined components 
from the production process. 
Monitoring and control of the cellular physiology, and through this, control of 
bioprocess also is important to have success in a proper process development and it is a 
great challenge in bioprocess engineering. As was mentioned under section 1.4, 
bioprocesses are generally difficult to control due different and several factors. 
 
Considering the problems mentioned above, this work was focused in the 
following aims: 
 
o First, development of a transient transfection process easy to perform, cost-
effective, for large-scale application using the mammalian cells, HEK293 in 
suspension (HEK293s), comprising the development and optimization of a 
chemically defined medium to produce cultures totally free of serum and animal 
proteins or animal-origin components. 
 
o Second, characterization and optimization of this transfection process using 
two different methods:  
 
a) Determination of the intracellular nucleotide ratios, which reflect the 
physiological state of mammalian cells, prerequisite for a successful 
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production process, and therefore, evaluate the HEK293s cells metabolic 
energy and growth potential with respect of increasing productivity. 
 
b) The use of the electronic nose, BioNose, for on-line monitoring to 
characterize and optimize transfection process.  
 
To achieve the first aim, the initial experiments of this work show results towards 
the adaptation of HEK293s cells either to serum-free or protein-free media formulations 
to guarantee chemically defined culture conditions for further transient transfection 
processes. This has implicated the development of a serum/protein-free medium that 
facilitates the transient transfection procedure, avoiding washing of cells prior to the 
addition of the transfection complex and without changing the medium after the 
procedure.  
Once that cells were adapted to the developed medium, further experiments were 
performed to optimize the DNA:PEI ratio in order to obtain highest transfection 
efficiencies using less amount of DNA.  
 
To achieve the second aim of this thesis work, analysis of the intracellular 
nucleotide ratios was applied to the characterization of the HEK293s cells from an early 
and a late passage number, transfected and untransfected, either cultivated in serum-
containing and serum-free media. This method gives information about the cell 
metabolic energy under different culture conditions, guiding the optimization of the 
transfection process towards an increase in the cell productivity. 
 
On the other hand, on-line monitoring using a prototype electronic nose, BioNose, 
has been applied to investigate its use as a reliable tool for process characterization, 
monitoring the cell cultivation and distinguishing between different process conditions.
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2. Materials and Methods 
All standard chemicals used were of reagent grade, and purchased from Sigma 
(Deisenhofen, Germany), Difco Laboratories (Detroit, MI, USA), Merck (Darmstadt, 
Germany), Serva (Heidelberg, Germany), Riedel-de-Haen (Seelze, Germany), Fluka 
(Buchs, Switzerland), J.T. Baker (Griesheim, Germany) if not specified. 
All the solutions were prepared in ultra pure water obtained from the water system 
Super-Q™ (Millipore GmbH, Eschborn, Germany). 
2.1 Equipments used 
The equipments used in this work are described in the table 2.1a. 
Equipment Manufacturer Model Others 
Autoclave Souter Moller GmbH, 
Köln, Germany. 
Sterilizer  
Autoclave (barrel) Webeco GmbH, Bad 
Schwartau, Germany. 
83343 - Sterilizer  
Cell count chamber Assistent, Germany. Neubauer 
Improved 
0,0025 mm² 
0,1 mm depth 
Cell counter CASY 
1 
Schärfe System 
GmbH, Reutlingen, 
Germany 
Model TTC  
Centrifuge 
(Eppendorf) 
Heraeus, Kendro 
Laboratory products, 
Hanau, Germany 
Omnilab Biofuge 
pico 
 
Centrifuge (conic 
tubes) 
Heraeus, Kendro 
Laboratory products, 
Hanau, Germany 
Digifuge GL  
Electroporator 
 
Bio-Rad Laboratories, 
Life Science 
Research, Hercules, 
CA, USA 
1-Gene pulser II 
2- Pulse controller 
plus 
3-Capacitance 
extender plus 
 
ELISA reader SLT Lab instruments, 
Crailsheim, Germany 
340 ATTC Software: Easy 
WIN basic. 
Ver.1.0b 
Flow cytometry Becton Dickinson, 
Bedford, MA, USA 
FACSCalibur CellQuest Pro 
software 
Table 2.1a: Equipments used in this work. 
25  2.  Materials and Methods 
 
Equipment Manufacturer Model Others 
Fine balance Sartorius AG, 
Göttingen, Germany 
Analytic A 200 S  
Gas mix station MKS Instrument 
Deutschland GmbH, 
München, Germany 
BS 931 A  
Gel-Analysis Bio-Rad Laboratories, 
Life Science 
Research, Hercules, 
CA, USA 
Gel Doc 2000 Quantity One 
software 
Glucose-Lactate-
Analyzer 
YSI 2700, Yellow 
springs instruments, 
Ohio, USA 
Select 
biochemistry 
analyzer 
Glucose and 
Lactate membranes
Incubator Forma Scientific, 
Labotec GmbH, 
Göttingen, Germany 
CO2 incubator 
Model 3028 
 
 Heraeus, Kendro 
Laboratory products, 
Hanau, Germany 
CO2 incubator, 
Cytoperm 8080 
 
Ion pair reversed-
phase HPLC 
Kontrom Instruments, 
Milan, Italy 
  
Balance Sartorius AG, 
Göttingen, Germany 
LC 2201 P  
Microscope Nikon, Düsseldorf, 
Germany 
Inverse 
microscope 
Diaphot 
 
Microtiter plate 
reader  
Labsystems 
Multiskan, Finland 
MCC/340  
Mini gel chamber  GIBCO BRL, Life 
Technologies, 
Gaithersburg, MD, 
USA 
HORIZON®58  
Osmometer KNAUER, Berlin, 
Germany 
Semi-micro 
osmometer type 
Dig.L 
 
pH-Meter Knick, Berlin, 
Germany 
761 Calimatic  
Power source Bio-Rad Laboratories, 
Life Science 
Research, Hercules, 
CA, USA 
Power-PAC 300  
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Equipment Manufacturer Model Others 
Refrigerated 
centrifuge  
Heraeus, Kendro 
Laboratory products, 
Hanau, Germany 
Multifuge 3 S-R  
Shaker B.Braun AG, 
Melsungen, Germany
Certomat  
Spectrophotometer Amersham Pharmacia 
Biotech, Upsala 
Sweden 
Ultraspec 3100 
pro 
UV/Visible 
Spectrophotometer
 
Spinner tableau 
(biological stirrer) 
Wihl O. Schmidt 
GmbH, 
Braunschweig, 
Germany 
Techne, MCS-
1045 
 
Sterile clean-bench Heraeus, Kendro 
Laboratory products, 
Hanau, Germany 
LaminAir 
HLB 2472 
 
Tubes pump Millipore 
Corporation, Bedford, 
MA, USA 
Masterflex L/S 
easy load 
 
Ultracentrifuge Sorvall Instruments, 
Kendro Laboratory 
products, Hanau, 
Germany  
RC5C Rotor: GSA and 
SS-34 
UV-light 
(equipment) 
Herolab, Molekulare 
Trenntechnik, 
Wiesloch, Germany 
RH-5  
Video copy 
processor 
Herolab, Molekulare 
Trenntechnik, 
Wiesloch, Germany 
  
Vortex Scientific Industries, 
INC 
Bohemia, NY, USA 
Vortex Genie 2  
Water bath Kottermann, Uetze-
Hänigsen, Germany 
Type 3042  
Water bath: 
circulators 
LAUDA Dr. Wobser 
GmbH & CO.KG 
Königshofen, 
Germany 
Type RC 6 CP  
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2.2 Materials used  
The materials used in this work are described in the table 2.2a. 
Article Manufacturer Specification 
Cell culture flask BD Biosciences, Bedford, MA, 
USA 
Tissue culture flask 0.2 µm 
vented blue plug seal cap 
Conic tubes Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
50.0 mL polystyrene conical 
tube 
 Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
15.0 mL polystyrene conical 
tube 
Cryogenic tubes Nalge Company, Rochester, 
NY, USA 
Nalgene Cryoware, 
Cryogenic vials 
Eppendorf tubes Eppendorf AG, Hamburg, 
Germany 
Eppendorf tubes: 1.5 mL 
2.0 mL 
FACS-tubes Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
5.0 mL polystyrene round-
bottom tube 
Filter for tube pump Pall Gelman Laboratory, Ann 
Arbor, MI, USA 
AcroCap 0.1 µm 
Freezing container 
cells, NALGENE  
“Mr. Frosty” 
Nalge Company, Rochester, 
NY, USA  
 
Glass flasks Schott Glass, Mainz, Germany 40.0 mL, 500.0 mL, 1000.0 
mL, 2000.0 mL, 5000.0 mL, 
10000.0 mL 
Micro pipettes Gilson, Inc., Middleten, WI, 
USA 
P2, P10, P20, P100, P200, 
P1000 
Pipette Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
Serological pipette 
Polystyrene 
Pipettes tips Sarstedt, Nümbrecht, Germany Pipette-tips 200 µL 
 Greiner GmbH, Esslingen, 
Germany 
Bio-one pipette-tips 1000 µL 
Plasmid extractions 
kits 
Qiagen GmbH, Hilden, 
Germany 
QIAprep spin miniprep kit 
  QIAGEN plasmid maxi kit 
  QIAGEN plasmid giga kit 
  QIAquick gel extraction kit  
Table 2.2a: Materials used in this work.
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Article Manufacturer Specification 
Poly-propylene 
membrane tubing 
Akzo Nobel, Wuppertal  
Reactor ISOTHERM, Karlsruher 
Glastechisches Werk (KGW), 
Germany 
1.6 L 
Spinner flask Techne, Cambridge, UK 150.0 mL flask 
  1000.0 mL flask 
Syringes Omnifix-F, B.Braun, 
Melsungen, Germany 
1.0 mL 
50.0 mL 
Syringe filters Pall Gelman Laboratory, Ann 
Arbor, MI, USA 
Acrodisc syringe filter 0.1 µm 
Supor membrane 
  Acrodisc syringe filter 0.2 µm 
Nylon membrane, DMSO 
safe 
 Millex®-HV, Millipore 
Corporation, Bedford, MA, 
USA 
0.22 µm filter, PVDF 
(Durapore) 
   0.45 µm filter – 4 mm 
Well-plates Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
12-well polystyrene non- 
tissue culture treated plate 
  96 well tissue culture plate, 
flat bottom with low 
evaporation lid 
 Nalge Nunc International, 
Rochester, NY, USA 
Nunc- Immuno™96 well™ 
plates 
 
2.3 Cell line and bacterial strains 
2.3.1 Cell line 
o Human embryonic kidney 293 cells: 
All the experiments were performed using human embryonic kidney cell line 293 
(HEK293). A cell line derived from ATCC no. CRL 1573 adapted to grow in 
suspension (HEK293s) (Coté et al. 1998; Garnier et al. 1994).  
These cells were kindly provided by Dr. Amine Kamen (Animal Cell Technology 
and Downstream Processing Group, Biotechnology Research Institute, National 
Research Council Canada, Montreal, Canada).  
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2.3.2 Bacterial strains 
o Escherichia coli JM109 competent cells, high efficiency (Promega, USA). 
o Escherichia coli XL 1 Blue, competent cells (Stratagene, USA). 
2.4 Culture media 
When the medium was prepared in the laboratory, sterilization was done by filtration 
through a 0.1 µm pore diameter filter. The additives were added to the different media 
following manufacturer’s instructions. Supplements were first sterilized. In all cases, 
culture media were tested for sterility by incubating at 37 °C for three days and stored at 
4 °C. 
FCS (from Sigma or Biochrom, KG, Berlin, Germany) was heated by incubation in 
a water bath at 56 °C for 1 h for complement inactivation and further stored at 4 °C.  
2.4.1 For mammalian cells: 
o DMEM -Ca2+ (GBF). Homemade calcium-free DMEM was used as basic 
medium. When necessary, DMEM was supplemented either with FCS, vitamin solution 
(Vit.; MEM Vitamin solution 100 ×; Sigma, Catalogue no. M6895) or Pluronic F-68 
(Pl.; Sigma). The medium chemical composition is described in Table A1 in the 
Appendix section. 
 
o Gene Therapy Medium-2. Serum-free (Sigma, Germany; Catalogue no. G0791). 
Medium containing small amounts of recombinant proteins and polypeptides derived 
from plant protein hydrolysates. It contains no animal-derived proteins.  
 
o Pro 293s-CDM (BioWhittaker, UK; Catalogue no. 12-765Q). Chemically 
defined medium, containing only one protein, r-Insulin. It is optimized for high-density 
production cultures.  
 
o CD 293 (Gibco, Invitrogen™, life technologies, Germany; Catalogue no. 11913-
019). Chemically defined serum- and protein-free medium. It has been formulated 
without components of human or animal origin.  
 
o 293 SFM II (Gibco, Invitrogen™, life technologies, Germany; Catalogue no. 
11686-029). A defined, serum-free medium formulated without human or animal origin 
components. It has a low protein content (10 mg L-1). For specific experiments, this 
medium was supplemented with 1 mmol L-1 Asp, 150 µmol L-1 His, 500µmol L-1 Thr 
and 100 µmol L-1 Trp. (see results section 3.1.1) 
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o FreeStyle™ 293 Expression Medium (Gibco, Invitrogen™, life technologies, 
Germany; Catalogue no. 12338-026). Serum- and protein-free medium specifically 
developed to support the growth and transfection of FreeStyle 293-F cells grown under 
a suspension-type culture conditions. The L-Glutamine substitute, Glutamax-1, was 
present in the medium. 
 
o Opti-MEM® I (Gibco, Invitrogen™, life technologies, Germany) (Catalogue no. 
31985-047). Medium contains low serum concentration and low protein content. 
 
o Hybridoma-SFM (H-SFM) (Gibco, Invitrogen™, life technologies, Germany; 
Catalogue no. 12045-076). Serum-free and low protein medium for hybridoma growth 
and monoclonal antibody production. For specific experiments, this medium was 
supplemented either with Pl., lipids (Lip.; Sigma) or EDTA as is described in the Table 
A2 in the Appendix. 
 
o SMIF 7 (GBF, Braunschweig, Germany). Chemically defined and protein-free 
medium developed for BHK-21 cell culture. Details about its composition are in 
http://www.gbf.de/eu/index.htmL. 
 
o Ex-Cell 293™ (JRH Biosciences, KS, USA; Catalogue no. 14570). Serum-free 
and animal-protein free medium developed for the long-term growth of HEK293 and 
related cells.  
 
o ExCell 293™ modified (JRH Biosciences, KS, USA; Catalogue no. 81079). This 
medium has the same characteristic as Ex-Cell 293™ (JRH Biosciences, KS, USA; 
Catalogue no. 14570) but it does not contain dextran sulfate. 
 
o FS:DMEM (GBF, Braunschweig, Germany). This medium was developed 
during this thesis work (see details under 3.5.3 and 3.6.1). Briefly, it was a mixture of 
FreeStyle™ 293 Expression Medium (Gibco, Invitrogen™, life technologies, Germany; 
Catalogue no. 12338-026) and DMEM -Ca2+ + 4 % Vit. (MEM Vitamin solution 100 ×; 
Sigma, Catalogue No. M6895). When amino acids (600 µmol L-1 Asp and 100 µmol L-1 
Glu) were added it was called FS:DMEM + AA. 
 
During this work, many different combinations of media and additives were used. 
Detailed information about each medium will be given for every experiment in the 
respective section. 
31  2.  Materials and Methods 
 
2.4.2 For bacterial culture: 
o LB (Luria Bertani) medium: 10 g L-1 Bacto-tryptone, 5 g L-1 Bacto-yeast extract, 
10 g L-1 NaCl. The components were diluted in Milli Q water and the pH was adjusted 
to 7.0. This medium was autoclaved for 20 min at 121 °C. 
  
o LB-Ampicillin medium: Sterile LB medium was supplemented with ampicillin 
(Sigma) stock solution (50 mg mL-1) to a final concentration of 50 µg mL-1. 
 
o LB-Ampicillin agar: To prepare LB solid medium, 15 g L-1 Bacto-agar was 
added. After sterilizing and cooling, ampicillin was added. The final concentration was 
the same as used for the liquid medium. The medium was mixed, filled into petri dishes 
under the sterile hood and stored at 4 °C. 
 
o LB-Kanamycin medium: Sterile LB medium was supplemented with kanamycin 
to a final concentration of 50 µg mL-1 (stock solution of 50 mg mL-1). 
 
o LB-Kanamycin agar: Same agar as the LB-Ampicillin agar but ampicillin was 
replaced by kanamycin to a final concentration of 50 µg mL-1 (stock solution of 50 mg 
mL-1).  
 
o SOB-medium: 20 g L-1 Bacto-tryptone, 5 g L-1 Bacto-yeast extract, 0.5 g L-1 
NaCl. The components were dissolved in Milli Q water and the pH was adjusted to 7.0. 
This medium was autoclaved 20 min at 121 °C. 
 
o SOC-medium: 50 µL of 2 mmol L-1 Glucose (sterile) and 50 µL of 1 mmol L-1 
Mg-solution (MgSO4 × 7 H2O) were added, just before use, to 5 mL SOB-medium. 
2.5 Culture conditions of HEK293s cells  
2.5.1 Cultivation under serum-containing medium 
The cells were cultured in suspension using spinner flasks in humidified incubators at 
37 °C and 12 % of CO2. 
The spinner experiments were performed either in small spinner flask (150 mL) with 
a maximum working volume of 70 mL, or in big spinner flasks (1000 mL) with a 
maximum working volume of 400 mL. Cells were stirred at 40 rpm in the first 
experiments and further at 80 rpm to avoid aggregates (see result section 3.1.1), on a 
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spinner tableau. Small or big spinners were inoculated at cell concentrations between 
2.0 × 105 mL-1 and 3.5 × 105 mL-1.  
Bioreactor cultivations are explained in section 2.5.4. 
All cultivation were performed in batch mode (Tokashiki and Yokoyama 1997).   
2.5.2 Cultivation under serum-free medium 
The culture conditions were the same as in 2.5.1. However, the initial cell 
concentration was in the range of 3.5 × 105 mL-1 and 5.0 × 105 mL-1.  
Bioreactor cultivations are explained in section 2.5.4.  
2.5.3 Cell clusters disintegration 
To avoid the formation of cells clusters, the cells were vigorously vortexed before being 
inoculated into the appropriate culture flask. The cell inoculum was transferred into a 50 
mL conic flask with 10 mL of the culture and vortexed for 15 to 20 s. The same 
procedure was used for the sub-culturing until the cultures grew as homogenous single 
cells (1 to 3 – 4 passages). Cells were stirred at 80 rpm. 
For cells that were already in culture, the spinner speed was increased from 40 to 80 
rpm and the same procedure as was explained above was followed. 
2.5.4 Bioreactor cultivation 
HEK293s cells were grown in bioreactors using serum-containing and serum-free 
media.  
The cultures were carried out in a stirred tank bioreactor at 37 °C and 40 rpm. A 1.8 L 
bioreactor was used with a working volume between 1.4 L and 1.6 L. 
 The bioreactor was equipped with 7 m of polypropylene membrane tubing to enable 
bubble-free aeration of the culture (Lehmann et al. 1987). The total gas flow was 
adjusted to 100 mL per minute (12.5 % CO2, regulated O2 and N2). Dissolved oxygen 
was measured on-line and maintained at 40 % of air saturation. The electronic nose 
system was connected to the off-gas line of the reactor. For details see section 2.15. All 
bioreactors were inoculated with a starting cell concentration between 2.5 × 105 mL-1 
and 3.5 × 105 mL-1. Batch culture processes were performed. 
Cultures using serum-free medium were carried out under the same conditions as in 
serum-containing medium but using a higher stirring rate (50 to 70 rpm), and a higher 
cell inoculum concentration (3.5 - 5.0 × 105 mL-1). 
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2.6 Adaptation of cells to serum-free culture medium 
The cells from the mid-exponential growth phase with a viability above 90 % (2.14.3) 
were used for adaptation to serum-free culture. Different serum-free media were used as 
explained in detail in the results sections 3.1.1 and 3.5. 
All procedures were performed in small spinner flasks using a working volume of 
50 mL. 
During the adaptation procedure a sample was taken daily to measure the total cell 
number, viability, glucose and lactate, LDH and amino acids concentration (see section 
2.10 and 2.11). 
 
The cells were considered fully adapted to the new serum-free medium when they 
grew as single cells (or small clumps), with a viability of more than 90 % and with 
growth rate similar to those in serum-containing medium. The adaptation time depended 
upon the medium and the protocol used, and it varied from 5 to 10 cell passages (sub-
culture at an initial cell concentration of about 5.0 × 105 mL-1 every time that they have 
reached a cell concentration of 1.5 × 106 mL-1). Different adaptation protocols were 
used:  
2.6.1 Sequential adaptation using cell density effect 
The initial cell concentration was 5.0 × 105 mL-1. Every third day a medium exchange 
was performed by progressive replacing the complete cell volume. This helped to 
achieve a successful conditioning during the adaptation of the cells.   
At the beginning of the culture, the amount of serum was 5 % and the successive 
passage were done in order to have 1 %, 0.2 %, 0.04 % and 0 % serum content, 
respectively. In this last step the cells were washed with the new serum-free medium 
and grew until 1.5 × 106 mL-1. An aliquot of the cells was taken for 
cryopreservation(see section 2.7.1) and the rest of the cells was sub-cultured at a cell 
concentration of 5.0 × 105 mL-1. 
For every medium change, the complete volume was taken from the spinner flasks 
and transferred to conical tubes. A volume of 10 mL was taken from the tube and 
refilled into the spinner flask. The rest of the cell culture was centrifuged (1200 rpm, 3 
min), the supernatant was discarded, and 40 mL of new serum-free medium was added.  
2.6.2 Sequential adaptation with successive cell dilutions 
In this case a progressive medium exchange was performed when the cell concentration 
reached 1.5 × 106 mL-1. Subsequently, the cells were sub-cultured at a cell concentration 
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of 5.0 × 105 mL-1 in a medium containing half of the serum content compared to the 
previous culture. 
Serum reduction was started from a portion of 5 % in the initial cultures to 2.5 %, 
1.25 %, 0.62 %, 0.31 % and 0 %. At this point, cells were washed once with the new 
serum-free medium. As it was described before, when the cells reached a concentration 
of 1.5 × 106 mL-1, a cell bank was deposited, and the cell culture was continued with 
different sub-cultures at an initial cell concentration of 5.0 × 105 mL-1 to 1.5 × 106 mL-1 
until the cells were fully adapted.  
2.6.3 Direct adaptation 
Cells at a concentration of 5.0 × 105 mL-1 growing in serum-containing medium were 
washed one time with the serum-free medium and directly sub-cultured under the new 
conditions. Every time, that the culture reached a cell concentration between 1.5 × 106 
mL-1 and 2.0 × 106 mL-1, the cells were sub-cultured at the same cell concentration as 
the initial inoculum. This sub-culture was repeated between 3 to 6 times until the cells 
were fully adapted. 
2.7 Cryopreservation of cell lines and bacterial strains 
2.7.1 Cryopreservation of cell lines 
Cells were frozen at a rate of 1 °C to 3 °C per minute using cryoprotective additives or 
chemicals to minimizing the detrimental effects of increasing solute concentrations and 
ice crystal formation. A special freezing container “Mr. Frosty” (see table 2.2a) filled 
with isopropanol was used. The cells should have a high viability above 95 %, being in 
the exponential growth phase. The container and the cryoprotectant medium were pre-
incubated at 4 °C. 1.0 × 107 cells were frozen on each vial. Cells were centrifuged (3 
min, 1200 rpm, RT), the pellet was dissolved in the freezing medium and 1.8 mL of this 
suspension were transferred to the cryogenic vials. The vials were immediately 
transferred to Mr. Frosty, and stored at –70 °C for at least one day. Subsequently, they 
were stored in the gas phase of liquid nitrogen at a temperature below –135 °C. 
The different cryoprotector media used were the following: 
 
o Cells growing in DMEM -Ca 2+ + 5 % FCS + 0.1 % Pluronic F68 + Vitamin 
solution: 10 % cryoprotective agents, dimethylsufoxide (DMSO; Riedel-de-Haen, 
Seelze, Germany) + 90 % fresh medium.  
 
o Cells growing in serum free media: 10 % DMSO + 10 % methylcellulose + 80 
% fresh medium. 
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o Cells growing in FreeStyle and (FreeStyle-DMEM) media: 10 % DMSO + 90 % 
of a mixture of conditioned and fresh media (1:1).  
2.7.2 Cryopreservation of bacteria 
The recombinant bacteria were cultivated in LB liquid medium at 37 °C overnight. 500 
µL of the culture was added into a sterile vial with 500 µL of glycerol as 
cryopreservative.It was homogenized and frozen at –70 °C. 
2.8 Revitalization of cell lines and bacterial strains 
2.8.1 Revitalization of cell lines 
To revitalize the cell lines in all different media, the same procedure was applied. The 
cryogenic vial was taken from the liquid nitrogen storage tank and quickly thawed by 
incubating in a water bath at 37 °C for 3 min. The cells were transferred to a conic tube 
with 10 mL of fresh medium, warmed at 37 °C, following centrifugation at 1200 rpm 
for 3 min at RT. The supernatant was discarded and the pellet was resuspended in 10 
mL of warm fresh medium, left for 3 min at RT to allow the diffusion of the DMSO 
from the cells to the media, and centrifuged again in the same conditions as the first 
time. This pellet was resuspended in a definite fresh warm medium volume and counted 
to determine the cell viability and the percentage of cell recovery. 
2.8.2 Revitalization of bacteria  
To recover bacteria, a small inoculum was taken with a loop from the tubes with the 
frozen bacteria. The inoculum was streaked in a LB-agar plate with the corresponding 
selective antibiotic. The tube was again stored at –70 °C and the plate was incubated at 
37 °C overnight. After that, one colony was taken from the plate and inoculated into the 
LB liquid culture medium with the appropriate antibiotic.  
2.9 Master cell bank and work cell bank 
Once the cells were fully adapted to a new medium, a master cell bank was generated.  
Cell viability, growth rate, duplication time (see section 2.14), fungal and bacterial 
contaminations were tightly controlled. When all of these parameters were satisfied, 
cells were expanded. When the cells reached the middle of the exponential growth 
phase, 5 to 10 cryogenic tubes with 1.0 × 107 cells were frozen (see section 2.7.1) and 
this constitutes the master cell bank. One to three tubes from this bank were thawed (see 
section 2.8.1) for quality control, assessing viability, growth rate, population doubling 
time and contamination. Once these tests were satisfactory, cells were cultured as 
mentioned before, and 50 cryogenic tubes containing 1.0 × 107 cells of each one were 
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frozen. This constitutes the working cell bank. The cells to perform all the experiments 
were taken from this cell bank, which guaranteed to work always with cultures in the 
same range of passage number and quality. 
2.10 Cell analysis 
2.10.1 Total cell determination 
Total cell number was assessed using different methods. 
o Nuclei fixation and staining: 0.5 – 1.0 mL of cell suspension were taken, 
centrifuged (3 min, 1200 rpm, RT) and 80 % of the supernatant were replaced with 
crystal violet solution (see below). This solution was homogenized using a vortex for at 
least 1 min, and nuclei were counted with a hemocytometer (Sandford et al. 1951). 
 
Crystal violet solution: 0.1 mol L-1 citric acid, 0.1 mg mL-1 crystal violet and 1 % V 
V-1 Triton X-100. 
 
o Nuclei concentration was assessed by using an automatic cell counter (CASY 1): 
between 0.5 mL and 1.0 mL of cell suspension was taken, centrifuged (3 min, 1200 
rpm, RT) and 80 % of supernatant was replaced with CASY cell extraction buffer (see 
below). The components were dissolved, the solution was heated at 40 °C, sterilized by 
filtration and stored at RT. The pellet was resuspended by vortexing for 30 s. An aliquot 
of this suspension (100 µL) was transferred to 5.0 mL CASY-ton buffer (see below) and 
counted (capillary: 150 µm, span with: 0 – 20 µm).  
 
CASY cell extraction buffer: 21.00 g L-1 citric acid. H2O, 10.01 g L-1 
cetyltrimethylammoniumbromide. 
CASY-ton buffer: 7.93 g L-1 NaCl, 0.35 g L-1 Na2.EDTA, 0.4 g L-1 KCl, 0.22 g L-1 
NaH2PO4 × H2O, 2.45 g L-1 Na2HPO4 × 2H2O, 0.2 g L-1 NaN3 (0.02 %). The buffer was 
filtrated and stored at 4 °C. 
2.10.2 Determination of viable cells 
Viable cells were measured using the Trypan blue exclusion method.  
Briefly, cells were diluted 1:1 or 1:2 with 0.5 % trypan blue solution (Roche 
Diagnostics, Mannheim, Germany), incubated for al least 1 min at RT and viable cells 
were counted by using the Neubauer hemocytometer chamber. 
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2.11 Metabolism analysis 
2.11.1 Glucose and lactate determination 
Glucose and lactate concentration were determined daily in duplicates in every cell 
culture supernatant using a glucose/lactate analyzer (Table 2.1a). The method is based 
on enzymatic oxidation (immobilized glucose oxidase and L-lactate oxidase, 
respectively). The formed hydrogen peroxide is oxidized at a platinum electrode and the 
respective electricity is measured. 
2.11.2 Determination of lactate dehydrogenate (LDH) activity  
LDH activity was measured as the reduction of pyruvate to lactate. The reduction is 
coupled to the oxidation of NADH to NAD+, which was followed spectrophotometically 
at 340 nm (Wrobleswski and LaDue 1955). 
60 µL of supernatant (store at 4 °C not more than 3 days) were mixed with 420 µL 
of 30 mmol L-1 NaH2PO4 buffer and 60 µL of 10 mmol L-1 pyruvate, preheated to 37 
°C. 60 µL of 2.7 mmol L-1 NADH solution was quickly added, obtaining a total volume 
of 600 µL and the enzyme kinetics were immediately measured at 340 nm during 60 s 
using an Ultraspec 3100Pro. A regression coefficient was calculated expressing the 
activity as catalytic units per minute. The NADH solution was prepared freshly every 
two to three days and kept at 4 °C together with the other two solutions. 
2.11.3 Amino acid analysis 
Amino acids were quantified using a reversed phase high performance liquid 
chromatography (RP-HPLC) and an internal Norvalin or Citrulin standard (Larsen and 
West 1981).  
In this work, 500 µL of supernatant were taken from every cell culture sample and 
stored at –20 °C until they were measured. 
2.12 Intracellular nucleotide analysis 
The method was used as previously reported (Ryll and Wagner 1991; Ryll and Wagner 
1992) with few modifications. 
Briefly, samples taken from spinner flasks were determined 1 h after standard 
analysis (see above). For bioreactor experiments, one common sample was taken and 
the nucleotides were analyzed 0.5 h before cell concentration and other parameters 
tested. 
A sample of 1.0 – 5.0 mL containing about 2.0 × 106 cells was taken and immediately 
stored on ice. The sample was centrifuged for 3 min at 190 × g at 0 °C followed by the 
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removal of the supernatant. The cell pellet was resuspended in 300 – 500 µL chilled 0.5 
mmol L-1 perchloric acid (PCA), stored on ice for 3 min, and centrifuged at 2000 × g for 
2 min at 0 °C. The supernatant was collected and stored on ice, and the pellet was 
extracted once again, stored on ice and centrifuged as previously described. The second 
supernatant was pooled with the first one and the pH was adjusted to 6.5 using a 
microelectrode and a chilled solution of 2.5 mmol L-1 KOH and 1.5 mmol L-1 KH2PO4. 
After mixing the sample, the sample was place on ice for 2 min and centrifuged at 2000 
× g for 2 min at 0 °C to precipitate KClO4. The volume of the clear supernatant was 
determined, filtered through a 0.45 µm filter, frozen in N2 liquid and stored at –70 °C 
until analysis on an ion pair reversed-phase HPLC (IP-RP-HPLC). 
The HPLC separation of nucleotides was principally carried out as described by Ryll 
and Wagner (1991), using a gradient system of two buffers containing KH2PO4/ 
K2HPO4 and KH2PO4/K2HPO4/CH3OH. The buffer’s pH was set to 5.6 and 5.9 
respectively using KOH (modification of the standard method). Peak identification was 
performed by comparing retention times with nucleotide standard runs between every 
10 – 12 samples. Quantification of the peaks was done by manual integration using a 
MT-450 Kromasystem 2000 and relating the integrated peak area to standard curves in 
the range of 100 – 10 000 pmol. In this range, the authors found a linear correlation 
between peak area and concentration. 
2.12.1 Special calculation using the intracellular nucleotide pools 
o Adenylate energy charge (AEC): AEC was defined by Atkinson (Atkinson 1969) 
as an indicator of the metabolic state of the cells, giving the information of the 
intracellular energy charge. 
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The following ratios were defined by Ryll and Wagner (Ryll and Wagner 1992): 
 
o NTP ratio: it is the ratio of the sum of purines triphosphates and pyrimidines 
triphosphates. 
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o U ratio: it is the ratio of UTP and both UDP N-acetyl-hexosamines, UDP-
GalNAc and UDP-GlcNAc. 
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UDP – GNAc = UDP – GalNAc + UDP- GlcNAc  
 
o NTP/U ratio: it is the ratio of the NTP ratio and the U ratio. 
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o Percentage determination: indicate the relative amount of one component to the 
total nucleotide pools. For example, the following is the percentage of UTP. 
 
100% ⋅∑= Nucleotide
UTPUTP  
 
∑ Nucleotide= ATP + GTP + UTP + CTP + UDP-GNAc + ADP + GDP +      
 AMP + NAD + NADP 
2.13 Protein analysis 
The protein content of the supernatant was measured using the Coomasie Plus™ Protein 
Assay Reagent (Pierce, USA). This is a quick and ready-to-use coomassie-binding, 
colorimetric method for total protein quantification. It is a modification of the well-
known Bradford method (Bradford 1976) but with an improved linearity for a defined 
range of protein concentration. The assay was performed in test tubes. For high protein 
concentration, 50 µL of the sample was transferred to 1.5 mL of the reagent (macro 
test). For the samples with lower protein concentration, 1 mL of the sample was taken 
and transferred to 1 mL of the reagent (micro test). After 10 min, the color formed was 
measured at 595 nm (Instructions Coomassie Plus ™ Protein Assay Kit, Pierce, 
Rockford, IL, USA). 
The protein concentration was estimated using the absorbance obtained from serial 
dilutions of a protein (BSA; Gibco, Invitrogen™, life technologies, Germany) at a 
standard concentration as a reference. The standard curve was performed for both 
40  2.  Materials and Methods 
 
methods (micro and macro test) following the procedure recommended (Stoscheck 
1990). 
2.14 Mathematical analysis  
2.14.1 Growth rate (µ) 
12
12 lnln
tt
xx
−
−=µ  
 
Where x1 and x2 are the concentration of the living cells per mL in the time point t1 
and t2. 
The growth rate (µ) is possible to calculate manually or directly from the slope 
value from the regression curve in the exponential phase of the cell culture. In this 
work, the logarithmic of the viable cells was always plotted as a function of the 
cultivation time and normally, µ was directly obtained from the slope curve. 
2.14.2 Population doubling time (td) 
µ
2ln=td  
 
Where µ is the growth rate. 
2.14.3 Cellular viability (V %) 
100×=
Ct
CvV  
 
Where Cv is the concentration of the viable cells (2.10.2) and Ct is the total cell 
concentration (2.10.1). 
2.15 BioNose 
As explained in the Introduction section (1.4.2), an electronic nose, BioNose (EU 
BioNose Project QLK3-CT-1999-00435; Applied Sensors, Sweden), is build up 
according to the same principle as the human nose. An array of chemical gas sensors - 
typically conducting polymers, metal oxide semiconductors (MOS), metal oxide 
semiconductor field efficient transistors (MOSFET) are combined (Mandenius et al. 
1999). Every sensor is more or less unspecific to the measured gas mixture and the 
information is instead revealed by studying the complex total response pattern from the 
whole array. All measurements are performed in cycles during which the sensors are 
alternatively exposed to reference air, to the sample headspace, and then again to 
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reference air to allow the sensors recover. A cycle is divided into three phases: Baseline, 
Sample and Recovery. The duration of these phases should be optimized for each 
application. For each sensor and each cycle, several characteristic signal parameters are 
then calculated: baseline, on/off derivative, on/off integral and response - describing the 
sensor-substance dynamics (Fig. 2.15a).  
 
     
 
 
 
 
 
 
 
 
 
 
 
Using multivariate analysis (see section 2.16) and/or artificial neural networks it has 
been shown the possibility to select the important sensor responses in the array pattern 
and, based on them, build prediction models for various substances (Mandenius et al. 
1999).  
Connected to the off-line of the bioreactor, the sensors are presented to gas mixtures 
coming from the culture off gas for short time periods and a response is measured. 
Before and after exposure, the sensors are ”washed” with reference gas. To obtain 
measurements unaffected by the prior measurement, an important aspect in setting up 
the BioNose, is to ensure that the time the sensor is cleaned with reference gas is long 
enough (Bachinger and Mandenius 2000b). 
As long as a constant flow is present in the direction from the bioreactor, it is 
possible for the BioNose to be connected at any time without violating the sterile 
barrier. For this reason the BioNose does not need to withstand sterilization in an 
autoclave. This enables the use of normal sensors, which do not need to withstand heat 
sterilization.  
Fig. 2.15a: The measurement cycle of the electronic nose. The on integral and off integral represent 
chosen times over which the rise of the signal is integrated, and on derivative and off derivative 
chosen times where the signal rise and fall are derivated. Diagram from NST Senstool manual, 2000.  
Recovery
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Different Bionose experiments were performed. HEK293s cells were used growing 
in serum-containing medium and in serum-free medium. Both cultures were also 
evaluated during transfection procedure mediated by PEI (see section 2.18.1). 
For details see section result no. 3.7.2. 
2.15.1 BioNose setup 
The BioNose used, was equipped with 10 MOSFET sensors and 6 MOS sensors 
operated at 140 – 170 °C and 300 °C respectively. The electronic nose also contained a 
CO2 sensor, a temperature sensor block and temperature controlled reference air 
humidification. Data was collected using NST Senstool software. Reference gas was 
measured for 100 s to obtain a base line level, followed by a 30 s sampling from the 
reactor off gas and 1070 s recovery time applying reference gas. Each sample cycle took 
20 min. Reference gas flow was 160 mL min-1, gas flow 62 mL min-1 and sensor block 
temperature 55 °C. Reference gas was cooled to 12 °C, the reactor off gas was pre-
treated by cooling at 20 °C in order to reduce humidity. The exhaust gas line 
temperature was 34.5 °C.  
The total bioreactor and BioNose set up can be seen in figure 2.15.1a. 
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2.16  Multivariate analysis 
In practice, the main use of multivariate methods is to extract the relevant information 
from a huge data set.  
2.16.1 Principal component analysis (PCA) 
The principle of the PCA has been already explained in the Introduction section under 
1.4.3.1. PCA can be seen as the basis of multivariate analysis and was used to evaluate 
the pattern response. Different PCA models were built using the NST Senstool 
Fig. 2.15.1a: The bioreactor and 
BioNose set up. (Obtained from EU 
BioNose Project QLK3-CT-1999-
00435). 
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software. Sensors, which gave a noisy response, were avoided. The outlier’s 
measurements (points that deviates significantly from the rest of the population) were 
deleted. The most relevant sensors were selected using the loading plot and the most 
relevant principal components were found. Data analyses were performed either with or 
without scaling method looking which of them gives best result. Normalization scaling 
was done such that the all measurement vectors obtain a total length of one, giving all 
measurements equal importance. The idea behind normalized measurement scaling is to 
extract information from the signal patterns rather than from the magnitudes of the 
signal. 
2.17 Molecular cloning 
2.17.1 Expression vectors 
The expression vectors used in this work were the following: 
 
o pSBC-EGFP-rhuEPO (4832 bp)  
 
              
Xmn I (4396) 
Xho I (356) 
 
 
This expression vector was constructed in our Cell Culture Technology Department, 
(GBF, Braunschweig, Germany) by Noushin Irani (Irani 2000; Irani et al. 2002). It is a 
bicistronic plasmid, which contains the internal ribosome entry sites (IRES) from the 
poliovirus between the enhanced green fluorescent protein (EGFP) and the recombinant 
human erythropoietin gene (rhuEPO). These genes are under control of the SV40 virus 
promoter/enhancer (SV40 P/E). This vector also bears the ampicillin resistance gene. 
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o pIRES2-EGFP (5300 bp) (BD Biosciences, Clontech, CA, USA) 
 
                   
 
(From: http://www.bdbiosciences.com/clontech/techinfo/vectors/vectorsF-
I/pIRES2-EGFP.shtmL) 
This plasmid contains the IRES element of the encephalomyocarditis virus (ECMV) 
between the multiple clone side (MCS) and the EGFP gene to be translated from a 
single bicistronic mRNA. It was designed for the efficient selection (by flow cytometry 
or other methods) of transiently transfected mammalian cells expressing EGFP and the 
protein of interest. Genes are under control of the immediate early Cytomegalovirus 
promoter (pCMV IE, 589 bp). This vector bears the kanamycin and neomycin resistance 
genes. 
 
o pTracer™ -CMV2 (6210 bp) (Invitrogen, Life Technologies, CA, USA) 
 
                     
 
This vector was kindly provided by Dr. Manfred Wirth, Regulation and 
Differentiation Department GBF, Braunschweig, Germany. It contains the immediate-
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early CMV promoter (654 bp) and the ampicillin and zeocin resistance genes 
(http://www.invitrogen.com/content/sfs/manuals/ptracercmv2_man.pdf). 
 
o pCR-3-EPO (5715 bp) 
 
           
EcoR I (714)
 
 
This plasmid was kindly provided by Dr. Eckart Grabenhorst, Proteinglycosylation 
Department, GBF, Braunschweig, Germany.  
It was constructed by using the vector pCR™ 3 (Invitrogen, Life Technologies, CA, 
USA) (http://invitrogen.com/content/sfs/vectors/pcr3.pdf) and a cloned human 
erythropoietin gene (Powell et al. 1986). The rhuEPO gene is under the CMV promoter 
control. The vector also contains the ampicillin resistance gene. 
 
o pEPO-IRES2-EGFP (6014 bp) 
 
    
pEPO-IRES2-EGFP
EGFP
rhu EPO-Gene
IRESKan / Neo R
CMVie-p
Nde I (235)
Xho I (1320)
Xmn I (1586)
Kpn I (650)
Kpn I (825)
Kpn I (1356)
Kpn I (1819)
6014 bp
 
  
This bicistronic vector was generated during this thesis work. It has the rhuEPO and 
the EGFP genes under the CMV promoter control. It was constructed using the 
plasmids pIRES2-EGFP and pCR-3-EPO (Fig. 2.17.2a). This vector contains the 
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kanamycin and neomycin resistance genes. For details see the result section number 
3.3.1. 
 
o pCMV-EGFP-EPO (5388 bp) 
 
           
pCMV-EGFP-EPO
rhuEPO-Gene
EGFP
Polio 5´UTR (IRES)
Amp R
hCMVpromoter
XhoI (1)
Xmn I (4080)
Nde I (2625)
NdeI (4888)
Kpn I (90)
Kpn I (949)
Kpn I (1646)
Kpn I (5325)
5388 bp
 
This bicistronic vector was generated during this thesis work using the plasmids 
pTracer™ -CMV2 and pSBC-EGFP-rhuEPO. It contains an upstream EGFP gene and a 
downstream rhuEPO gene. These genes are under the CMV promoter. It contains the 
gene, which confers resistant to ampicillin (see Fig. 2.17.2b). For details see the section 
3.3.2. 
 
o pEGFP-N1 (4700 pb) (BD Biosciences, Clontech, CA, USA)  
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(From:http://www.bdbiosciences.com/clontech/techinfo/vectors/vectorsE/pEGFP-
N1.shtmL). This vector contains the EGFP gene under control of the immediate early 
Cytomegalovirus promoter and carries the kanamycin and neomycin resistance genes.  
 
o pL1EGFP1L (4525 bp) 
 
             
 
This vector contains the EGFP gene under control of the immediate early 
Cytomegalovirus promoter. It carries the ampicillin resistance gene. 
 
These last two plasmids were kindly provided by Dr. Christiane Beer, Regulation 
and Differentiation Department GBF, Braunschweig, Germany.  
2.17.2 Construction of bicistronic vectors 
Both plasmids were constructed with the aim to have a bicistronic plasmid with a strong 
promoter (CMV) for expression in mammalian cells, a model-protein to evaluate the 
productivity of transient transfected mammalian cells (rhuEPO), and reporter gene to 
evaluate the transfection efficiency (EGFP) (see 2.19).  
For the construction of bicistronic vectors, standard protocols were followed. These 
protocols are described below (2.17.2.1 to 2.17.2.8) (Sambrook et al. 1989). 
Figures 2.17.2a and 2.17.2b show a scheme of the strategy performed for the 
construction of the plasmid pEPO-IRES2-EGFP and pCMV-EGFP-EPO, respectively. 
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Fig. 2.17.2a: Strategy for construction the bicistronic vector pEPO-IRES2-EGFP. 
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Fig. 2.17.2b: Strategy for construction the bicistronic vector pCMV-EGFP-EPO.  
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2.17.2.1 E. coli transformation 
Two different protocols were used to transform the different E. coli strains 
(manufacturers’ recommendations): 
o Electroporation: it was the recommended method to transform the XL 1 Blue 
competent cells, which were used to host all plasmids. Electroporation was performed 
using the following settings on the electroporator: capacitance extender: 500 µF; 
capacitance: 25 µF; pulse controller: 200 Ω; gene pulser (volt-set): 2.5 kW (max.). 
In an eppendorf tube, 1 µL of plasmid of a concentration of 0.1 µg µL-1, was added. 
The competent E. coli cells were thawed very quickly on ice, 50 µL of the competent 
cells were added to the plasmid solutions, resuspended once, and incubated for 
approximately 30 s on ice. During this time, 500 µL of SOC medium was prepared. The 
solution (plasmid and E. coli) was transferred to a transformation cuvette and put into 
the gene pulser. The two buttons of the pulser were pushed until signal and the 500 µL 
of prepared medium were given to the cuvette. The solution was transferred to a new 
reaction tube, which was immediately placed on ice. 50 µL were used to prepare a LB 
agar plate with the corresponding antibiotics. The plates were incubated upside down, 
overnight at 37 °C. 
 
o Heat shock: this standard method was recommended to transform the JM 109 
competent cells (see Technical Bulletin No. 095, Promega, Madison, WI, USA). 
Briefly, sterile polypropylene tubes were chilled on ice and the competent cells were 
thawed on ice for approximately 5 min. The thawed competent cells were mixed gently 
and 50 µL were transferred into each of the chilled tubes. 1 to 25 ng of DNA (in a 
volume not higher than 5 µL) were added per 50 µL of competent cells and the tube 
were quickly flicked several times. The tubes were immediately placed on ice for 10 
min. After that, the cells were heat-shocked for 45 – 50 seconds in a water bath at 
exactly 42 °C and then, placed on ice for 2 min more. After that, 450 µL of cold (4 °C) 
SOC medium were added to each transformation reaction. The mix was incubated for 
60 min at 37 °C with shaking (180 rpm). After that, the tubes were centrifuged (2000 
rpm, 5 min) to concentrate the transformed bacterial, and aliquots were evenly spread 
onto LB plates with the appropriate antibiotics. They were incubated overnight at 37 °C. 
2.17.2.2 DNA mini-preparation 
Successful transformations were checked by means of plasmid mini-preparations using 
the “QIAprep spin miniprep kit protocol” (see table 2.2a).  
Selected colonies were taken with a sterile toothpick. A small sample was taken in 
order to have a backup. The bacteria were transferred into LB-antibiotic medium 
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reagent cups (2 mL of prepared medium in 10 mL glass cup). These cups were 
incubated either 6 h or overnight at 37 °C in a shaker at 180 rpm. The following day, the 
cell suspension was transferred into a 2.5 mL Eppendorf tube and centrifuged (2 min, 
7000 rpm, at RT). After this step, the pellet can be frozen at –20 °C, if necessary; 
otherwise the Qiagen protocol was followed. The DNA concentration should be 
between 25 µg and 50 µg in 50 µL of the elution buffer. 
2.17.2.3 Digestion of DNA with restriction enzymes 
The purpose of endonuclease digestion is to cleave the DNA in specific sites either for 
analytical or for preparative purposes. The amount of employed DNA for analytical 
purposes depends on the expected DNA bands in the gel and is normally between 0.5 
µg and 1.0 µg. For preparative purposes, the DNA content varies between 10 to 20 µg. 
The amount of the restriction enzyme depends also on the DNA content. With 
increasing DNA content either the applied enzyme or the incubation time of digestion 
must be increased. However, the maximum amount of enzyme must be 10 % of the total 
cocktail volume, otherwise the elevated glycerin concentration, in which the enzymes 
are stored, would disturb the enzymatic activity. For each enzyme, its own 10× buffer 
or/and 100× BSA was used, as indicated by the manufacturer. The final volume of 
enzyme digestion was completed with water. In the case of a double digestion, a buffer 
in which both enzymes were active was used. 
In this work, all enzymes were purchased from New England BiolabsInc., Hitchin, 
Hertfordshire, UK in the concentrations indicated below: 
 
o EcoRI (Catalogue no.: R0101S): 20,000 U mL-1 
o NdeI (Catalogue no.: R0111S): 20,000 U mL-1 
o XhoI (Catalogue no.: R0146S): 5,000 U mL-1 
o KpnI (Catalogue no.: R0142S): 10,000 U mL-1 
o XmnI (Catalogue no.: R0194S): 20,000 U mL-1 
  
“Control digestion” was performed to check whether the DNA isolated from the 
bacterial clones has the correct fragment of interest in correct orientation and position.   
For a final reaction volume of 10 µL, the following master-mix was prepared: 
- 1 µL 10× enzyme buffer 
- max. 1 µL enzyme 
- × µL DNA (2.5 to 5.0 µL) 
- 0.1 µL 100× BSA 
- × µL water (complete to 10 µL of total volume) 
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“Preparative digestion” was performed with the aim to have more desired DNA 
fragments and for isolating it from the agarose gel. 
 
For example for a final reaction volume of 40 µL: 
- 4 µL 10× enzyme buffer 
- 1.5 or 2.0 µL enzyme 1 
- 2.5 or 2.0 µL enzyme 2 
- × µL DNA (6.0 to 10.0 µL) 
- 0.5 µL 100× BSA 
- × µL water (complete to 40 µL of total volume) 
 
The digestion started when the enzyme/s and the sample/s were incubated 1 – 2 h at 
37 °C. For preparative digestion, a minimum incubation time of 2 h and maximum of 
overnight were used. Samples were prepared for electrophoresis. 
2.17.2.4 Gel preparation and electrophoresis 
For analytical and preparative purpose a 1 % agarose (Agarose NA, Pharmacia, 
Uppsala, Sweden) gel were prepared as follows: agarose was dissolved in 30 mL 
running buffer (TAE-buffer, see below), shortly heated in a microwave oven, cooled (≈ 
85 °C) and ethidium bromide was added to a final concentration of 0.5 µg mL-1. The 
liquid agarose gel was mixed carefully, poured in a mini gel chamber avoiding bubble 
formation, and it was left to solidify. The running buffer contained the same ethidium 
bromide concentration as the gel. 
5× Loading buffer was added to the DNA samples (1/5 of cocktail volume). 
Samples were loaded into the gel wells, and were run at 100 V. The process was 
stopped when the bromophenol blue band was closed to the end of the gel. A DNA 
marker, λ Hind III (prepared in the Regulation and Differentiation Department GBF, 
Braunschweig, Germany) was loaded in parallel with the samples. The DNA bands 
were detected under UV-light and photographed. 
 
50x TAE-buffer: 242 g L-1 Trisma-Base, 57.1 mL L-1 acetic acid, 100 mL L-1 0.5 mol 
L-1 EDTA, pH 8.0.  
50x TAE buffer was diluted 1:50 before use. 
5x Loading buffer: 0.25 % (V V-1) Bromophenol blue, 40 % (W V-1) sucrose in 
water. 
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2.17.2.5 Isolation of the plasmid 
To isolate the DNA fragment of interest from the plasmid, a restriction enzyme 
digestion was carried out for two hours at a 37 °C. The DNA fragments were separated 
in an agarose preparative gel. The gel was run as it was explained in the previous 
section (2.17.2.4). The DNA fragments were excised from the gel using a scalpel 
visualized under the UV-light. The DNA was eluted from the gel using the QIAquick 
gel extraction kit (see table 2.2a) according to the manufacturer’s description. After the 
DNA extraction, an analytical gel was prepared to estimate the amount of DNA 
recovered from the gel. 
2.17.2.6 Ligation 
The ligation cocktails used generally contained three times the molar amount of the 
insert respect to the vector. The amount of DNA was calculated from the analytical gel 
(2.17.2.5). The T4 DNA Ligase (Catalogue No.: M0202S; 400,000 U mL-1, New 
England BiolabsInc., Hitchin, Hertfordshire, UK) was used for all the experiments.  
1 µL of the T4 DNA Ligase in a 20 µL of total reaction was used, according to the 
manufacturer’s instructions: 
- 2 µL 10× ligase buffer 
- 1 µL T4 DNA Ligase 
- × µL of fragment 1 (vector) 
- × µL of fragment 2 (insert, must be two or three times more 
concentrated than the vector) 
- × µL water (complete to 20 µL of total volume) 
 
Incubation time was between 2 to 3 hours at RT.  
2.17.2.7 DNA maxi-preparation – DNA giga-preparation 
Maxi-preparation or giga-preparation is necessary if a large amount of plasmid-DNA is 
needed. In order to confirm whether the selected colony contained the right insert, a 
mini preparation was done. Once, it was confirmed, the bacteria were cultivated in 
large-scale culture and the plasmid was isolated. 
For this purpose, the selected colony was incubated in 10 mL LB-antibiotic medium 
for approximately 5 h at 37 °C to produce the pre-culture. Two 2-L Erlenmeyer flasks 
were filled, each with 200 mL with the same medium, inoculated with 5 mL pre-culture 
and incubated at 37 °C overnight in a shaker (180 rpm). The next day, either the Qiagen 
plasmid maxi kit or Qiagen plasmid giga kit (see table 2.2a) was used to isolate the 
plasmid DNA, according to manufacturer’s instructions. 
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The concentration of DNA was measured (see below, 2.17.2.8) and the presence of 
the expected plasmids was checked by restriction pattern analysis (2.17.2.3). 
2.17.2.8 Determination of DNA concentration 
The DNA concentration and the quality of the DNA solution were determined by 
measuring the absorption at two wavelengths. The DNA solution was diluted 1:100 in 
TE-buffer (see below) and 100 µL of this solution was transferred into a quartz cuvette 
(Pharmacia, Uppsala, Sweden). The absorption was measured spectrophotometrically at 
260 nm and 280 nm. The ratio between OD260 and OD280 should be between 1.75 and 
2.0; otherwise, if the ratio is lower, the DNA is contaminated with proteins. An OD260 = 
1 corresponds to a DNA concentration (double stranded) of 50 µg mL-1. 
 
DNA concentration (µg mL-1)= OD260 × 50 × dilution factor 
 
TE-buffer: 10 mmol L-1 Tris-HCl, 1 mmol L-1, pH: 8.0. 
2.18 Transient transfection methods 
One of the aims of this work was to develop and optimize a scale-up transient 
transfection method in mammalian cells using serum-free medium. One of the DNA 
delivery methods for plasmid, polyethylenimine (PEI), has been shown to be suitable 
for scale-up operations. It has the advantage of being cost-effective (see Introduction 
section 1.3.2). For this reason, in this work, different experiments using PEI were 
performed working with cell culture under serum-containing and serum-free conditions. 
2.18.1 Transient transfection mediated by PEI 
All the experiments were performed using the HEK293s cells, growing in different 
media which are described in each experiment (see details in results sections 3.2, 3.4, 
3.6 and 3.7). During the first phase of the exponential growth, the cells were in very 
good conditions showing a viability above 90 % and grew as single cells or small 
clusters at a concentration between 5.0 × 105 mL-1 and 1.0 × 106 mL-1. Cells were 
incubated at 37 °C and 12 % of CO2. 
Stock solutions of PEI were prepared using a 25 kDa linear PEI (Polysciences, 
Warrington, PA, USA) in a concentration of 1 mg mL-1. They were prepared in water, 
neutralized with HCl, sterilized by filtration (0.22 µm) and aliquoted and stored at –70 
°C. 
In all the experiments a plasmid concentration between 0.02 µg µL-1 and 2.0 µg µL-1 
with a A260/A280 ratio between 1.75 and 2.00 was used. pEPO-IRES2-EGFP and 
pCMV-EGFP-EPO plasmids were utilized in these experiments. 
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2.18.1.1 Small-scale transient transfection 
Two protocols were used. In both cases, the transfection procedures were performed in 
serum-containing or/and in serum-free medium. (See details in sections 3.2, 3.4 and 
3.6). All experiments were done in duplicate in a 12-well plate. 
For the complex formation, different ratios between DNA and PEI were used to 
determine the lowest amount of DNA with the highest transfectability. This was 
prepared at RT under a laminar flow sterile hood as it is explained below. 
 
o Protocol A: Cell wash step before the addition of transfection complex 
Three hours before transfection, cells cultured under the conditions explained in 2.18.1, 
were harvested in the middle of the exponential growth phase. They were centrifuged (3 
min at 1200 rpm), washed one time with fresh new medium and finally, resuspended in 
this medium at a concentration of 1.0 × 106 mL-1 in a conic tube. In order to enrich 
single cells, the tube was vortexed for 20 s and 500 µL of the cell suspension were 
distributed per well. The plate was incubated at 37 °C, 12 % CO2 for three hours, until 
the addition of the transfection complex.  
For the preparation of the transfection complex, DNA was diluted in fresh serum-
free medium in a volume equivalent to one-tenth of the culture volume to be used in the 
transfection. Two minutes later, PEI was added, and the mixture was immediately 
vortex-homogenized and incubated for 10 min at RT prior to the addition to the cells.  
Once the DNA:PEI complex was added to the cells, the plate was additionally 
incubated for three hours under the same conditions. Then, the volume was completed 
to 1 mL by the addition of fresh medium, gently shaken and further incubated until flow 
cytometry analysis (see 2.19.1) (normally between 48 h to 72 h later). The supernatants 
were stored at –20 °C for later analysis of EPO (see 2.19.2). 
 
o Protocol B: Transfection without cell wash step before the addition of 
transfection complex 
Cells cultured under the conditions explained in the section before and collected in the 
middle of the exponential growth phase, were counted 24 h before to perform the 
transfection procedure. They were diluted to a concentration of about 3.0 × 105 mL-1 and 
5.0 × 106 mL-1 and were further incubated until next day. Cells were counted again and 
when they nearly doubled their concentration (between 5.0 × 105 mL-1 and 1.0 × 106  
mL-1, 24 h conditioned medium), they were transfected as explained below.  
900 µL of cell culture were seeded per well, previous vortex-homogenization for 
approximately 20 s. The plate/s was/were incubated for the time during the complex 
formation was prepared in the same condition as before. The complex formation was 
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done as explained in the protocol A, section 2.18.1.1. 100 µL of this was added to the 
cells, gently shaken and incubated further until its analysis using flow cytometry (see 
2.19.1). The supernatants were stored at –20 °C for later analysis of EPO (see 2.19.2). 
2.18.1.2 Transfection in spinner flask 
The transfections were performed without cells washing step before the addition of the 
transfection complex, using serum-containing and serum-free media. In all cases the 
preparation of transfection complexes were made following the protocol A explained 
under 2.18.1.1. 
Cells were inoculated in a big spinner flask (1000 mL) using a working volume of 
200 mL, with an initial concentration between 3.0 × 105 mL-1 and 5.0 × 105 mL-1. Cells 
were transfected 24/48 hours later, when the cell concentration was reached 6.0 × 105 
mL-1 and 1.0 × 106 mL-1, respectively. 
The complex was prepared by diluting the DNA in 20 mL of fresh serum-free 
medium (1/10 from the total volume to be transfected) and by adding PEI two minutes 
later. This mixture was vortexed and incubated for 10 min at RT until the addition to the 
culture. 
Then the culture was further incubated under the same conditions as before and a 
sample was taken daily to determine the cell concentration, the viability, glucose and 
lactate, LDH, amino acids (named as standard determinations, section 2.10 and 2.11) 
and nucleotide concentrations (2.12). A fraction of the cells was taken to analyze the 
GFP expression using flow cytometry (see 2.19.1). Culture supernatants were stored at 
–20 °C for later analysis of EPO (2.19.2). 
2.18.1.3 Transfection in bioreactor 
A 1.8 L bioreactor with a working volume between 1.4 L and 1.6 L, was inoculated at a 
cell concentration between 3.0 × 105 mL-1 and 5.0 × 105 mL-1. When the cell 
concentration was nearly duplicated, 24/48 hours later, the cells were transfected. For 
the complex formation, the DNA was diluted in 50 mL of fresh serum-free medium and 
two minutes later PEI was added. After 10 min of incubation at RT, the complex was 
added to the bioreactor through the inoculum tube, following by a wash with 20 mL of 
serum-free medium. The conditions of the culture were the same as those described in 
2.5.4, with the difference that the stirrer speed was increased to 60 and 70 rpm. A 
sample was taken daily to perform the standard determinations (section 2.10 and 2.11) 
and nucleotide concentrations (2.12). A fraction of the cells was taken to analyze the 
GFP expression using flow cytometry (see 2.19.1). Culture supernatants were stored at 
–20 °C for later analysis of EPO (2.19.2). 
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2.19  Evaluation of transfection 
In this work, the model proteins, EGFP and rhuEPO, were used to evaluate transfection 
procedures.   
2.19.1 Green Fluorescent Protein determination 
The EGFP, the reporter protein, was measured by flow cytometry. This parameter was 
used to evaluate the transfection efficiency. 
Cells were counted and 5.0 × 10 5 to 1.0 × 10 6 of them were added into a sterile 
Eppendorf tube and centrifuged 3 min at 2000 rpm. The supernatants were stored at –20 
°C for later EPO analysis. Cells were washed twice with PBS (without Ca2+ and Mg2+) 
and resuspended in a volume of 300 µL to 400 µL of the same buffer for immediate 
flow cytometry analysis. The cells were transferred to the FACS-tube, homogenized 
using a vortex for guaranteeing single cells measurement, and analyzed. 
The percentage of GFP-positive cells was assessed using the CellQuest Pro 
software. Only viable cells were determined for the expression of GFP, considering 
3000 events per measurement. A control of untransfected cells (negative control) was 
measured to eliminate fluorescent background from the cells.  
2.19.2 Erythropoietin quantification 
Erythropoietin quantification was performed by sandwich Enzyme-Linked 
Immunosorbent Assay (ELISA) to evaluate the productivity of the transient transfected 
mammalian cells. 
ELISA microplates were coated with 400 ng of affinity-purified monoclonal 
antibody mAb 2B2 (Laboratorio de Cultivos Celulares, Santa Fe, Argentina) diluted in 
coating buffer (50 mmol L-1 carbonate buffer, pH: 9.6) and incubated either 1 h at 37 °C 
or overnight at 4 °C. The plates were washed with 0.05 % Tween 20 in PBS (T-PBS) 
and then blocked with PBS-1 % BSA to prevent non-specific binding (1 h at 37 °C). 
After washing with T-PBS, the plates were loaded with the samples. Standard curves 
were achieved by 1:2 serial dilutions of purified rhuEPO (Laboratorio de Cultivos 
Celulares, Santa Fe, Argentina) from 4 µg mL-1 to 7.8 ng mL-1 dissolved in cell culture 
medium (the same medium in which the transfected cells were cultivated). This control 
was performed in triplicates. Samples were diluted 1:2 and serial dilutions were 
performed with the same culture medium. Plates were incubated for 1 h at 37 °C, 
washed with T-PBS and incubated with rabbit anti-rhuEPO polyclonal antibodies (pAb, 
Laboratorio de Cultivos Celulares, Santa Fe, Argentina), diluted 1:1,000 with 0.1 % 
BSA – 0.05 % Tween 20 in PBS (BSA-T-PBS). After 1 h incubation at 37°C, the plates 
were washed and incubated with peroxidase-labelled goat anti-rabbit antibody (DAKO, 
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DakoCytomation, CA, USA; Cat. no. P0448) diluted 1:1,000 in BSA-T-PBS. After the 
final wash, the plates were incubated in the dark with 50 mmol L-1 citric acid-phosphate 
buffer, pH: 3, containing 3.0 mg mL-1 o-phenylenediamine and 0.12 % (V V-1) 
hydrogen peroxide (substrate solution). The absorbance was measured at 450 nm with a 
micro-titer plate reader. 
EPO concentration was calculated by interpolating the absorbance from the plot in 
logarithmic scale of standard absorbance vs. standard concentration. 
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3. Results 
3.1 Adaptation to serum-free medium 
First, HEK293s cells were either adapted to a serum-free medium or a protein-free 
medium formulation to guarantee chemically defined culture conditions for further 
transient transfection processes. 
3.1.1 Sequential adaptation using cell density effect 
The following experiments were performed by a progressive medium exchange, using 
high cell concentrations in order to facilitate the cell adaptation process due to a better 
conditioning of the culture medium. The following serum-free media were used: (1) 
Gene Therapy Medium-2 (GTM-2), (2) Pro 293s-CDM, (3) CD 293 and (4) 293 SFM 
II. The adaptation was done according to the protocol described in 2.6.1. DMEM -Ca2+ 
+ Vit. + Pl. + 5 % FCS medium was used as control. 
Samples were taken from the four spinners daily. For each culture, cell 
concentration, viability, glucose and lactate concentration, as well as LDH activity and 
amino acids concentration were routinely assessed (data not shown). These 
measurements were called standard determination (2.10 and 2.11). 
During the adaptation process and the first passage in the new serum-free medium, 
cells growth was characterized by forming large aggregates (more than 50 cells) making 
a homogenous sampling difficult. Despite this, a backup of cell samples from all four 
cultures was performed and 10 to 15 cryogenic vials per spinner flask were stored in the 
gas phase of liquid nitrogen using the cryopreservation protocol (see under 2.7.1). 
One cryogenic vial of each different condition (1), (2), (3) or (4) was thawed. Cells 
were cultured in the respective serum-free medium and sub-cultured when they reached 
a concentration between 1.5 × 106 mL-1 to 2.0 × 106 mL-1. Generally, four sub-cultures 
were performed. Medium (1) was excluded from further experiments because the cells 
did not grow during 12 days of cultivation. 
During cell cultivation in the three remaining media, large cell aggregates of more 
than 50 cells occurred. Therefore, the following experimental steps were carried out in 
order to break down the cell clumps (2.5.3). Figure 3.1a show an example of the 
different steps during cluster disintegration. 
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After four sub-cultivations, cells in medium (3) and (4) grew as a single cell culture 
and those in medium (2) grew in clusters (more than 20 – 30 cells). 
Taken into account that a homogeneous cell suspension is an important prerequisite 
for successful and efficient transfection and due to the fact, that cells only cultured in 
medium (3) and (4) grew as single cells, medium (2) was excluded from the further test 
phase. 
Batch cultures were performed for eight days in small spinner flasks using CD 293 
(3) and 293 SFM II (4) media. Standard parameters were determined. At the end of the 
batch cultivation, four amino acids were found to be limited (data not shown). 
Therefore, both media were suplemented with 1 mmol L-1 Asp, 150 µmol L-1 His, 500 
µmol L-1  Thr, and 100 µmol L-1 Trp. 
Succesive sub-cultivations were performed using both suplemented media. The 
standard parameters were measured. Similar results were found for both media (data not 
shown). 
Population doubling time (td) of HEK293s cells growing in CD 293 + AA was 
comparably high and between 60 h and 70 h, whilst td of the respective cells growing in 
293 SFM II + AA was lower and between 30 h and 35 h. Notice, that the control in 
serum-containing DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium was between 20 and 30 
h. Cells growing in 293 SFM II + AA showed a better disintegration of clusters and 
single cell-type growth than cells growing in CD 293 + AA. Therefore, HEK293s cells 
growing in 293 SFM II + AA were considered to be fully adapted to the new serum-free 
medium. Therefore, this medium was selected for further experiments. Finally, a batch 
culture, was performed to better characterize HEK293s in this 293 SFM II + AA 
medium (Fig. 3.1b). The maximum cell concentration was about 3.5 × 106 mL-1 with a 
viability above 95 % during the first 96 h of culture. After this period the viability 
dropped dramatically when the cells entered the stationary phase (A), and correlated to 
a drastic increase of the LDH (C). The lactate concentration in the supernatant was 
below 0.6 g L-1 and the glucose concentration was maintained above 1.5 g L-1 (C). 
Fig. 3.1a: Different development of aggregates during cell cluster disintegration of HEK293s cells 
cultured in 293 SFM II. (from A to E): Cell culture stirred at 40 rpm (A) and in the next four sub-
cultures at 80 rpm (B to E).  
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These sets of experiments showed that the adaptation protocol using progressive 
medium exchange under high cell concentrations allowed the HEK293s cells to 
fully adapt to the serum-free 293 SFM II + AA medium. Therefore, these cells 
growing in this medium were chosen to perform the preliminary transfection 
experiments (see section 3.2 and section 3.4.1). 
 
3.2 Preliminary transient transfection experiments using PEI and 
the pSBC-EGFP-rhuEPO vector plasmid 
The pSBC-EGFP-rhuEPO vector plasmid was used for stable expression in BHK-21 
cells transfected using the calcium-phosphate method as previously reported (Irani 
2000; Irani et al. 2002). The preliminary transient transfection experiments with 
HEK293s cells were also performed using this vector, but PEI as mediator according to 
Protocol A (cell wash step before the addition of transfection complex), section 
2.18.1.1. 
HEK293s cells cultured in serum-free 293 SFM II + AA medium and in DMEM-
Ca2+ + Vit. + Pl. + 5 % FCS medium were transfected using different ratios of 
DNA:PEI. Results from flow cytometry analysis showed no significant transfection, 
evaluated by GFP expression, for all DNA:PEI ratios adjusted after 48 h or 72 h post 
transfection (hpt) (data not shown). 
Two expression vectors, pEGFP-N1 and L1eGFP 1L (see details under 2.17.1) 
bearing the EGFP gene under control of the CMV promoter were tested. First, small-
scale transient transfections (Protocol A, section 2.18.1.1) using HEK293s cultured in 
serum-containing medium (DMEM -Ca2+ + Vit. + Pl. + 5 % FCS) were performed.  
A ratio of 1.0:1.5 of DNA:PEI (µg:µg), having the highest transfection efficiency in 
previous experiment (Durocher et al. 2002) was used. For the complex formation the 
following media were used: 
1- Serum-free medium (w/o s):            DMEM -Ca2+ + Vit. + Pl. 
2- Serum-containing medium (with s): DMEM -Ca2+ + Vit. + Pl.+ 5 % FCS 
 
Transfections were performed using both vectors containing the CMV promoter, 
and were compared to the reference vector pSBC-EGFP-rhuEPO containing the SV40 
promoter.  
Cells were analyzed by flow cytometry at 72 hpt. The respective results are shown 
in figure 3.2.a. Transfection efficiencies were higher than 95 % with pEGFP-N1 and 
L1eGFP 1L plasmids for complexes formed in serum-containing and serum-free 
medium. A transfection efficiency of nearly 20 % was reached with the pSBC-EGFP-
rhuEPO plasmid only for complex formed under serum-free medium conditions. 
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These results showed, that the highest transfection efficiency was reached under 
PEI-mediated transient transfection using vectors bearing the CMV promoter. 
Therefore, for the constructions of the new bicistronic vectors containing the 
EGFP reporter gene and the EPO model gene, the CMV promoter was chosen. 
 
3.3 Construction of bicistronic plasmids 
Two different bicistronic plasmids were constructed, both containing the EGFP and the 
EPO genes under control of the CMV promoter, thus generating different model 
plasmids as explained below.  
3.3.1 Construction of pEPO-IRES2-EGFP vector 
The construction of the pEPO-IRES2-EGFP vector followed the protocol indicated in 
2.17.2, figure 2.17.2a. Part of the CMV promoter and the rhuEPO gene were removed 
from the pCR-3-EPO vector using the NdeI and XhoI restriction enzymes (2.17.2.3) and 
ligated with the NdeI / XhoI digested pIRES2-EGFP vector (2.17.2.6). The CMV 
Fig. 3.2a: HEK293s cells cultured in serum-containing medium (DMEM -Ca2+ + Vit. + Pl. + 5 % 
FCS) were transfected with 1 µg DNA from different plasmid and 1.5 µg PEI. The percentage of 
GFP-positive cells was measured 72 hpt. The DNA:PEI complex for transfection was prepared in 
serum-free medium (DMEM -Ca2+ + Vit. + Pl.) (hatched red columns: complex without serum) and 
in serum-containing medium (DMEM -Ca2+ + Vit. + Pl. + 5 % FCS) (hatched gray columns: complex 
with serum). Errors bars represent + standard deviation (SD) of one experiment done in duplicate. 
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promoter was regenerated and the rhuEPO gene was inserted upstream of the IRES site 
of the encephalomyocarditis virus (ECMV) and the EGFP gene (Fig. 3.3.1a).  
 
pIRES2-EGFP and pCR-3-EPO vectors were digested (2.17.2.3) as described below 
and separated in the agarose gel under preparative conditions. Fragments were cut out 
from the gel under UV light (2.17.2.5; Fig. 3.3.1b).  
Digestion was carried out using NdeI and XhoI restriction enzymes at the same time 
for a total volume of 40 µL according to the protocol described in section 2.17.2.3. The 
digestion was incubated 2h at 37 °C.  
The NdeI enzyme cuts both plasmids within the CMV promoter. The XhoI 
restriction sites are in the MCS of the pIRES2-EGFP vector and downstream of the 
rhuEPO gene in the pCR-3-EPO vector. As a result, part of the CMV promoter plus the 
rhuEPO gene fragment were cut out from the pCR-3-EPO vector obtaining one insert of 
about 1075 bp. This fragment was used for subsequent ligation with the fragment 
obtained from the pIRES2-EGFP vector (4929 bp) (Fig. 3.3.1b). 
Fig. 3.3.1a: Construction of the bicistronic vector pEPO-IRES2-EGFP. pIRES2-EGFP and the pCR-
3-EPO vector were digested with NdeI and XhoI. The revealing rhuEPO gene fragment plus part of 
the CMV promoter were ligated with the pIRES2-EGFP fragment. The CMV promoter was 
regenerated and the rhuEPO gene was inserted in the MCS, upstream of the IRES site and the EGFP 
gene resulting in the new bicistronic vector, pEPO-IRES2-EGFP. 
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Both fragments were purified using the QIAquick gel extraction kit protocol and the 
purified yield was verified in a 1 % agarose gel (data not shown). Fragments were 
ligated following the protocol as indicated in 2.17.2.6 for a total volume of 20.0 µL.  
The generated plasmid was amplified in bacteria JM 109, using the heat-shock 
method for the transformation (2.17.2.1).  
For the screening, ten clones were selected and cultured in LB-Kanamycin medium 
in order to be used for DNA mini-preparation (2.17.2.2). Accuracy of the constructed 
vector was controlled with a restriction analysis using the KpnI enzyme. 
Four KpnI restriction sites exist within the new bicistronic vector pEPO-IRES2-
EGFP located at 650 bp, 825 bp, 1356 bp and 1819 bp. Hence, four bands were 
expected: the smallest at 175 bp, two bands around 531 bp and 436 bp and the biggest 
band at about 4845 bp (Fig. 3.3.1c). The results showed that nearly all clones were 
correct.  
 
Fig. 3.3.1b: Preparative digestion with the NdeI and XhoI restriction enzymes of the plasmids pCR-3-
EPO and pIRES2-EGFP. The digested plasmids were separated on 1 % agarose gel. Fragment of ~ 
1075 bp (from pCR-3-EPO vector) contains part of the CMV promoter plus the rhuEPO gene. For 
pIRES2-EGFP, the interested fragment was the one of ~ 4929 bp. In this plasmid, part of the CMV 
promoter and the MCS were cut out.
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One clone was selected to perform the DNA maxi-preparation (2.17.2.7) to prepare 
sufficient DNA for further transfection processes. DNA concentration and purity were 
measured as indicated in 2.17.2.8. The 260/280 ratio was higher than 1.75, indicating a 
DNA purity above 95 %. See table 3.3.1a. 
 
Absorbance 
Plasmid 
260 nm 280 nm 
Ratio: 
260/280 
DNA-
concentration 
pEPO-IRES2-EGFP 0.438 0.246 1.78 2.19 mg mL-1 
 
Finally, a control digestion with the KpnI enzyme was performed using the DNA 
obtained from the DNA maxi-preparation. The results were the same as in figure 3.3.1c, 
confirming the correct ligation of the new bicistronic vector (data not shown). 
Table 3.3.1a: pEPO-IRES2-EGFP purity and concentration obtained from the DNA maxi-
preparation. 
Fig. 3.3.1c: Electrophoresis of 1 % agarose gel showing different clones (1 to 10) from the pEPO-
IRES2-EGFP vector digested with the KpnI. The expression vector has four restriction sites for KpnI 
generating four bands in the gel, aproximately at 4845 bp, 531 bp, 436 bp and 175 bp. C: control of 
the vector without digestion. 
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This new bicistronic vector, pEPO-IRES2-EGFP, was used for the optimization of the 
transient transfection process. 
3.3.2 Construction of pCMV-EGFP-EPO vector 
For the construction of the pCMV-EGFP-EPO vector (section 2.17.2, Fig. 2.17.2.b), 
parts of the ampicillin resistant gene and the CMV promoter from the pTracerCMV2 
vector (2.17.1) were removed by XmnI and XhoI digestion. The pSBC-EGFP-rhuEPO 
vector (2.17.1) was cleaved with XmnI and XhoI restriction enzymes and an ampicillin 
resistant gene fragment plus the SV40 promoter were removed. After ligation, the 
ampicillin resistant gene was regenerated in the new construct and the CMV promoter 
was placed upstream of the EGFP and rhuEPO genes having the polio 5´UTR IRES site 
located between both genes (Fig. 3.3.2a). 
  
 
Fig. 3.3.2a: Construction of the bicistronic vector pCMV-EGFP-EPO starting from pTracerCMV2 
and the pSBC-EGFP-rhuEPO vectors. After cleaving both plasmids by XmnI and XhoI digestion, the 
CMV promoter plus a fragment of the ampicillin resistant gene were ligated into the fragment from 
the pSBC-EGFP-rhuEPO, from which a fragment of the ampicillin resistant gene plus the SV40 
promoter were removed. The ampicillin resistant gene was regenerated and the EGFP and rhuEPO 
genes placed under control of the CMV promoter, resulting in new bicistronic vector, pCMV-EGFP-
EPO. 
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pTracerCMV2 and pSBC-EGFP-rhuEPO vectors were digested using both enzymes 
simultaneously in a total volume of 40 µL according the protocol described in material 
and methods, section 2.17.2.3. They were incubated overnight at 37 °C. 
Digested fragments were preparatively separated in an agarose gel (2.17.2.4) and cut 
out (2.17.2.5, Fig. 3.3.2b). The XmnI enzyme has one restriction site in the ampicillin 
resistant gene of both plasmids and one additional site at 1609 bp in the pTracerCMV2 
plasmid. The XhoI enzyme has three restriction sites in this plasmid, one in the MCS, at 
986 bp, and the other two, at 2275 bp and at 3101 bp. The pSBC-EGFP-rhuEPO 
plasmid, has only one restriction site after the SV40 promoter and upstream of the 
EGFP-gene. Therefore, two bands were expected in the case of this vector, one of 4040 
bp, the interested one, and the other of 792 bp. Five bands were expected for the 
pTracerCMV2 vector: 2786 bp, 1309 bp (interested fragment), 826 bp, 666 bp and 623 
bp (Fig. 3.3.2b).  
 
 
 
As was explained for the construction of the pEPO-IRESs-EGFP vector, both 
fragments were purified using the QIAquick gel extraction kit protocol and the purified 
Fig. 3.3.2b: Preparative digestion with the XmnI and XhoI restriction enzymes of the plasmids pSBC-
EGFP-rhuEPO and pTracerCMV2. The digested plasmids were separated on 1.0 % agarose gel. 
Fragment of ~ 4040 bp (from pSBC-EGFP-rhuEPO), that contains part of the ampicillin resistant 
gene and the SV40 promoter, was removed. For pTracerCMV2, the desired fragment was the one of 
1309 bp, which has parts of the ampicillin resistance gene and the CMV promoter.  
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yield was verified in a 1 % agarose gel (data not shown). Fragments were ligated 
following the protocol as indicated in 2.17.2.6.  
The new plasmid was amplified in bacteria JM 109, using the heat-shock method for 
the transformation (2.17.2.1).  
Ten clones were selected to continue with the liquid cultures in LB-Ampicillin 
medium and later, DNA mini-preparation was performed (2.17.2.2). The vector was 
verified by restriction analysis using the same restriction enzymes as for the preparative 
digestion (XmnI and XhoI). Therefore two fragments were expected, one at 
approximately 4000 bp (from pSBC-EGFP-rhuEPO plasmid) and the other at about of 
1300 bp (from pTracerCMV2 plasmid) (Fig. 3.3.2c). 
 
 
 
Fig. 3.3.2c: Electrophoresis of 1 % agarose gel showing different clones (1 to 10) from the pCMV-
EGFP-EPO vector digested with XmnI and XhoI restriction enzymes. This figure shows, that all 
clones were correct. A: isolated fragment from pSBC-EGFP-rhuEPO (~ 4000 bp); B: isolated 
fragment from TracerCMV2 (~ 1308 bp); C: control of the vector without digestion.  
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These results showed that all clones were correctly transformed. Clone number 9 
was selected for the DNA maxi-preparation (2.17.2.7) to produce enough DNA for 
further transfection processes. DNA concentration and purity were measured as 
indicated under 2.17.2.8. The 260/280 ratio was higher than 1.70, indicating a DNA 
purity above 95 %. See table 3.3.2a. 
 
Absorbance 
Plasmid 
260 nm 280 nm 
Ratio: 
260/280 
DNA-
concentration 
pCMV-EGFP-EPO 0.417 0.242 1.73 2.09 mg mL-1 
 
Finally, a control digestion with the same restriction enzymes (XmnI and XhoI) was 
performed using the DNA obtained from the maxi-preparation. The result was the same 
as shown in figure 3.3.2c, thus verifying the integrity of the new bicistronic vector (data 
not shown). 
 
In this section two different bicistronic vectors were constructed to be used in 
different further transient transfection processes. Both vectors harbored the EGFP 
and the EPO genes under control of the CMV promoter (CMVp: 589 bp and 654 
bp from pEPO-IRES2-EGFP and pCMV-EGFP-EPO vectors, respectively).  
The pEPO-IRES2-EGFP plasmid contained the rhuEPO gene upstream of the 
IRES site of the encephalomyocarditis virus (ECMV) and the EGFP gene 
downstream of the IRES. In contrast, the pCMV-EGFP-EPO vector was 
characterized by the inverse orientation containing the EGFP first followed by the 
IRES site from the Polio 5´UTR, and the rhuEPO as second gene. pEPO-IRES2-
EGFP was used as standard vector to optimize the transfection procedure. 
 
3.4 Small-scale transient transfection mediated by PEI using 
bicistronic plasmid 
3.4.1 Cell wash before the addition of the transfection complex  
The following experiments were performed with cells cultured in small-scale using a 
12-well plate. Cells were washed prior to transfection under PEI-mediated conditions. 
This transfection procedure followed Protocol A as indicated under section 2.18.1.1, 
using the bicistronic vector pEPO-IRES2-EGFP. 
Table 3.3.2a: pCMV-EGFP-EPO purity and concentration obtained from the DNA maxi-preparation.  
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HEK293s cells cultured in serum-free 293 SFM II + AA medium and in serum-
containing DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium were transfected using a ratio 
of 1.0:1.5 of DNA:PEI (µg:µg). The complex was formed in serum-free 293 SFM II + 
AA or DMEM -Ca2+ + Vit. medium according to the better results obtained in the 
preliminary experiments described in section 3.2. Cells were analyzed by flow 
cytometry 48 and 72 hpt. The results showed 72 % and 67 % GFP-positive cells after 48 
hpt and 72 hpt, respectively for transfection in serum-containing medium. No 
significant transfection for the procedure in serum-free conditions could be observed 
(data not shown). The experiment was performed three times obtaining always the same 
results (data not shown). 
In order to evaluate whether these results were due to an inhibition in the 
transfection procedure from the 293 SFM II + AA medium applied, HEK293s cells 
cultured in this medium were washed with DMEM -Ca2+ + Vit. + Pl. + 5 % medium 3 h 
before transfection, and sub-cultured in this same medium. The complex was prepared 
in DMEM -Ca2+ + Vit. and added to the cells. Six hours later, the cells were centrifuged 
(2000 rpm, 3 min) and washed one time with the 293 SFM II + AA medium. Cells were 
seeded again in 12-well plates, using the same serum-free medium as washed, for 
further incubation until flow cytometry analysis, 48 hpt. In parallel, HEK293s cultured 
in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS and in 293 SFM II + AA media were 
transfected. The results showed, that similar transfection efficiency as in serum-
containing medium was reached (75 % and 70 %) with cells cultured under serum-free 
conditions when one medium exchange for the transfection was done (293 SFM II + 
AA medium to DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium). In contrast, transfection 
under serum-free conditions without medium exchange showed no significant 
transfectability (less than 1.5 %) (Fig. 3.4.1a).  
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3.4.2 Transfection without cell wash before the addition of transfection 
complex 
The first aim of this work was to define a simple and scalable transfection process. In 
order to reach this objective, two steps had to be simplified: the 3 h incubation period of 
the DNA:PEI complex with cells in reduced culture volume, and the medium change 3 
h prior to transfection. We assumed, that a reduced culture medium could promote the 
interaction of the DNA:PEI complex with the cells and thus increasing transfection 
efficiency (Durocher et al. 2002). A medium change was reported to be necessary to 
avoid deleterious effects of conditioned medium on the transfection efficiency 
(Schlaeger and Christensen 1999). This medium exchange step is a comparably simple 
procedure in small-scale but represents a significant hurdle at scales in the range of 
liters. Therefore, transient transfection without the preceding cell wash step was 
Fig. 3.4.1a: HEK293s cultured in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS and in 293 SFM II + AA 
medium were transfected with 1.0 µg of DNA and 1.5 µg of PEI. The complex was prepared in 
serum-free medium (DMEM -Ca2+ + Vit.). The figure shows that cells growing under serum-free 
conditions with one medium exchange from 293 SFM II + AA medium to DMEM -Ca2+ + Vit. + 
Pl. + 5 % FCS for transfection reached a similar transfection efficiency as cells cultured under 
serum-containing conditions. In contrast, transfection under serum-free conditions alone showed 
no significant transfection. TTran.: Transient Transfection. Errors bars represent + SD of one 
experiment done in duplicate. 
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performed under PEI-mediating conditions, following the protocol B described under 
the section 2.18.1.1. 
HEK293s cultured in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium were used to 
perform this experiment. The complex formation was prepared as indicated in the 
previous section 3.4.1 (1.0 µg of pEPO-IRES2-EGFP and 1.5 µg of PEI) and added to 
the cells. Results from flow cytometry analysis showed transfection efficiency in the 
same range (70 %) 48 hpt as it was found for the transfection procedure with the wash 
step (data not shown).  
Transfection was done with both plasmids (pEPO-IRES2-EGFP and pCMV-EGFP-
EPO) obtained the results showed in figure 3.4.2a. Transfection efficiencies higher than 
60 %, with the first plasmid, and 90 % with the second, were reached following the 
transfection procedure without cell wash before the addition of the transfection 
complex. 
 
These results clearly showed that the transfection without a preceding wash step 
was possible in HEK293s cultures under serum-containing conditions.  
 
Fig. 3.4.2a: HEK293s growing in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS were transfected with 
DNA:PEI (1.0µg:1.5µg) without a preceding cell wash step before the addition of transfection 
complex.  pEPO-IRES2-EGFP (in red) and pCMV-EGFP-EPO (in gray) were used. GFP-positive 
cells were quantified by flow cytometry, 48 hpt. Errors bars represent + SD of one experiment done 
in duplicate. 
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3.5 Optimization of serum-free medium for transfection 
The next experiments were directed to the development of a serum-free medium, in 
which a successful transfection without cell wash step of adapted HEK293s will be 
possible. 
FreeStyle™ 293 expression medium (see 2.4.1) was especially developed for 
supporting growth and transfection (without cell wash step) of the special FreeStyle 
293-F cell line, which is a subclone of the 293 cell line (FreeStyle™293 Expression 
Manual, www.invitrogen.com). Therefore, this serum-free medium was chosen to 
perform the next experiments. 
HEK293s cells already adapted to the SFM 293 II + AA serum-free medium were 
thawed (revitalization protocol under 2.8.1) and cultured in the same medium. Three 
sub-cultures were performed under these media conditions. Subsequently, cells were 
washed one time with FreeStyle™ 293 expression medium and were directly cultured in 
this new formulation at a cell concentration of about 5.0 × 105 mL-1. The cells were sub-
cultured four times always when they reached a cell concentration of about 1.5 × 106 
mL-1. The same standard parameters as indicated in section 3.1.1 were determined. The 
viability was always above 90 % (data not shown). In the last sub-culture, cells entered 
a lag phase-like situation after 15 days, growth ceased and viability dropped down (data 
not shown). 
Due to the fact, that the cells were not completely adapted to the new FreeStyle™ 
293 expression medium, one direct experiment was performed in order to check 
whether it is already possible to transfect the cells without wash step. In parallel, 
FreeStyle™ 293 expression medium was compared to the standard serum-containing 
medium DMEM -Ca2+ + Vit. + Pl. + 5 % FCS. The same protocol as already explained 
under 3.4.2 was applied using the pEPO-IRES2-EGFP vector for complex formation. 
This complex was built in DMEM -Ca2+ + Vit., and in Opti-MEM® I medium according 
to manufacturer’s protocol. This medium contained less than 1 % of FCS. The day 
before transfection, cells from sub-culture 2 after adaptation and growing in FreeStyle™ 
293 expression medium, were taken and a new inoculate of a concentration between 3.5 
× 105 mL-1 and 5.0 × 105 mL-1 was performed. Approximately 24 h later, a cell 
concentration of about 7.0 × 105 mL-1 and a viability of 96 % was adjusted. Transfection 
in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS was used as control. Results taken from the 
flow cytometry analysis (48 hpt) revealed nearly 25 % GFP-positive cells in FreeStyle™ 
293 expression medium/Opti-MEM® I medium, and nearly 10 % when the complex 
was prepared in DMEM -Ca2+ +Vit. (Fig. 3.5a). 
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The Hybridoma-SFM medium (H-SFM, section 2.4.1) was initially developed for 
growth of hybridoma cells. A custom-made low-calcium H-SFM medium supplemented 
with 1 % of FCS was used in several experiments previously reported (Coté et al. 1998; 
Durocher et al. 2002) to support cell growth of HEK293s cells and to perform transient 
transfection with these cells. Therefore, H-SFM + Pl. medium (2.4.1) was decided to 
use also in the next experiments. 
The same adaptation protocol as taken for the FreeStyle™ 293 expression medium 
was applied. HEK293s cells grew to a cell concentration of 1.5 × 106 mL-1 within two 
days. Very large clusters (more than 50 cells) occurred which could not be disintegrated 
following the protocol described in section 2.5.3. Due to the fact, that a homogeneous 
cell suspension is considered to be an important prerequisite for successful transfection, 
this culture medium was excluded from further transfection test. 
In order to find a suitable serum-free medium for growth and transfection of 
HEK293s cells as single cell suspension without applying a wash step before 
Fig. 3.5a: Transfection of HEK293s cells (without wash step) cultured in DMEM -Ca2++ Vit. + Pl. + 
5 % FCS (in red) and in FreeStyle™ 293 expression medium (in black). Cells were transfected with 1 
µg of DNA (pEPO-IRES2-EGFP) and 1.5 µg of PEI. GFP was measured by flow cytometry 48 hpt. 
The complex was prepared in DMEM -Ca2+ + Vit. for both cultures and either in Opti-MEM I 
medium, for cells cultured under serum-free condition. Errors bars represent + SD of one experiment 
done in duplicate. 
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transfection, different serum-free adaptation protocols to several media manufactures 
were tested in parallel as is explained below.  
3.5.1 Sequential adaptation with successive cell dilution  
The following experiments were characterized by a discontinuous reduction of the FCS 
content when HEK293s cells reached a cell concentrations of 1.5 × 106 mL-1. The 
adaptation process to the different serum-free media H-SFM + Pl.and SMIF 7 followed 
the protocol described in material and methods under 2.6.2. 
HEK293s cells cultured in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS was used as initial 
culture. Samples were taken daily and the standard parameters (2.10 and 2.11) were 
determined routinely (data not shown). 
During adaptation to H-SFM + Pl., large clusters, of more than 50 cells, occurred 
which could not be disintegrated (see protocol under 2.5.3). Therefore, this medium was 
discarded from further test. 
Very big aggregates also appeared during adaptation to SMIF 7 medium. When 
SMIF 7 with a reduced amount of Ca2+ (10 µmol L-1 CaCl2) was used, smaller clumps 
appeared, but the HEK293s cells stop growing after the third sub-culture. They entered 
a lag phase of seven days resulting in the decision to stop further evaluation of this 
medium formulation (data not shown).  
3.5.2 Direct adaptation 
Some medium manufactures recommend a direct adaptation. Here, the cells cultured in 
serum-containing medium were washed with the respective new serum-free medium 
and directly sub-cultured under the new conditions. This direct adaptation process was 
used for H-SFM + Pl. and Ex-Cell 293™ media (2.4.1) following the protocol described 
under 2.6.3.  
The direct adaptation to H-SFM + Pl. medium was performed without successful 
results. Large cell aggregates were occurred as also observed for the other two 
adaptation processes. H-SFM + Pl. was supplemented with EDTA to prevent formation 
of clumps, and additionally lipids were added according to Cote et al., 1998 (2.4.1). A 
new direct adaptation protocol with this supplemented medium (H-SFM + Pl. + Lip. + 
EDTA) was performed obtaining the same results as before (data not shown) such that 
the medium was excluded for further experiments, too. 
The direct adaptation to the serum-free Ex-Cell 293™ medium gave better results. 
HEK293s cells grew as small clumps between 5 and 10 cells after the third sub-culture. 
Additional three sub-cultures were run and a batch cultivation was performed during 
eight days in a small spinner flask. The standard parameters (2.10 and 2.11) were 
determined. The viable cell concentration reached 8.0 × 106 mL-1 with viability higher 
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than 95 % and no glucose limitation was observed during the entire batch culture (data 
not shown). The population doubling time of HEK293s cells growing in ExCell 293™ 
medium was 31.5 h. Therefore, HEK293s cells growing in ExCell 293™ medium were 
considered fully adapted to this new serum-free medium. 
A direct adaptation to a serum-free medium was successfully performed from Ex-
Cell 293™ to the Ex-Cell 293™ modified medium (2.4.1). Cell clusters between 20 to 
50 cells were formed at high cell concentration. To evaluate the medium as standard in 
future cultivations, a batch culture was performed for eight days. Standard parameters 
(2.10 and 2.11) were determined. The viable cell concentration reached nearly 8.0 × 106 
mL-1 with a viability of more than 90 %. Subsequently, the cells rapidly entered the 
death phase (data not shown). No glucose limitation was observed as in batch culture 
using ExCell 293™ medium (data not shown). The population doubling time of these 
cells was 30.8 h. 
3.5.3 Preliminary transient transfection experiments using different 
serum-free media 
Transient transfection in small-well plates was performed using the different serum-free 
media in which HEK293s cells could be fully adapted (293 SFM II + AA, ExCell 293™ 
and Ex-Cell 293™ modified media). 
1 % of FCS was added to the serum-free medium in parallel experiments as 
recommended by Durocher et al. (2002) to improve transient transfection (FreeStyle™ 
293 Expression Manual, www.invitrogen.com, Invitrogen Technical Services).  
The following mediums were used as specified below: 
 
1- Ex-Cell 293™ medium 
2- Ex-Cell 293™ medium + 1 % FCS 
3- Ex-Cell 293™ modified medium 
4- Ex-Cell 293™ modified medium + 1 % FCS 
5- 293 SFM II + AA + 1 % FCS 
 
For the HEK293s cells cultured in media 1 and 3, cells were counted and seeded in 
the plate at a concentration of 5.0 × 105 mL-1 per well (900 µL × well), three hours 
before transfection. Plates were further incubated. 
For media 2, 4 and 5, cells growing in the respective medium without serum were 
washed one time with the corresponding medium with 1 % FCS and seeded in the plate 
at the same cell concentration mentioned above. They were further incubated for three 
hours until the transfection procedure was performed.  
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Transfection in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS was performed in parallel as 
control. HEK293s cells cultured in each different medium (1 to 5), without transfection, 
were used as negative control. 
The DNA:PEI (1.0:1.5, µg:µg) complex was formed in DMEM -Ca2+ + Vit. for all 
transfections, using the pEPO-IRES2-EGFP vector.  
Flow cytometry measurements were performed 48 hpt. 
The following table (Table 3.5.3a) shows the results for each medium. Every 
measurement was calibrated with the corresponding control. These results showed no 
significant transfection for every medium tested. Every data represent the average from 
two different experiments.  
Medium: Positive 
control 
(DMEM 
-Ca2+ + 
Vit. + Pl. 
+ 5 % 
FCS) 
1 
Ex-Cell 
293™ 
medium 
2 
Ex-Cell 
293™ 
medium 
+ 1 % 
FCS 
3 
Ex-Cell 
293™ 
modified 
medium 
4 
Ex-Cell 
293™ 
modified 
medium 
+ 1 % 
FCS 
5 
293 
SFM II 
+ AA + 
1 % 
FCS 
GFP-
positive 
cells (%) 
74.59 0.24 0.10 3.02 1.50 0.10 
 
Further experiments were performed, but preparing the transfection complex in each 
serum-free medium used in the previous experiment instead of DMEM -Ca2+ + Vit. 
medium. The results taken from flow cytometry analysis (48 hpt) showed no significant 
transfection for all media used. Untransfected (controls) and transfected cell cultures 
showed less than 0.5 % of GFP-positive cells (data not shown).  
In order to investigate, whether the presence of serum improves the transfectability, 
experiments were done using Ex-Cell 293™ modified medium and the 293 SFM II + 
AA medium supplemented with different amounts of FCS (2.5 % and 5 %), but without 
any successful (increase transfectability) results. 
At this point, only 10 % GFP-positive cells were reached after transfection in 
FreeStyle™ 293 expression medium and complex formation in serum-free DMEM -Ca2+ 
+ Vit. medium (Fig. 3.5a) and only 3.02 % GFP-positive cells were found using the Ex-
Cell 293™ modified medium (see table 3.5.3a). It was not clear whether the low 
transfectability was due to an inhibition by components of the serum-free medium 
and/or by the absence of unknown components important for transfection, which are 
Table 3.5.3a: Small-scale transient transfection of HEK293s cells in different serum-free media. 
Three hours before transfection, cells were washed with the respective medium and seeded in the 
plate for transfection. The DNA (pEPO-IRES2-EGFP):PEI (1.0:1.5, µg:µg) complex was prepared in 
DMEM -Ca2+ + Vit. for all cases, incubated at RT for 10 min and added to the cells. Flow cytometry 
measurements were performed 48 hpt. Transfection in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS was 
performed as positive control. Every data represents the average from two experiments.  
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present in FCS. This assumption was concluded from results obtained when cells 
cultured in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS were washed before transfection and 
transferred in the same medium without serum, resulting in no significant transfection 
(data not shown). In order to identify a possible inhibition from medium components, 
these two media were diluted with DMEM -Ca2+ + Vit., expecting to have a higher 
percentage of GFP-positive cells. Media were prepared in the following way: 
 
I) [Ex-Cell 293™ modified:(DMEM -Ca2+ + Vit.)], [1:1] 
II) [293 FreeStyle™ expression medium:(DMEM -Ca2+ + Vit.)], [1:1] 
 
Cells already adapted to Ex-Cell 293™ modified serum-free medium were washed 
one time with each medium (I and II) in the mid-exponential growth phase and sub-
cultured in these media at an initial cell concentration of 5.0 × 105 mL-1. These two new 
cultures were continuously sub-cultured every second or third day to maintain the cell 
concentration between 1.5 × 106 mL-1 and 2.0 × 106 mL-1. After the third passage, cells 
were prepared for small-scale transient transfection without cell wash. The complex 
(1.0:1.5, µg:µg; DNA (pEPO-IRES2-EGFP):PEI) was prepared in DMEM -Ca2+ + Vit. 
medium. GFP-positive cells were visualized by flow cytometry analysis 48 hpt. 
Transfection in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS was used as control. Figure 3.5.3a 
shows that the mixed medium II, [293 FreeStyle™ expression medium:(DMEM -Ca2+ + 
Vit.)], [1:1] revealed a transfection efficiency as obtained for the control.  
Transfection under serum-free medium II conditions was performed three times in 
duplicate and the same result was obtained (data not shown). 
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With this result the first aim of the work was achieved, namely to find a serum-
free and/or protein-free medium formulation to guarantee chemically defined 
culture conditions for further transient transfection processes without washing the 
cells prior to the addition of the complex and without changing the medium after 
the transfectionaprocedure – a prerequisite for large-scale transfection. 
 
3.6 Process optimization for transfection in serum-free medium 
The next experimental step was driven to optimize and characterize the HEK293s cell in 
the new serum-free [FreeStyle™ 293 expression medium:(DMEM -Ca2+ + Vit.)], [1:1] 
medium (2.4.1). 
3.6.1 Establishment of cells completely adapted to the new serum-free 
medium 
Two different batch cultivations in small spinner flask (50 mL working volume) were 
performed for eight days in the new serum-free medium composition, [FreeStyle™ 293 
Fig. 3.5.3a: HEK293s cells growing in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS (in red), in [Ex-Cell 
293™ modified:(DMEM -Ca2+ + Vit.)], [1:1] (in black) and in [293 FreeStyle™ expression 
medium:(DMEM -Ca2+ + Vit.)], [1:1] (in gray) were transfected with (DNA:PEI), (1.0:1.5, µg:µg) 
prepared in DMEM -Ca2+ + Vit.. GFP was measured by flow cytometry analysis 48 hpt. Errors bars 
represent + SD of one experiment done in duplicate. 
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expression medium:(DMEM -Ca2+ + Vit.)], [1:1], (FS:DMEM) in order to characterize 
the HEK293s cells under these new conditions. 
Cell concentration, viability, glucose and lactate concentration, as well as the LDH 
activity were measured (Fig. 3.6.1a). The cell concentration reached was about 3.0 × 106 
mL-1. Viability was higher than 95 % during the cultivation period (Fig. 3.6.1a; A). 
Population doubling time was between 30 and 37 h. When glucose fell short of a 
concentration of 1.50 g L-1, cells started to consume lactate (Fig. 3.6.1a; B). At the end 
of the cultivation, LDH was comparably high at a value of about 10 µkat L-1 (Fig. 
3.6.1a; C). 
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Fig. 3.6.1a: Two batch cultivations of HEK293s cells growing in FS:DMEM medium. Both cell 
cultures were performed in small spinner flasks (50 mL working volume) during eight days. Cell 
concentration and viability (A), glucose and lactate concentration (B), and LDH activity (C) were 
determined. 
83 3.  Results 
Amino acids were analyzed (2.11.3) to identify a possible nutrient limitation. The 
pattern of amino acids was similar for both batch cultures. Figure 3.6.1b shows the 
amino acid concentrations in the supernatant of HEK293s during batch culture in 
FS:DMEM medium. The arrows (↓) indicate a depletion in the amino acids aspartate 
(Asp) and glutamate (Glu) at the end of the batch culture (216 h). Therefore, this 
medium was supplemented with 600 µmol L-1 of Asp and 100 µmol L-1 of Glu in future 
and was called FS:DMEM + AA. 
 
HEK293s cells were cultured in this FS:DMEM + AA medium and, after a 
minimum of four sub-cultures, a batch cultivation was performed for ten days. 
Standard parameters (Fig. 3.6.1c) were measured. The viable cell concentration was 
higher in medium with AA at the end of the exponential growth phase compared to the 
non-supplemented formulation (6.5 × 106 mL-1 compared to 3.0 × 106 mL-1). Cell 
viability was higher than 95 % during the complete batch process (Fig. 3.6.1c; A). 
Lactate was consumed after 144 h of cultivation although the glucose concentration was 
still at 1.50 g L-1 at this cultivation time (Fig. 3.6.1c; B). At this point, LDH presented 
values of more than 6 µkat L-1 (Fig. 3.6.1c; C). At the beginning of the stationary 
growth phase (at 144 h) aggregates of about 20 to 30 cells occurred. The population 
double time of the HEK293s in this new serum-free medium was between 30 and 36 h. 
Batch culture of HEK-293s in FS:DMEM medium
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Fig. 3.6.1b: Amino acid concentrations in the culture supernatant of HEK293s cells growing in 
FS:DMEM medium. The ↓ indicate Asp and Glu limitation at the end of the culture batch (216 h). 
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Fig. 3.6.1c: Batch culture of HEK293s cells in FS:DMEM + AA medium. Culture was performed in 
small spinner flasks (50 mL working volume) during ten days. Cell concentration and viability (A), 
glucose and lactate concentration (B), and LDH activity (C) were determined. 
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Amino acids were analyzed in this new batch culture and no limitation could be 
detected (data not shown). 
 
HEK293s cells were considered completely adapted to the new serum-free and 
protein-free FS:DMEM + AA medium and a working cell bank was generated. 
These cells had the passage number 60. 
Finally, this medium was chosen to perform all the following experiments under 
serum-free conditions. 
 
3.6.2 DNA:PEI ratio optimization 
Different DNA:PEI ratios were evaluated in order to decrease the amount of the DNA 
used obtaining highest transfectability at minimum DNA dosage. HEK293s cultured in 
FS:DMEN + AA medium were transfected using different ratios of DNA (pEPO-
IRES2-EGFP):PEI (µg:µg). One small-scale experiment (12-well plate) was performed 
in duplicate. Flow cytometry analyses were performed 48 hpt. Figure 3.6.2a shows that 
the highest transfection efficiencies were obtained using a DNA:PEI (µg:µg) ratio of 
0.50:1.50.  
Fig. 3.6.2a: HEK293s cells cultured in FS:DMEM + AA medium were transfected using different 
ratios of DNA (pEPO-IRES2-EGFP vector) and PEI. One small-scale experiment (12-well plate) was 
performed in duplicate. GFP was measured by flow cytometry analysis 48 hpt. Errors bars represent 
+ SD of one experiment done in duplicate.  
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This experiment, using the same DNA:PEI ratios, was repeated and gave the same 
results as presented above (data not shown). In order to further decrease the amount of 
the DNA used, another transfection experiment was performed for DNA:PEI (µg:µg) 
ratios: 0.25:1.00 and 0.25:1.50. The transfectability was below 30 % (data not shown).  
 
The rhuEPO concentration was quantified by the specific ELISA (2.19.2) in the cell 
culture supernatant stored at –20 °C, 48 hpt. Figure 3.6.2b shows the results in which 
the highest expression level of rhuEPO was obtained using the DNA:PEI (µg:µg) ratio 
of 0.50:1.50, which correlated well with the highest transfectability determined by the 
GFP-positive cells. 
 
Summarizing, these results showed that a DNA:PEI (µg:µg) ratio of 0.5:1.5 
guaranteed on the one hand highest transfection efficiency and on the other hand 
the highest expression level for the model protein. Therefore, this ratio was chosen 
to perform future transient transfection processes.   
Fig. 3.6.2b: HEK293s cultured in FS:DMEM + AA medium were transfected with different amounts 
of DNA (pEPO-IRES2-EGFP vector) and PEI. rhuEPO from the cell culture supernatant at 48 hpt 
was quantified by ELISA. Errors bars represent + SD of one small-scale experiment done in 
duplicate. 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0.50:1.00 0.50:1.50 0.75:1.00 0.75:1.25 1.50:1.25
 DNA:PEI (µg:µg)
rh
uE
PO
 c
on
c.
 / 
(µ
g 
m
L-
1 )
 
87 3.  Results 
3.7 Scale-up and characterization of transient transfection 
The next step was to scale-up the transient transfection procedure to spinner flasks with 
200 mL working volume. HEK293s cells growing in FS:DMEM + AA medium were 
initially cultured at a cell concentration of about 3.0 × 105 mL-1 to 5.0 × 105 mL-1. 
Transfection procedure was performed, when the cell concentration reached a value 
between 6.0 × 105 mL-1 and 1.0 × 106 mL-1 and the viability maintained above 98 % 
(approximately 24h or 48 h after the seeding). The complex formation was induced in 
20.0 mL of DMEM -Ca2++ Vit. (1/10 of the total volume to be transfected), as it was 
already explained under 2.18.1.2). The plasmid pEPO-IRES2-EGFP was used in the 
DNA:PEI ratio of 0.5:1.5, µg:µg. Briefly, first DNA was added and, two minutes later, 
PEI. The complex was homogenized (by vortex) and incubated for 10 minutes at RT 
before the addition to the cells. Every 12 hpt samples were taken for flow cytometry 
analysis and the respective cell supernatants were stored at –20 °C for the quantification 
of rhuEPO. Cell concentration, viability, substrates and metabolites were determined as 
described before (section 2.10 and 2.11). Figure 3.7a shows that the maximum 
transfectability, expressed as GFP-positive cells, was reached between 60 and 72 hpt 
with a value of 70 %. The highest rhuEPO productivity was reached 72 hpt with a 
concentration of 1.58 µg mL-1. 
Fig. 3.7a: HEK293s cells growing in FS:DMEM + AA medium (200 mL working volume, in spinner 
flask) were transfected (↓) using a DNA:PEI (µg:µg) ratio of 0.5:1.5, without washing the cells. GFP-
positive cells were quantified by flow cytometry (•) and rhuEPO (♦) was measured by ELISA every 
12 hpt.  
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Different transfection experiments were performed in big spinner flasks (200 mL 
working volume) using HEK293s cells growing under serum-free (FS:DMEM + AA) 
and serum-containing (DMEM -Ca2+ + Vit. + Pl. + 5 % FCS) medium conditions 
following the same protocol as described before (section 2.18.1.2). The cells used were 
from an early (between 40 and 77) and late (between 89 and 150) passage numbers. Cell 
concentration, viability, substrates and metabolites as well as intracellular nucleotides 
were determined as described in material and methods section (2.10, 2.11 and 2.12). 
 
Table 3.7a summarizes different transient transfections performed in serum-free 
medium with HEK293s cells from an early and a late passage number using pEPO-
IRES2-EGFP and pCMV-EGFP-EPO plasmids. The GFP-positive cells were identified 
between 60 and 72 hpt as well as the rhuEPO and the total protein concentration of the 
cell supernatant stored at –20 °C.   
These results showed, that cells from an early passage number (70 and 76), 
transfected with the plasmid pEPO-IRES2-EGFP, presented highest transfection 
efficiencies (73.22 % and 70.49 %, respectively) compared to their counterparts from a 
late passage number (89 and 101: 51.02 % and 55.62 %, respectively). The same results 
were also observed for cells transfected with the plasmid pCMV-EGFP-EPO with 95.97 
% compared to 69.48 %. However, the absolute values reached were higher than for 
cells transfected with the first plasmid. Moreover, the expression of the rhuEPO showed 
the same tendency as the transfection efficiency expressed by the GFP-positive cells, 
but no difference between transfection with the different plasmids could be observed. 
EPO represented between 2.5 % and 10 % of the total protein concentration. 
 
89 3.  Results 
Transfection of HEK293s cells in serum-free medium 
(DNA:PEI = 0.5 µg:1.5 µg) 
 
Cell passage 
number: 
 
Plasmid used: 
GFP-positive 
cells 
(%) 
 
(60 – 72 hpt) 
rhuEPO 
conc. 
(µg mL-1) 
 
(60 – 72 hpt) 
Total protein 
conc. 
(µg mL-1) 
 
(60 – 72 hpt) 
 
70 (early) 
 73.22 1.54 14.80 
 
76 (early) pEPO-IRES2- 70.49 1.58 17.12 
 
89 (late) 
EGFP 51.02  1.17 34.51 
 
101 (late) 
 55.62  1.29 51.18 
 
70 (early) pCMV- 95.97 1.59 19.94 
 
101 (late) 
EGFP-EPO 69.48 n.d. 57.08 
n.d.= not determined 
 
Table 3.7b shows the same experiments as in Table 3.7a but the transfection 
procedure was done under serum-containing conditions. HEK293s cells from an early 
and a late passage number and the plasmids pEPO-IRES2-EGFP and pCMV-EGFP-
EPO were used (same conditions as in serum-free medium). Identification of GFP-
positive cells as well as rhuEPO and protein concentrations in the cell culture 
supernatant were determined between 60 and 72 hpt. 
In this case, the highest transfection efficiencies (80.15 % – 86.39 % compared with 
43.97 % to 71.3 %) were reached when cells from a late passage number (116 and 150) 
were transfected either with pEPO-IRES2-EGFP and pCMV-EGFP-EPO. Considering 
the results from transfection of cells from the same early passage no. 42, highest values 
of 58.37 % for the second plasmid, which contains EGFP as first gene, were found 
compared to 43.97 % for GFP-positive cells for the first plasmid. This has confirmed 
the results from transfections under serum-free conditions.  
For the transfection procedure using the pEPO-IRES2-EGFP plasmid, highest 
productivity of the rhuEPO between 2.07 and 2.60 µg mL-1 were obtained in the 
supernatant of cells cultured under serum-containing conditions compared to 1.17 to 
1.58 µg mL-1 in serum-free medium. This difference was not observed with the pCMV-
EGFP-EPO plasmid.  
Table 3.7a: The different transfection experiments performed under serum-free conditions at a 
glance.  
90 3.  Results 
EPO represented approximately 0.02 % of the total protein concentration. 
Transfection of HEK293s cells in serum-containing medium 
(DNA:PEI = 0.5 µg:1.5 µg) 
 
Cell passage 
number: 
 
Plasmid used: 
GFP-positive 
cells 
(%) 
 
(60 – 72 hpt) 
rhuEPO 
conc. 
(µg mL-1) 
 
(60 – 72 hpt) 
Total protein 
conc. 
(µg mL-1) 
 
(60 – 72 hpt) 
 
40 (early) 
 71.3 2.60 1381.96 
 
42 (early) pEPO-IRES2- 43.97  2.07 1364.24 
 
116 (late) 
EGFP 80.15 2.34 1369.50 
 
42 (early) pCMV- 58.37 n.d. 1367.46 
 
150 (late) 
EGFP-EPO 86.39 1.41 1380.88 
n.d.= not determined 
3.7.1 Intracellular nucleotide pools 
Intracellular nucleotide pools have been reported to reflect the physiological state of 
BHK, hybridomas and CHO cells culture (Grammatikos et al. 1999; Ryll et al. 1994; 
Ryll and Wagner 1992). They represent the driving forces for cell growth and 
metabolism. The knowledge of the correct cell physiology is a prerequisite for a 
successful production process.  
In order to evaluate the HEK293s cells metabolic energy and growth potential with 
respect of increasing productivity, and therefore to characterize and optimize the 
transient transfection procedure, the intracellular nucleotide pattern of these cells was 
analyzed under different culture conditions. 
 
Intracellular nucleotides were quantified as explained under materials and methods 
in section 2.12. AEC, NTP ratio, U ratio and NTP/U ratio were calculated as described 
before (2.12.1). 
The absolute value of the NTP/U ratio for cells in good physiological state varies 
with cell type, medium and culture mode. Every cell line reveals a specific range which 
indicates a good physiological state (Grammatikos et al. 1999; Ryll and Wagner 1992). 
Therefore, the characteristic range of HEK293s cells under different conditions was 
studied. 
Table 3.7b: The different transfection experiments performed under serum-containing conditions at a 
glance. 
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HEK293s cells from early and late passage numbers were cultivated in 200 mL 
spinner flasks in serum-containing medium, DMEM -Ca2+ + Vit. + Pl. + 5 % FCS, and 
in serum-free medium, FS:DMEM + AA. In parallel, batch cultures without (w/o) 
transfection/with (w.) transfection were performed to characterize the cells. Cell 
concentration, viability, substrates and metabolites as well as intracellular nucleotides 
were determined every day (2.10, 2.11 and 2.12). 
3.7.1.1 Early vs. late passage number 
Serum-containing medium 
First, HEK293s cells from early (77) and late (101) passage numbers growing under 
serum-containing conditions were evaluated. Diagram A from figure 3.7.1.1a; A shows 
that cells from the exponential growth phase proliferated to about 3.5 × 106 mL-1 within 
72 h of cultivation before they entered the stationary phase. During the first hours of 
culture (cultivation time: 0 and 24 h) the NTP/U ratio maintained below 3.3 (horizontal 
black dash line). This period indicated best physiological conditions. Then (↓), this ratio 
increased more than two-fold in cultures with cells from an early passage number (from 
3.28 to 9.77) and from 3.14 to 4.92 in cultures with cells from a late passage number. 
This increase indicated a worsening of the cellular conditions and a poor growth 
potential, and therefore, the cells entered the phase of reduced exponential growth. This 
situation was confirmed 1 day later by counting the cell number in both cultivations 
(vertical black dash line). Usually, a 50 – 100 % increase in NTP/U value from the basal 
level is enough to consider this phase as sub-optimal cell state (Grammatikos et al. 
1999).   
This increment in the NTP/U ratio showed different characteristics between cells 
from early and late passage numbers. In the first case, the NTP/U ratio reached its 
maximum after 96 h of culture, but in the second case 48 h later (blue dot line for early 
passage number, and red dot line for late passage number) indicating a further 
worsening of cell state and the beginning of the starvation phase (Fig. 3.7.1.1a; A). 
These results indicated a change in the cell physiological character during aging of this 
cell type. 
 
92 3.  Results 
     
The adenylate energy charge (AEC) was determined and presented values of about 
0.96 in both cell types throughout the batch culture. 
 
Viability, glucose, lactate and LDH were compared between both batch cultures 
(Fig. 3.7.1.1a; B, C and D). The vertical black dash line indicates the end of the 
exponential phase. The behavior of the cultures with cells from different ages was the 
same in nearly all parameters, characterized by a viability of more than 90 % for the 
total culture time (Fig. 3.7.1.1a; B). Except lactate production, which was higher (1 g   
L-1 more) in cultures with cells from the early passage number (Fig. 3.7.1.1a; C).  
 
 
 
 
Fig. 3.7.1.1a; A: Two batch cultures of HEK293s from an early (blue filled symbol) and a late (red 
open symbol) passage number cultivated under serum-contaning conditions (DMEM -Ca2+ + Vit. + 
Pl. + 5% FCS). The cell concentration (symbol: square) and NTP/U (symbol: circle) ratio were 
determined. The horizontal black dash line shows the low values of the NTP/U ratio, indicating best 
physiological state. The arrow indicates the point at which an increase in the NTP/U ratio was 
observed indicating a worsening of the cell conditions. The vertical blue dot line and the vertical red 
dot line indicate the maximum increase of the NTP/U ratio for cultures with cells from the early 
passage number and the late passage number, respectively. The vertical black dash line indicated the 
end of the exponential phase. 
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93 3.  Results 
 
Fig. 3.7.1.1a; B, C and D: Two batch cultures of HEK293s from an early (blue filled symbol) and a 
late (red open symbol) passage number under serum-containing conditions (DMEM -Ca2+ + Vit. + Pl. 
+ 5% FCS). Viability (B), glucose and lactate (C) and LDH (D) were evaluated and compared 
between both cells ages. The vertical black dash line indicated the end of the exponential phase. 
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Serum-free medium conditions 
The same procedure was done for cells growing under serum-free conditions. HEK293s 
from the early passage number 70 and from the late passage number 101 were 
cultivated in FS:DMEM + AA medium. 
Diagram A from figure 3.7.1.1b shows that cells of a late passage number (red open 
square) grew exponentially to about 4.0 × 106 mL-1 within 72 h before entering the 
stationary phase. Cells of an early passage number (blue filled square) continuously 
grew until a cell concentration of 5.5 × 106 mL-1 within 120 h of culture. However, they 
showed a lower growth rate (µ) of about 19.4 × 10-3 h-1 (compared to a µ of 27.4 × 10-3 
h-1 for cells of the late passage no.). The reduced growth rate could be visualized by the 
NTP/U ratio, which amounted to less than 2.3 and maintained more or less during the 
first hours (0 and 24; horizontal black dash line). Then it (↓) increased until the end of 
the batch culture without reaching a maximum. Cultures of cells from a late passage 
number also showed a NTP/U ratio of less than 2.3 and maintained during the first 
hours of the culture. Then (↓) the NTP/U ratio increased and reached a maximum at 144 
h of the culture. 
In these cells, an NTP/U ratio of less than 2.3 indicated cells could be found 
indicating good physiological conditions.  
The NTP/U ratio of cultured cells from a late passage number ranged between 1.54 
and 1.83 in the first two days, then it increased to 2.86 in the following 24 h indicating a 
worsening of the cell conditions and the end of the exponential growth phase (vertical 
red dash line). This could be confirmed 48 h later by counting the cells. For cultures 
with cells from an early passage number, the NTP/U ratio was between 1.57 and 1.91 at 
the beginning of the culture (0 and 24 h), followed by an increase of 50 % 48 h later. 
This indicated the end of the exponential growth phase which was also confirmed 48 h 
later by counting the stationary cell number (vertical blue dash line, 110 h of cultivation 
time). The further dramatically increase of this ratio indicated the starvation phase, 
when the cell viability dropped down (Fig. 3.7.1.1b; B). 
An AEC of 0.98 to 0.95 throughout the batch culture was found for cells from the 
early passage number and of 0.97 to 0.93 for the respective cells from the late passage 
number. 
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Viability, glucose, lactate and LDH from both cultures were compared (Fig. 
3.7.1.1b; B, C and D, respectively). The vertical dash lines indicate the end of the 
exponential phase for cells from a late passage number (red) and for cells from an early 
passage number (blue). After this point, in both cases, the viability started to decline (B) 
and the LDH (D) increased abruptly. For cells from a late passage no., the glucose 
concentration was already depleted from the medium (conc.: 0.42 g L-1) after 114 h of 
cultivation with a maximum lactate concentration of nearly 2.0 g L-1. In contrast, 
glucose was still present at a concentration of 1.8 g L-1 for cells from an early passage 
number and lactate concentration reached 1.3 g L-1 (C). Hence, cells coming from a late 
passage number reached the stationary and starvation phase earlier. 
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Fig. 3.7.1.1b; A: Cell concentration and NTP/U ratio were evaluated from two batch cultures of 
HEK293s from an early (blue filled symbol) and a late (red open symbol) passage number cultured 
under serum-free conditions (FS:DMEM + AA). The horizontal black dash line showsd low values of 
NTP/U ratio, indicating a good physiological state. The arrow indicates the point at which an increase 
in the NTP/U ratio was observed. The vertical red dot line indicated the maximum increase of the 
NTP/U ratio for cells from the late passage number. The vertical red dash line and the vertical blue 
dash line indicate the end of the exponential growth phase for cells from the late and the early 
passage number, respectively. 
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Fig. 3.7.1.1b; B, C and D: Batch cultures of HEK293s from an early (blue filled symbol) and a late 
(red open symbol) passage number cultivated under serum-free conditions (FS:DMEM + AA). 
Viability (B), glucose and lactate (C) and LDH (D) were evaluated and compared between cells from 
both passage numbers. The vertical dash line indicated the end of the exponential phase (blue for 
early passage no. and red for late passage no.).  
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This experiment, which compared cells taken from early and late passages and 
cultivated under serum-free and serum-containing conditions, was repeated and gave the 
same results as presented above (data not shown). 
3.7.1.2 Early vs. late passage number – Transfected cells 
Serum-containing medium 
HEK293s cells from an early (40) and a late (116) passage number were cultivated in 
DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium in a spinner flask (200 mL working 
volume). They were transfected following the standard protocol (see under 2.18.1.2), 
using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg). GFP was evaluated by 
flow cytometry 60 hpt. 
The transfectability of cultured cells from the early passage was 71.30 % GFP-
positive cells compared to 82.07 % in cultures with cells from a late passage (Table 
3.7.1.2a). 
Transfection of HEK293s in serum-
containing medium 
(DNA:PEI = 0.50µg:1.50µg) 
Transfectability expressed in GFP-
positive cells (%) 
(60 hpt) 
Early passage number (40) 71.30 
Late passage number (116)  82.07 
 
Diagram A of figure 3.7.1.2a shows the transfection of HEK293s cells at a 
concentration of 1.0 × 106 mL-1 (↓).Subsequently, they continued growing with a lower 
growth rate (see table 3.7.1.2b), as indicated by the NTP/U ratio and the population 
doubling time. During the first hours before transfection this ratio amounted to less than 
3.3 and maintained in both cases (horizontal black dash line). Then (↓), the ratio started 
to increase slowly indicating a worsening of the cell conditions and a poor growth 
potential, thus reaching a maximum at 144 h of the cultivation time for cultures with 
cells from an early passage (blue dot line), whilst this maximum could not be 
determined for cultures with cells from a late passage. For cultures with youngest cells, 
the ratio increased more than 50 % 24 h after the transfection procedure, whilst with the 
oldest cells showed this increase after 48 h. The dramatic further increase indicated a 
further worsening of the cell state, which was noticed first in transfected cells from an 
early passage number. 
This increment of the NTP/U ratio has shown different characteristics between 
transfected cells from an early and late passage number under serum-containing 
medium. This was also found for the same cells, but without transfection and cultivated 
Table 3.7.1.2a: Transfectability obtained in serum-containing medium. 
98 3.  Results 
under identical conditions (3.7.1.1). These results confirmed a change in the cell 
character during aging of this cell line. 
The AEC revealed values of approximately 0.97 during all the process for both 
batch cultures. 
 
 Growth rate µ [h-1] 
Before TTran.        After TTran. 
Population doubling time td [h] 
Before TTran.        After TTran. 
Early passage no. 
(40) 
    29.6 × 10-3             13.1 × 10-3           23.4                        52.9 
Late passage no. 
(116) 
    30.8 × 10-3             15.3 × 10-3           22.5                        45.3 
 
 
Fig. 3.7.1.2a; A: HEK293s cells from an early (blue filled symbol) and a late (red open symbol) 
passage number cultured under serum-containing conditions (DMEM -Ca2+ + Vit. + Pl. + 5 % FCS) 
were transfected (↓) using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg). The cell 
concentration (square symbol) and the NTP/U ratio (circle symbol) were estimated. The horizontal 
black dash line shows the low values of the NTP/U ratio, indicating best physiological state. The 
black arrow indicates the point at which a slow increase in the NTP/U ratio was observed indicating a 
worsening of the cell conditions and a poor growth potential. The vertical blue point line indicates the 
maximum increase of the NTP/U ratio of cells from the early passage. 
-24 0 24 48 72 96 120 144 168 192
106
0
10
20
30
40
50
60
70
80
90
 C
el
l c
on
c.
 / 
m
L-
1  (
Pa
ss
:4
0)
 C
el
l c
on
c.
 / 
m
L-
1  (
Pa
ss
:1
16
)
Cultivation time / h
Late passage no.
Early passage no.
A
Transfection
 N
TP
/U
 ra
tio
 / 
- (
Pa
ss
: 4
0)
 N
TP
/U
 ra
tio
 / 
- (
Pa
ss
: 1
16
)
 
Table 3.7.1.2b: Growth rate (µ) and population doubling time (td) of HEK293s cells from an early 
and a late passage number cultivated in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium before and 
after transient transfection (TTran.) procedure. 
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Viability of cells from both cultures was higher than 90 % (Fig. 3.7.1.2a; B). 
Determination of glucose and lactate concentration (Fig. 3.7.1.2a; C) as well as LDH 
activity (Fig. 3.7.1.2a; D) revealed no difference between transfected cells from an early 
and late passage number. 
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Fig. 3.7.1.2a; B, C and D: HEK293s cells from an early (filled blue symbol) and a late (open red 
symbol) passage number cultured under serum-containing conditions (DMEM -Ca2+ + Vit. + Pl. + 5 
% FCS) were transfected using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg). Viability 
(B), glucose and lactate (C) and LDH (D) were estimated and compared.  
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Serum-free medium 
HEK293s cells from the early passage number 70 and from the late passage number 101 
were cultivated in FS:DMEM + AA medium in 200 mL spinner flasks. They were 
transfected following the standard protocol (2.18.1.2), using a DNA (pEPO-IRES2-
EGFP):PEI ratio of 0.5:1.5 (µg:µg) as explained above. GFP was evaluated using flow 
cytometry 60 hpt. 
Higher transfectability was reached in cultures with cells from the early passage no. 
(73.22 %) compared to cultures with cells from the late passage no. (55.62 %) (Table 
3.7.1.2c). 
Transfection of HEK293s in serum-
free medium 
(DNA:PEI = 0.50µg:1.50µg) 
Transfectability expressed in GFP-
positive cells (%) 
(60 hpt) 
Early passage number (70) 73.22 
Late passage number (101) 55.62 
 
The transfection procedure was performed at a cell concentration of 1.0 × 106 mL-1 
(↓) as shown in diagram A of figure 3.7.1.2b. Subsequently, the growth rate of both 
cultures decreased (see table 3.7.1.2d) as in transfected cells under serum-containing 
conditions (Table 3.7.1.2b). 
The NTP/U ratio was lower than 2.3 and more or less constant during the first hours, 
before transfection of both cell cultures (horizontal black dash line; diagram A of figure 
3.7.1.2b). Then (↓), the NTP/U ratio started to increase slowly up to 5 during the 
following 24 h post transfection, which again indicated the reduced growth already 
observed for transfected cells under serum-containing medium (Fig. 3.7.1.2a; A). 
However, the NTP/U ratio of cells from the late passage number dramatically increased 
under serum-free conditions after 90 hpt and reached a maximum of more than 250 at 
144 h of the cultivation time (red dot line) indicating that the cells entered the stationary 
and starvation phase. In contrast, the NTP/U ratio of the respective cells of the early 
passage number did not reach a maximum and only increased to a comparably low 
value below 10. In conclusion, the maximum value of the NTP/U ratio for the cells from 
the late passage was more than 20-fold higher compared to the respective value 
obtained from cells of the early passage. 
 
The AEC maintained at 0.98 during both batch cultures and decreased to 0.90 at the 
end of the culture (161.50 h) for transfected cells from the late passage number.   
 
Table 3.7.1.2c: Transfectability obtained in serum-free medium. 
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 Growth rate µ [h-1] 
Before TTran.        After TTran.
Population doubling time td [h] 
Before TTran.        After TTran. 
Early passage no. 
(70) 
    33.3 × 10-3             10.9 × 10-3           20.8                        63.6 
Late passage no. 
(101) 
    41.8 × 10-3             12.8 × 10-3           16.6                        54.1 
 
Standard parameters showed a viability of more than 90 % during the complete 
process with a decrease to 87 % at the end of the batch culture of transfected cells from 
a late passage no. (Fig. 3.7.1.2b; B). This last result correlated with the drastical 
increase of the LDH (Fig. 3.7.1.2b; D). As has been observed for cultures with cells 
from a late passage no. under the same medium conditions but without transfection (Fig. 
3.7.1.1b; C), the glucose concentration was depleted at the end of the batch culture (140 
h of the cultivation time; glucose conc.: 0.18 g L-1) and the lactate concentration 
Fig. 3.7.1.2b; A: HEK293s cells from an early (blue filled symbol) and a late (red open symbol) 
passage number cultured under serum-free conditions (FS:DMEM + AA) were transfected (↓) using a 
DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg). The cell concentration (square symbol) and 
the NTP/U ratio (circle symbol) were estimated. The horizontal black dash line shows the low values 
of the NTP/U ratio, indicating best physiological state. The black arrow indicates the point at which a 
slow increase in NTP/U ratio was observed indicating a worsening of the cell conditions and a poor 
growth potential. The vertical red dot line indicates the maximum increase of the NTP/U ratio of cells 
from a late passage number. 
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Table 3.7.1.2d: Growth rate (µ) and population doubling time (td) of HEK293s cells from an early 
and a late passage number cultivated in FS:DMEM + AA medium before and after transient 
transfection (TTran.) procedure.  
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reached a maximum of 2.18 g L-1. In the respective culture, with cells from an early 
passage no., however, at the same time of cultivation, glucose was still present (conc.: 
1.9 g L-1) and the lactate concentration was 1.42 g L-1 (Fig. 3.7.1.2b; C). As was 
observed before (3.7.1.1), cells from a late passage reached the stationary and starvation 
phase earlier than cells from an early passage. 
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Fig. 3.7.1.2b; B, C and D: HEK293s cells from an early (blue filled symbol) and a late (red open 
symbol) passage number cultured under serum-free conditions (FS:DMEM + AA) were transfected 
using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg). Viability (B), glucose and lactate 
(C) and LDH (D) were evaluated and compared.  
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3.7.1.3 Transfected vs. untransfected cells 
Serum-containing medium 
HEK293s cells (passage no.: 40) were cultivated in DMEM -Ca2+ + Vit. + Pl. + 5 % 
FCS medium in two spinner flasks (200 mL working volume) at a cell concentration of 
5.0 × 105 mL-1. Transfection was performed in one spinner flask as explained before 
(3.7.1.2) and samples were taken every 12 hpt for flow cytometry analysis. The cell 
culture supernatant was stored at –20 °C for its later quantification of the rhuEPO by the 
respective ELISA (section 2.19.2). 
To the control, 20.0 mL of DMEM -Ca2+ + Vit. medium, without the transfection 
complex, were added to the second spinner flask. 
The maximum transfection efficiency expressed as GFP-positive cells was 
approximately 70 % between 72 and 96 hpt (see Fig. 3.7.1.3a; A). 
Cells were transfected at a concentration of 1.0 × 106 mL-1 (↓) and subsequently, the 
growth rate decreased (see table 3.7.1.3a). This correlated with the increase of the 
NTP/U ratio (red open circle, Fig. 3.7.1.3a; A), which showed a value of 3.3 before 
transfection (0 and 24 h of cultivation time) (horizontal black dash line), indicating 
good physiological conditions and cells in the exponential growth phase with a high 
growth potential. After transfection, the NTP/U ratio increased to a value above 5 
within 24 h (↓) indicating a slight worsening of the culture conditions and a poorer 
growth potential. The NTP/U ratio further increased reaching a maximum value 96 hpt, 
indicating a very low quality of the culture conditions. Only by controlling the cell 
concentration and viability at 144 h of the culture (96 hpt) alone, one cannot foresee this 
worsening of the physiology of the cells (Fig. 3.7.1.3a; B).  
For the control spinner, the first low increase of the NTP/U ratio was observed at 72 
h of the cultivation time, indicating the end of the exponential growth phase. This could 
be confirmed one day later by counting the cells. The addition of the 20 mL DNA-free 
medium, did not substantially affect the growth rate (see table 3.7.1.3a). The drastical 
increased of the NTP/U ratio, reaching its maximum at 120 h, indicated the starvation 
phase, which could be verified one to two days later by a drop in the cell viability 
(81.63 %) and higher values of the LDH activity (between 8.99 and 11.61 µkat L-1) 
(Fig. 3.7.1.3a; B and D). The maximum NTP/U value was reached 24 h before that of 
the transfected cells. Moreover, the absolute value of the NTP/ ratio for untransfected 
cells was two-fold higher (151.08) compared to 73.74 for transfected cells indicating the 
different cell characteristics between transfected and untransfected cells.  
Despite the fact, that the transfected cells showed a growth rate, which was more 
than half of that of the untransfected ones (13.1 × 10-3 compared to 32.0 × 10-3; table 
106 3.  Results 
3.7.1.3a), the glucose and lactate concentration showed no difference between both cell 
types throughout the total batch culture (Fig. 3.7.1.3a; C). 
As expected, the AEC was higher than 0.90 for both cell cultures. 
 
 Growth rate µ [h-1] 
Before add.            After add. 
Population doubling time td [h] 
Before add.                After add. 
Untransfected cells     36.8 × 10-3             32.0 × 10-3           18.8                        21.6 
Transfected cells     29.6 × 10-3             13.1 × 10-3           23.4                        52.9 
 
 
Fig. 3.7.1.3a; A: HEK293s cells (Pass: 40) were cultivated under serum-containing conditions 
(DMEM -Ca2+ +Vit. +Pl. + 5 % FCS) in two different spinner flasks. In one of them, cells were 
transfected (↑) using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg), prepared in DMEM -
Ca2+ + Vit. medium (red open symbol). To the control (blue filled symbol), 20.0 mL of DMEM -Ca2+ 
+ Vit. medium without the transfection complex were added. Cell concentration (square) and NTP/U 
ratio (circle) were evaluated. The horizontal black dash line shows the low values of the NTP/U ratio, 
indicating best physiological state. The black arrows (↓) indicate the points at which an increase of 50 
% in the NTP/U ratio could be observed (24 h for transfected cells, 72 h for untransfected cells). The 
vertical blue dot line and the red dot line indicate the maximum increase of the NTP/U ratio for 
untransfected cells and transfected cells, respectively. The vertical dash blue line indicates the end of 
the exponential phase for the control cells. 
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Table 3.7.1.3a: Growth rate (µ) and population doubling time (td) of two HEK293s cells batch 
cultures cultivated in DMEM -Ca2+ + Vit. + Pl. + 5% FCS medium, before and after the addition 
(add.) of medium alone (untransfected cells) or the transfection complex  (transfected cells).  
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Fig. 3.7.1.3a; B, C and D: HEK293s cells (Pass: 40) were cultivated under serum-containing 
conditions (DMEM -Ca2+ + Vit. + Pl. + 5% FCS) in two different spinner flasks. In one of them, cells 
were transfected using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg), prepared in 
DMEM -Ca2+ + Vit. medium (red open symbol). For the control (blue filled symbol), 20.0 mL of 
DMEM -Ca2+ + Vit. medium without the transfection complex were added. Viability (B), glucose and 
lactate (C) and LDH (D) were evaluated and compared. The vertical blue dash line indicates the end 
of the exponential phase for the control cells. 
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Production of rhuEPO as well as expression of GFP were analyzed during the batch 
culture and compared to the cell physiological state expressed as NTP/U ratio. Different 
works have shown that high productivity and good cell physiology may not always go 
hand in hand (Barnabé and Butler 1998; Grammatikos et al. 1999; Hayter et al. 1992; 
Milller et al. 1988; Ryll and Wagner 1992). This could be confirmed in this work. As 
shown in figure 3.7.1.3b, where the highest productivity of the rhuEPO (between 2.5 
and 6.0 µg mL-1) as well as the highest expression of the GFP-positive cells 
(approximately 70 %) were reached at the end of the batch culture. The respective 
increase of the NTP/U ratio showed a worsening of cell conditions and indicated a poor 
growth potential. 
 
Serum-free medium 
HEK293s cells (passage no.: 76) were cultivated in FS:DMEM + AA in two spinner 
flasks (200 mL working volume) at a cell concentration of 3.0 × 105 mL-1. The 
transfection procedure was performed in one spinner flask, whereas only medium was 
added to the other as control. The same protocol as for serum-containing medium was 
followed (see above under 3.7.1.3).  
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Fig. 3.7.1.3b: HEK293s cells (Pass: 40) cultivated under serum-containing conditions (DMEM -Ca2+ 
+ Vit. + Pl. + 5% FCS) were transfected (↓) using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 
(µg:µg), prepared in DMEM -Ca2+ + Vit. medium. NTP/U ratio (red open circle) was evaluated. The 
horizontal black dash line indicates the limit of the region of NTP/U values, where cells are in the 
exponential growth phase and have a good growth potential. GFP-positive cells (green filled 
diamonds) and rhuEPO (blue filled triangle) production were measured every 12 hpt.  
 
109 3.  Results 
The maximum transfection efficiency expressed as GFP-positive cells was 70 % 
between 60 and 72 hpt (see Fig. 3.7.1.3c; A). 
Cells were transfected at a concentration of 7.0 × 105 mL-1 (↓) and, as was 
previously shown (3.7.1.2), they continued growing with a lower rate (see table 
3.7.1.3b). This was correlated with the increase of the NTP/U ratio (red open circles, 
Fig. 3.7.1.3c; A). Before transfection, the NTP/U ratio was less than 2.3 and more or 
less constant (horizontal black dash line). 24 hpt an increase of more than 50 % was 
observed (1↓), indicating worsening of the culture. The ratio further increased until the 
end of the culture reaching a value of 7.14, which was substantially lower compared to 
untransfected cells (see below). The viability throughout the culture was more than 90 
% (Fig. 3.7.1.3c; B). 
In control culture (w/o transfection, filled symbol, Fig. 3.7.1.3c; A) the NTP/U ratio 
maintained at low values of 1.45 – 2.08 for the first 72 hours of cultivation when cells 
grew exponentially. The addition of the 20 mL medium, did not substantially affect 
their growth rate (see table 3.7.1.3b) as was observed for cells under serum-containing 
medium. The end of the exponential phase (increase of the NTP/U ratio more than 50 
%) was observed 48 h after the increase of the NTP/U ratio of the transfected cells (2↓; 
96 h cultivation time). The ratio further increased and showed a dramatic rise of more 
than 6-fold at 144 h of the cultivation time (from 2.90 to 18.17), indicating the 
starvation phase. This was determined 24 h later with a drop of more than 10 % in the 
viability (Fig. 3.7.1.3c; B) and an increase of the LDH activity from 4.63 µkat L-1 to 
13.02 µkat L-1 (Fig. 3.7.1.3c; D). At this cultivation time, the NTP/U ratio reached a 
value of 27.57 (Fig. 3.7.1.3c; A).  
At the end of the batch cultures (168 h of cultivation), the glucose concentration of 
culture supernatants from untransfected cells was 0.85 g L-1 compared to 2.01 g L-1 for 
the respective supernatant from transfected cells. Lactate in both culture supernatants 
did not reach an inhibitory concentration throughout the complete process. Its maximum 
was 1.4 g L-1, which was first achieved by the untransfected cells (120 h and 168 h of 
cultivation time, respectively) (Fig. 3.7.1.3b; C). Thus these cells, reached the stationary 
and the starvation phase earlier. 
These results verified the different cell characteristics between transfected and 
unstransfected cells previously shown in the experiments mentioned above. 
 
The AEC was more or less constant of about 0.98 for unstransfected and transfected 
cells throughout the batch cultures. 
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 Growth rate µ [h-1] 
Before add.            After add. 
Population doubling time td [h] 
Before add.                After add. 
Untransfected cells     24.8 × 10-3             22.7 × 10-3           27.9                        30.5 
Transfected cells     24.1 × 10-3             11.1 × 10-3           28.8                        62.4 
 
 
 
 
 
Fig. 3.7.1.3c, A: HEK293s cells (Pass: 76) were cultivated under serum-free conditions (FS:DMEM 
+ AA) in two different spinner flasks. In one of them, cells were transfected (↓) using a DNA (pEPO-
IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg), prepared in DMEM -Ca2+ + Vit. medium (red open 
symbol). For the control (blue filled symbol), 20.0 mL of DMEM -Ca2+ + Vit. medium without the 
transfection complex were added. Cell concentration (square) and NTP/U ratio (circle) were 
evaluated. The horizontal black dash line shows the low values of the NTP/U ratio, indicating best 
physiological state.  The black arrow 1 (1↓) indicates the point at which an increase of 50 % in the 
NTP/U ratio can be observed for transfected cells. For untransfected cells, the increase occured 48 h 
later (96 h cultivation time; 2↓). The vertical dash lines indicate the end of the exponential phase for 
the control cells. 
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Table 3.7.1.3b: Growth rate (µ) and population doubling time (td) of two HEK293s cells batch 
cultures cultivated in FS:DMEM + AA medium, before and after the addition (add.) of medium alone 
(untransfected cells) and the transfection complex  (transfected cells).  
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Fig. 3.7.1.3c; B, C and D: HEK293s cells (Pass: 76) were cultivated under serum-free conditions 
(FS:DMEM + AA) in two different spinner flasks. In one of them, cells were transfected (↓) using a 
DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg), prepared in DMEM -Ca2+ + Vit. medium 
(red open symbol). For the control (blue filled symbol), 20.0 mL of DMEM -Ca2+ + Vit. medium 
without the transfection complex were added. Viability (B), glucose and lactate (C) and LDH (D) 
were evaluated. The vertical dash lines indicate the end of the exponential phase for the control cells. 
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As was performed for transfected cells under serum-containing conditions, the 
production of the rhuEPO as well as the expression of GFP were analyzed during the 
batch culture. They were compared to the NTP/U ratio to characterize the cell 
physiological state during expression and production phase. It is shown in figure 
3.7.1.3d that a high productivity and a good cell physiology do not simultaneously 
change. The highest concentration of the rhuEPO (approximately 2.0 µg mL-1), as well 
as the highest percentage of the GFP expression (70 %) were reached between 60 and 
72 hpt (84 to 108 h cultivation time), whereas the NTP/U ratio values showed a 
worsening of the cell conditions and a poor growth potential. 
 
This experiment, which compared transfected and untransfected cells cultivated 
under serum-free conditions, was repeated one time and gave the same results as 
presented above (data not shown). 
3.7.1.4 Transfected cells vs. addition of PEI alone 
In order to investigate whether the different cell characteristics observed in transfected 
cells compared to untransfected cells was due to the physiological uptake of the PEI 
with DNA, PEI alone was added to the cell cultures under serum-containing and serum-
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Fig. 3.7.1.3d: HEK293s cells (Pass: 76) were cultivated under serum-free conditions (FS:DMEM + 
AA) and transfected (↓) using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg), prepared in 
DMEM -Ca2+ + Vit. medium (red open square). NTP/U ratio (red open circle) was evaluated. The 
horizontal black dash line indicates the limit, in which low ratio values means cells in the exponential 
phase and good growth potential. GFP-positive cells (green filled diamonds) and rhuEPO (blue filled 
triangle) production were measured every 12 hpt.  
113 3.  Results 
free medium conditions. These cell cultures were compared to the cultivated transfected 
cells previously performed under the same conditions.  
The PEI was dissolved in 20.0 mL of DMEM -Ca2+ + Vit. medium. and added to the 
cell cultures when they reached a concentration between 7.0 × 105 mL-1 and 1.0 × 106 
mL-1.  
 
Serum-containing medium 
 PEI was added to HEK293s cells (passage no.53) cultivated in DMEM -Ca2+ + Vit. + 
Pl. + 5 % FCS medium when the cells reached a concentration of 8.75 × 105 mL-1 (↑). 
This culture was compared with one other in which the transfection procedure was 
performed when the cells (passage no. 40) reached a concentration of 1.0 × 106 mL-1 
(↓). Diagram A of figure 3.7.1.4a shows an increase in the NTP/U ratio (↓) of more 
than 50 % after the addition of PEI (↑), indicating a worsening of the cell conditions. 
This increase was in the same range as observed for transfected cells. The ratio further 
increased reaching a maximum at 144 h of the cultivation time (vertical dot line) in both 
cultures. The difference between both cultures was in the absolute value of the ratio, 
which was more than 30 % higher in untransfected cells, indicating a worsening of the 
cell status at the end of the culture. This was verified 24 h later by counting the cells by 
identifying a drop in the viability (Fig. 3.7.1.4a; B) and an increase in the LDH activity 
(Fig. 3.7.1.4a; D). In addition, untransfected cells showed a higher growth rate of 15.0 × 
10-3 h-1 compared to transfected HEK293s cells (13.1 × 10-3 h-1), despite the fact that µ 
decreased to about 30 % after the addition of the PEI. Whilst in the transfected culture 
this decrease was clearer with 50 % after the addition of the transfection complex (see 
Table 3.7.1.4a). 
In spite of the different growth rates of both cultures, the determination of the 
glucose concentration showed identical values throughout the complete cultivation. 
However, a higher concentration of lactate was detected in cultures of transfected cells, 
2.15 g L-1 compared to 1.68 g L-1 for untrasnfected cells at the end of the batch culture 
(Fig. 3.7.1.4a; C). 
 
The AEC maintained values of 0.97 throughout both batch cultures, indicating that 
the energy charge alone did not give favorable access to information about the 
physiological state of the cells.  
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 Growth rate µ [h-1] 
Before add.            After add. 
Population doubling time td [h] 
Before add.                After add. 
Untransfected cells 
(addition of PEI 
alone) 
22.6 × 10-3             15.0 × 10-3 30.6                        46.2 
Transfected cells 
(addition of 
transfection complex) 
29.6 × 10-3             13.1 × 10-3 23.4                        52.9 
Table 3.7.1.4a: Growth rate (µ) and population doubling time (td) of two HEK293s cell batch 
cultures cultivated in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium before and after the addition 
(add.) of PEI alone (untransfected cells) and the transfection complex (transfected cells).  
Fig. 3.7.1.4a; A: The addition of PEI alone (↑) to HEK293s cells cultured under serum-containing 
conditions (DMEM -Ca2+ + Vit. + Pl. + 5 % FCS) (green filled symbols) was compared to a PEI-
mediated trasnfection of the same cells (red open symbols). Transfection was performed using a DNA 
(pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg) (↓). Cell concentration and NTP/U ratio were 
evaluated. The horizontal black dash line indicates the limit of the region, in which a low NTP/U ratio 
indicates cells in the exponential growth phase and in a good growth potential. The black arrow 
shows the point at which an increase of more than 50 % was observed for the NTP/U ratio, indicating 
a worsening in the cell status. The vertical black dash line indicates the end of the exponential phase 
for untransfected cells. The vertical green and red dot lines show the maximum increase of the 
NTP/U ratio for both batch cultures. 
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Fig. 3.7.1.4a; B, C and D: Viability (B), glucose, lactate (C) and LDH activity (D) were evaluated in 
transfected (red open symbols) and unstransfected (green filled symbols; addition of PEI alone) cells 
growing under serum-containing conditions (DMEM -Ca2+ + Vit. + Pl. + 5 % FCS). Cells were 
transfected using a DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 (µg:µg). 
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Serum-free medium 
The same experiment about the addition of PEI alone (w/o DNA) as pointed above was 
performed under serum-free conditions (passage no. 73) and compared to a culture, in 
which a complete trasnfection (PEI + DNA) was done (transfected cells, passage no.70).  
 
 Diagram A of figure 3.7.1.4b shows, that after the addition of PEI (↓) the NTP/U 
(2↑) ratio increased more than 50 % compared to the basal level (2.3, horizontal black 
dash line). This was observed 48 h later compared to the transfected cells (1↓). The 
NTP/U ratio further increased up to high values of 60 – 63 for untransfected (+ PEI) 
cells at the end of the batch culture (216 h cultivation time), indicating the starvation 
phase. This was also verified by a drop in the viability (Fig. 3.7.1.4b; B) and an increase 
in the LDH activity (Fig. 3.7.1.4b; D). The maximum NTP/U ratios from both cultures 
have not been determined throughout the complete batch cultures. 
As was already observed for untransfected cells growing under serum-containing 
conditions, a higher growth rate of 12.4 × 10-3 h-1 could also be detected compared to 
the transfected cells, despite the fact that the growth rate decreased after the addition of 
PEI more than 50 % (see Table 3.7.1.4b).  
In addition, the determination of the glucose concentration showed identical values 
through the complete cultivation time for both cultures, despite the fact that different 
growth rates were measured. Meanwhile, a higher lactate concentration was measured at 
the end of the culture of transfected cells, as also was found in serum-containing 
medium. However, the values reached a maximum of approximately 2.0 g L-1, double 
the amount of those found in untransfected cells under these conditions (Fig. 3.7.1.4b; 
C).  
 
The AEC maintained constant showing a value of 0.98 throughout both batch 
cultures. 
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 Growth rate µ [h-1] 
Before add.             After add. 
Population doubling time td [h] 
Before add.                After add. 
Untransfected cells 
(addition of PEI 
alone) 
35.1 × 10-3             12.4 × 10-3 19.7                        55.7 
Transfected cells 
(addition of 
transfection complex) 
33.3 × 10-3             10.9 × 10-3 20.8                        63.59 
 
 
 
 
Table 3.7.1.4b: Growth rate (µ) and population doubling time (td) of two HEK293s cell batch 
cultures cultivated in FS:DMEM + AA medium, before and after the addition (add.) of PEI alone 
(untransfected cells) and the transfection complex (transfected cells).  
Fig. 3.7.1.4b; A: The addition of PEI alone (↓; + PEI) to HEK293s cells cultured under serum-free 
conditions (FS:DMEM + AA) (green filled symbols) was evaluated and compared to a transfected 
culture (red open symbols), which was performed using a DNA (pEPO-IRES2-EGFP):PEI ratio of 
0.5:1.5 (µg:µg) (←). Cell concentration and NTP/U ratio were evaluated. The horizontal black dash 
line indicates the limit of the region, in which a low NTP/U ratio indicates cells in the exponential 
growth phase and in a good growth potential. The black arrow shows the point at which an increase 
of more than 50 % was observed for the NTP/U ratio, indicating a worsening in the cell status, (1↓: 
for transfected cells; and 2↑: addition of PEI alone). The vertical black dash line indicates the end of 
the exponential phase for untransfected cells.
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Fig. 3.7.1.4b; B, C and D: Viability (B), glucose, lactate (C) and LDH (D) were evaluated in cultures 
of transfected (red open symbols, conditions: DNA (pEPO-IRES2-EGFP):PEI ratio of 0.5:1.5 
(µg:µg)) and unstranfected cells (green filled symbols; addition of PEI alone) growing under serum-
free conditions (FS:DMEM + AA). The vertical black dash line indicates the end of the exponential 
phase for untransfected cells. 
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These results showed that nucleotide ratios can be used to distinguish between: 
 
o HEK293s cells from an early and a late passage number. 
o Cells cultured under serum-containing conditions from those under 
protein/serum-free medium conditions. 
o Transfected and untransfected cells in culture. 
o Cells uptake of the DNA:PEI complex (transfection procedure) from the 
uptake of PEI alone. 
 
These results indicated a change in the cell physiology during aging of the cell line 
and in their behavior not only due to different media conditions, even more, due to 
different uptake and expression-production processes. 
 
3.7.2 Scale-up to bioreactor scale. BioNose characterization 
Before scale-up the inocula were prepared. Therefore, the HEK293s cells were 
cultivated in a big spinner flask (300 mL working volume) under serum-containing 
and/or serum-free conditions. The cells were in very good conditions showing a 
viability above 90 % and grew as single cells or small clusters. They were initially 
cultured at a cell concentration of about 2.0 × 105 mL-1 and 3.5 × 105 mL-1 (under 
serum-containing conditions; see 2.5.1) and between 3.0 × 105 mL-1 to 5.0 × 105 mL-1 
(under serum-free conditions; see 2.5.2). Cells were incubated at 37 °C and 12 % of 
CO2 and stirred at 80 rpm. When the culture reached a cell concentration between 1.5 × 
106 mL-1 and 2.0 × 106 mL-1, the cells were sub-cultured at the same cell concentration 
as the initial inoculum in new spinner flasks. This sub-culture was repeated until enough 
cells were prepared to inoculate the 1.8 L bioreactor (between 1.4 L and 1.6 L working 
volume). All bioreactors under serum-containing conditions, were inoculated with a 
starting cell concentration between 2.5 × 105 mL-1 and 3.5 × 105 mL-1, in contrast to a 
cell concentration between 3.0 × 105 mL-1 to 5.0 × 105 mL-1 under serum-free 
conditions. The bioreactor cultures were performed using the conditions explained in 
section 2.5.4.  
 
The BioNose was connected to the off-gas line of the bioreactor (section 2.15). The 
data were collected using the NST Senstool software. As explained in section 2.16.1, 
the response pattern was evaluated using multivariate methods, in which different PCA 
models were built using the response values. Sensors, which gave a noisy response, 
were avoided. The outlier’s measurements were deleted. The most relevant sensors were 
selected using the loading plot and the most relevant principal components were found. 
 
120 3.  Results 
Data analyses were performed either with or without a scaling method in order to find 
which of them gave best results. Normalization scaling was done such that all the 
measurement vectors obtained a total length of one, giving all measurements equal 
importance. The idea behind the normalize measurement scaling is to extract 
information from the signal patterns rather than from the magnitudes of the signal.  
The first experiments using the BioNose were performed under serum-containing 
conditions and the seconds, under serum-free conditions as specified below. 
3.7.2.1 Transient transfection system in serum-containing medium 
The pattern of the BioNose for different phases of the process have been characterized 
individually and in combination: Sterility test, addition of PEI to the culture medium, 
batch culture of HEK293s cells, addition of PEI to cultured HEK293s cells, transfection 
of cultured HEK293s cells by DNA:PEI complex, expression of the recombinant 
proteins by transfected HEK293s cells. 
 
Sterile Test 
The contributed sensors were evaluated with the loading plot (data not shown). Their 
response was constant during the entire sterile test, with values between 11 and 13 
(arbitrary units) for MOSFET sensors (FE104 A and FE105A) and between 25 and 75 
(arbitrary units) for MOS sensors (MO102, MO103, MO104, MO105 and MO106) 
(data not shown).  
 
HEK293s batch culture 
The bioreactor was inoculated with 3.0 × 105 mL-1 HEK293s cells cultured in DMEM -
Ca2+ + Vit. + Pl. + 5 % FCS. The batch culture was stopped at a cell concentration of 
about 2.5 × 106 mL-1 with a viability above 98 % (Fig. 3.7.2.1a; A). At this point, 
glucose and lactate concentration in the culture supernatant were 1.78 g L-1 and 1.63 g 
L-1, respectively (Fig. 3.7.2.1a; B).   
 
121 3.  Results 
 
Analyzing the loading plot, three MOSFET sensor (FE 103 A, FE 103 B and FE 105 
B) and the MOS sensors, MO 102, MO 104, MO 105 and MO 106 were contributing 
partly in the response of the cultivation of the batch culture (data not shown). A small 
decrease was observed during the growth phase of the cells whilst FE 104 A, FE 104 B 
and MO 103 presented a constant response during the culture period (data not shown). 
Figure 3.7.2.1b shows the normalized score plot characteristics from the batch culture. 
PC 1, PC 2, and PC 3 together explained 96.9 % of the signal variance (Fig. 3.7.2.1b).  
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Fig. 3.7.2.1a: Batch culture of HEK293s cells in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS medium. The 
cell culture was performed in a bioreactor (1.4 L working volume) during 72 h. Cell concentration 
and viability (A), glucose and lactate concentration (B) were determined. 
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Addition of PEI to the cell culture 
PEI dissolved in 50 mL of DMEM -Ca2+ + Vit. was added to the HEK293s cell culture 
when the cell concentration was between 5.0 × 105 mL-1and 1.0 × 106 mL-1 with a 
viability of 100 % (Fig. 3.7.2.1c; A). The batch culture was performed during 125 h, 
showing at this time a glucose and lactate concentration of 1.13 g L-1 and 1.87 g L-1, 
respectively (Fig. 3.7.2.1c; B).  
Fig. 3.7.2.1b: Score plot from the HEK293s culture batch in DMEM -Ca2+ + Vit. + Pl. + 5% FCS. 
PC1 versus PC2 (A) and PC1 versus PC3 (B). PC1, PC2, and PC3 together explained 96.9 % of the 
signal variance. The points in a plot represent the measurement of the electronic nose at a reduced 
interval of 20 min. 
A
B
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The addition of PEI (Fig. 3.7.2.1d; A) resulted in a transient increase of the 
contributing MOSFET sensors, particularly FE104A, FE101B, and FE104B for 16 
hours. MOS sensors gave a weak response after the addition of PEI (Fig. 3.7.2.1d; B). 
The score plot revealed a characteristic pattern, which differentiated the response signal 
after the addition of the PEI with a displacement of these signals over a period of 14 - 
16 h (Fig. 3.7.2.1e). PC1, PC2, PC3 and PC4 explained 96 % of the variance. In figure 
3.7.2.1e PC1 is plotted versus PC2 (A) and PC1 versus PC3 (B). Normalization scaling 
was performed. 
This experiment was repeated and gave the same results as reported here. 
Fig. 3.7.2.1c: Addition of the PEI (↓) to the HEK293s cells cultured in DMEM -Ca2+ + Vit. + Pl. + 
5% FCS (A). The cell culture was performed in a bioreactor (1.4 L working volume) during 125 h. 
Cell concentration and viability (A), glucose and lactate concentration (B) were determined. 
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Fig. 3.7.2.1d: Addition of the PEI to the HEK293s cells cultured in DMEM -Ca2+ + Vit. + Pl. + 5% 
FCS. A shows the response of the contributed MOSFET sensors and in B of the MOS sensors. Sensor 
signals are given in arbitrary units. Time order represents every measurement of the electronic nose at 
a reduced interval of 20 min. 
125 3.  Results 
   
A
B
Fig. 3.7.2.1e: Score plot of the addition of the PEI to the HEK293s cells cultured in DMEM -Ca2+ + 
Vit. + Pl. + 5% FCS. PC1 versus PC2 (A) and PC1 versus PC3 (B). PC1, PC2, and PC3 together 
explained 93.3 % of the signal variance.(■): before addition of PEI, (●): uptake of PEI, (▲): end of 
batch culture. The points in the plot represent the measurements of the electronic nose at a reduced 
interval of 20 min. 1 to 3 show the trajectory of the signal response. 
126 3.  Results 
Transfection of HEK293 cells 
HEK293s cells (passage no. 56) cultivated in DMEM -Ca2+ + Vit. + Pl. + 5 % FCS 
medium) were transfected following the protocol described under 2.18.1.3.  
pEPO-IRES2-EGFP plasmid combined with PEI (1.0:1.5, µg:µg; respectively) were 
used for complex formation. The DNA:PEI complex was prepared in 50 mL of DMEM 
-Ca2+ + Vit. and added to the bioreactor through the inoculation tubing. This was 
washed with 20 mL of medium, immediately after inoculation. GFP was evaluated by 
flow cytometry every 12 hpt.  
The cells were transfected at a concentration of 8.2 × 105 mL-1 with a viability above 
99 % (Fig. 3.7.2.1f; A). The highest percentage of the GFP-positive cells (36.4 %) were 
reached at 56 hpt (111 h cultivation time), (Fig. 3.7.2.1f; A). 
At 74 h of cultivation (20 hpt) cells aggregates (about 20 cells) occurred, which 
increased at the end of the batch culture (between 50 and 70 cells).  
 The glucose concentration was depleted at the end of the batch culture (210 h of the 
cultivation time; glucose conc.: 0.08 g L-1) and the lactate concentration reached a 
maximum of 2.40 g L-1 (Fig. 3.7.2.1f; B).  
 
127 3.  Results 
 
The complete process was analyzed with the NST Senstool software. After transfecting, 
the MOSFET sensors (e.g. FE104A, FE104B) responded with a transient positive signal 
over a period of 25 - 27 h, which was longer, but similar, to the response of the sensors 
when only PEI was added (Fig. 3.7.2.1g; A). However, the MOSFET sensor, FE101B, 
which showed a suitable response pattern after the addition of PEI, did not show a 
signal, suggesting that it dropped out. In addition, MOS sensors also gave a 
characteristic weak signal after transfection of the cells (Fig. 3.7.2.1g; B). The 
normalized score plot revealed a characteristic pattern for the culture before and after 
transfection showing a clear shift of the data during the first 15 hpt, and from this time 
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Fig. 3.7.2.1f: HEK293s cells cultivated under serum-containing conditions (DMEM -Ca2+ + Vit. + Pl. 
+ 5% FCS) were transfected (↓) using a DNA (pEPO-IRES2-EGFP):PEI ratio of 1.0:1.5 (µg:µg), 
prepared in DMEM -Ca2+ + Vit. medium. GFP-positive cells was measured every 12 hpt (A). The cell 
culture was performed in a bioreactor (1.4 L working volume) during 216 h. Cell concentration and 
viability (A), glucose and lactate concentration (B) were determined. 
128 3.  Results 
until the end of the transfection culture (Fig. 3.7.2.1h). PC1, PC2, PC3, PC4, and PC5 
contributed to 96.7 % of the variance (data not shown). 
 
         
 
 
Fig. 3.7.2.1g: Transfection of the HEK293s cells cultured in DMEM -Ca2+ + Vit. + Pl. + 5% FCS. A 
shows the response of the contributing MOSFET sensors and in B of the respective MOS sensors. 
Sensor signals are given in arbitrary units. Time order represents every measurement of the electronic 
nose at a reduced interval of 20 min. 
 
B 
A
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A
B 
Fig. 3.7.2.1h: Score plot of the transfection process to the HEK293s cells cultured in DMEM -Ca2+ + 
Vit. + Pl. + 5% FCS. PC1 versus PC2 (A) and PC1 versus PC3 (B). PC1, PC2, and PC3 together 
contributed to 89.8 % of the signal variance. (■): before transfection, (●): 15 hours after transfection, 
(▲): 16 hpt until the end of the culture. The points in a plot represent the measurement of the 
electronic nose at a reduced interval of 20 min. 1 to 9 show the trajectory of the signal response from 
the beginning of the cultivation until the end of the procedure. 
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This experiment was repeated and gave the same results as presented above (data 
not shown). 
 
A third transient transfection was performed under the conditions mentioned above 
with a small modification. Cells were stirred at 80 rpm instead of 40 rpm. GFP was 
measured at 24, 48 and 72 hpt.  
The highest transfectability was 65 % between 48 and 72 hpt (Fig. 3.7.2.1i; A). The 
viability was above 95 % throughout the batch culture (Fig. 3.7.2.1i; A). The glucose 
concentration was depleted at the end of the culture (168 h of cultivation time) and the 
lactate concentration reached a concentration of 2.40 g L-1 (Fig. 3.7.2.1i; B). 
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Addition of PEI to the cell culture medium 
In order to check, whether the BioNose response was actually due to the physiological 
uptake of the PEI with or without DNA or only an artificial signal caused by the 
presence of PEI in the medium, PEI alone was added to the cell culture medium without 
the presence of HEK293s cells in the bioreactor. 
Figure 3.7.2.1j shows no response in the sensor signal when the PEI was added to 
the cell-free culture.  
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Fig. 3.7.2.1i: HEK293s cells cultivated under serum-containing conditions (DMEM -Ca2+ + Vit. + Pl. 
+ 5% FCS) were transfected (↓) using a DNA (pEPO-IRES2-EGFP):PEI ratio of 1.0:1.5 (µg:µg), 
prepared in DMEM -Ca2+  + Vit. medium. GFP-positive cells was measured at 24, 48 and 72 hpt (A). 
The cell culture was performed in a bioreactor (1.4 L working volume) during 168 h at 80 rpm. Cell 
concentration and viability (A), glucose and lactate concentration (B) were determined. 
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Figures 3.7.2.1k; A and 3.7.2.1k; B show the score plot after the addition of the PEI and 
the DNA:PEI, respectively to two different cultures. Both figures show the 
characteristic shift signal after the addition of either PEI or DNA:PEI.
 
 
 
 
Fig. 3.7.2.1j: Response of MOSFET and MOS sensors to the addition of PEI to DMEM -Ca2+ + Vit. 
+ Pl. + 5% FCS medium. Sensor signals are given in arbitrary units. Time order represents every 
measurement of the electronic nose at a reduced interval of 20 min. 
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A
B
Fig. 3.7.2.1k: Score plot of the addition of the PEI (A) and DNA:PEI (B) to two different HEK293s 
cells cultured in DMEM -Ca2+ + Vit. + Pl. + 5% FCS. (■): before addition of PEI or DNA:PEI, (●): 
between 10 to 15 hours after transfection, (▲): 11 to16 hpt until the end of the culture. 1 to 4/5 show 
the trajectory of the signal response. The points in a plot represent the measurement of the electronic 
nose at a reduced interval of 20 min. 
TTran. 010 TTran. 039 
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3.7.2.2 Transient transfection under serum-free medium conditions 
Two transient transfection experiments were performed in a 1.8 L bioreactor (1.6 L 
working volume) using the HEK293s cultivated in FS:DMEM + AA serum-free 
medium. These cultures were carried out under the same conditions as in serum-
containing medium but using a higher stirring rate (70 rpm instead of 40 rpm) (2.5.4). 
 
Sterile test 
First, the sterile test with this serum-free medium was assessed with the BioNose during 
three days obtaining similar results as the sterile test in serum-containing medium. The 
response of the sensors was constant during the entire test although the sensor profile 
differed to the previous experiments. The contributing sensors were the MOSFET 
FE103 A, FE104 A and FE104B (FE104 A and FE105A, for serum-containing medium) 
with values between 13 and 17 (arbitrary units) and the MOS sensors MO101, MO102, 
MO104, MO105 and MO106 with values between 28 and 40 (arbitrary units) (MO102, 
MO103, MO104, MO105 and MO106 for serum-containing medium) (data not shown).  
 
Transfection of HEK293s 
After the sterile test, the bioreactor was inoculated with HEK293s cells at a 
concentration of 4.5 × 105 mL-1. Once the cells reached a concentration between 7.0 × 
105 mL-1 and 8.5 × 105 mL-1, they were transfected using the DNA (pEPO-IRES2-
EGFP):PEI ratio of 1.0:1.5 (µg:µg) prepared in 50 mL DMEM -Ca2+ + Vit. as explained 
for the transfection procedure under serum-containing conditions. Cell concentration, 
viability, glucose and lactate concentration, as well as intracellular nucleotides were 
determined as described in materials and methods section (2.10, 2.11 and 2.12). The 
GFP-positive cells were identified between 60 and 72 hpt. 
 
The first experiment was performed with HEK293s cells from a passage number 70. 
They were transfected at a cell concentration of 7.55 × 105 mL-1 with a viability above 
94 % (Fig. 3.7.2.2a; A). The transfectability was 55.5 % expressed as GFP-positive cells 
at 60 hpt. 
The NTP/U ratio showed a value of 3.2 at the beginning of the culture, meaning 
cells in a poor physiological state. Before transfection, the ratio decreased to 2.7, but it 
was still higher than 2.3 (below to 2.3, indicated best physiological cell state). Then, the 
ratio further increased to a value of 11.75 without reaching a maximum throughout the 
cell culture (Fig. 3.7.2.2a; A).  
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The glucose concentration was maintained above 2.2 g L-1 at the end of the batch 
culture (240 h) and the lactate concentration reached a maximum of 1.5 g L-1 (Fig. 
3.7.2.2a; B). 
 
The complete process was analyzed with the BioNose. Diagram A in figure 3.7.2.2b 
shows that mainly the MOSFET sensors FE104A and FE104B responded by a 
substantial increase when the bioreactor was inoculated. This response further increased 
when the transfection was performed over a period of 8 to 10 h. This result was similar 
Fig. 3.7.2.2a: HEK293s cells were cultivated under serum-free conditions (FS:DMEM + AA) in a 
bioreactor (1.6 L working volume). The cells were transfected (↓) using a DNA (pEPO-IRES2-
EGFP):PEI ratio of 1.0:1.5 (µg:µg), prepared in DMEM -Ca2+ + Vit. medium (A). Cell concentration, 
viability and NTPP/U ratio (A), as well as glucose and lactate concentration (B) were determined. 
The horizontal black dash line (A) shows the low values of the NTP/U ratio, indicating best 
physiological state. 
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to that one obtained with FE104A and FE104B sensors under serum-containing 
conditions. MOS sensors presented a weak signal after the transfection procedure, 
especially MO104 and MO106 (Fig. 3.7.2.2b; B). 
 
       
B
Fig. 3.7.2.2b: Transfection of the HEK293s cells cultured in FS:DMEM + AA serum-free medium. 
Diagram A shows the response of the contributing MOSFET sensors and diagram B of the respective 
MOS sensors. Sensor signals are given in arbitrary units. Time order represents every measurement 
of the electronic nose at a reduced interval of 20 min. 
A 
B 
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The normalized score plot of the transfection procedure (Fig. 3.7.2.2c) showed a 
clear shift of the data after the addition of the DNA:PEI complex. PC1 and PC2 
contributed to 96.6 % of the variance response.  
 
A second transient transfection was performed using HEK293s cells (passage no. 
89) in the 1.8 L bioreactor under the same conditions mentioned above. Cells were 
transfected at a cell concentration of 8.0 g L-1 with a viability above 92 % (Fig. 3.7.2.2d; 
A). The transfection efficiency was 44.5 % at 70 hpt.  
The NTP/U ratio showed a value of 5.2 at the beginning of the culture, meaning 
cells in a poor physiological state. Before transfection, the ratio decreased to 2.3. After 
transfection, the ratio further increased showing a value of 250 at the end of the culture 
batch, indicating the starvation cell phase (Fig. 3.7.2.2d; A).  
The glucose concentration was depleted at the end of the batch culture (216 h) and 
the lactate concentration reached a maximum of 2.4 g L-1 (Fig. 3.7.2.2d; B).  
 
 
Fig. 3.7.2.2c: Score plot of the transfection process to the HEK293s cells cultured in FS:DMEM + 
AA serum-free medium.(■): before transfection, (●): 15 first hours after transfection, (▲): after 16 
hpt. 1 to 5 show the trajectory of the signal response. PC1 versus PC2 contributed to 96.6 % of the 
signal variance. The points in a plot represent the measurement of the electronic nose at a reduced 
interval of 20 min. 
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Data from the BioNose of both transient transfection processes were compared. The 
BioNose analysis of the complete process showed similar patterns of the contributing 
sensors in both cultivations (data not shwon). MOSFET and MOS sensors showed the 
characteristic weak signal response after the transfection procedure (data not shown).  
Diagrams A and B in figure 3.7.2.2e show the score plot of the complete 
transfection procedure from both cultivations (TTran. 040 and TTran. 044, respectively; 
TTran.: transient transfection). In the first one, the trajectory of the response data was 
clearer than in the second. It should be noticed, that during this last cultivation, the 
BioNose was shut down twice before adding the DNA:PEI complex and a third time 20 
-24 0 24 48 72 96 120 144 168 192 216 240
106
0
5
10
15
100
150
200
250
0
20
40
60
80
100
 C
el
l c
on
c.
 / 
m
L-
1  
Cultivation time / h
Transfection
 N
TP
/U
 ra
tio
 / 
- 
 
A
 V
ia
bi
lit
y 
/ %
 
-24 0 24 48 72 96 120 144 168 192 216 240
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
0.0
0.5
1.0
1.5
2.0
2.5
 G
lu
co
se
 / 
(g
L-
1 )
Cultivation time / h
 L
ac
ta
te
 / 
(g
L-
1 )
 
B
Fig. 3.7.2.2d: HEK293s cells were cultivated under serum-free conditions (FS:DMEM + AA) in a 
bioreactor (1.6 L working volume). The cells were transfected (↓) using a DNA (pEPO-IRES2-
EGFP):PEI ratio of 0.5:1.5 (µg:µg),  prepared in DMEM -Ca2+ + Vit. medium (A). Cell 
concentration, viability and NTPP/U ratio (A), as well as glucose and lactate concentration (B) were 
determined. The horizontal black dash line (A) shows the low values of the NTP/U ratio, indicating 
best physiological state. 
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h after the transfection procedure, producing a distortion in the score plot pattern (Fig. 
3.7.2.2e; B). 
A 
B
Fig. 3.7.2.2e: Score plot of the transient transfection procedure to two HEK293s cells bioreactor 
cultivations (TTran. 040 (A) and TTran. 044 (B); TTran.: transient transfection) using FS:DMEM + 
AA serum-free medium. (■): before addition of DNA:PEI, (●): between 10 to 15 hours after 
transfection, (▲): 11 - 16 hpt until the end of the culture. 1 to 5 in A and 1 to 8 in B show the 
trajectory of the signal response from the beginning of the cultivation until the end of the procedure. 
The points in a plot represent the measurement of the electronic nose at a reduced interval of 20 min. 
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 Figure 3.7.2.2f shows the score plot of both transfection procedures in details.  
 
These results showed, that the BioNose can generate characteristic pattern specific 
for a particular process. An electronic nose could be a tool to monitor cell 
cultivations as well as to distinguish between different culture conditions. 
Fig. 3.7.2.2f: Score plot of the transfection procedure using the HEK293s cells cultured in 
FS:DMEM + AA serum-free medium. Green square symbols: 4 h before addition DNA:PEI, red 
circle symbols: between 10 to 15 hpt and blue triangle symbols: between 11-16 to 20-34 hpt. Filled 
symbols corresponded to the first transfection procedure (TTran. 040) and open symbols to the 
second one, TTran. 044. The points in a plot represent the measurement of the electronic nose at a 
reduced interval of 20 min. 
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4. Discussion 
As was mentioned in the introduction section (1.3.2), large transient transfection has 
numerous key features. In addition, with this procedure it has been demonstrated that 
large amounts of protein can be produced within a few days (Bernard 2000; Durocher et 
al. 2002; Girard et al. 2002; Jordan et al. 1998; Meissner et al. 2001; Pham et al. 2003; 
Pick et al. 2002; Schlaeger and Christensen 1999; Wright et al. 2003; Wurm and 
Bernard 1999; Wurm and Bernard 2001). This satisfies the increasing demand for 
milligrams of r-proteins to be used in pre-clinical, biochemical, and biophysical studies, 
showing the importance of this technology for biopharmaceutical manufacturing. In this 
context, the results presented here, contribute to science and technology development in 
this field.  
4.1 Transient transfection 
Different key aspects need to be taken into account for an optimal large-scale transient 
transfection and r-protein expression in mammalian cells (1.3.2), such as the cell line, 
the transfection vehicle, the expression vector and the culture medium. The cell line, 
HEK293 cells in suspension (HEK293s), and the transfection vehicle, PEI, had been 
chosen for their characteristics already described in the introduction section 1.3.2. The 
expression vector was evaluated and the culture medium was developed in this work, 
obtaining successful results, which will be discussed below. 
 
The expression vector 
The results presented in section 3.2 showed that the highest transfection efficiencies 
were reached using vectors bearing the CMV promoter. Therefore, new bicistronic 
vector were constructed using this promoter (section 3.3). These results elucidated, that 
CMV-vectors resulted in high-level expression of many different genes in a wide 
variety of cell types. They are considerably stronger than both, the SV40 promoter and 
the long terminal repeat of Rous sarcoma virus (Foecking and Hofstetter 1986). 
Although they marked out that the level of expression is cell-type dependent, it appears 
to form the ideal promoter for the expression in mammalian cells, with few, if any, 
known disadvantages (Brightwell et al. 1997). It was described (Boshart et al. 1985) 
that the strong activity of the CMV enhancer is due to the high concentration of binding 
sites of cellular transcription factors. 
 
The culture medium 
Numerous problems are associated with the presence of serum in culture, such as 
possible contamination by infectious microorganisms which may be present in the 
142 4.  Discussion 
serum, or by serum proteins, as well as the high cost, batch-to-batch variability and the 
difficulty in removing serum proteins when purifying the product of interest (Broad et 
al. 1991; Butler 1986). These concerns are heightened when the final product is to be 
used as an injectable therapeutic (Coté et al. 1998). Numerous studies have already dealt 
with serum-free medium development (Jayme et al. 1997) however, a universal cell 
adaptation protocol does not yet exist. Therefore, different adaptation protocols were 
performed with the HEK293s cells at the beginning of this thesis work. Furthermore, 
the literature often oversimplifies the development process of a serum-free medium. 
Although certain lines can be adapted spontaneously from serum-containing medium to 
serum-free medium, others need a sophisticated mixture of adaptation and screening 
steps to be weaned from serum-containing medium (Coté et al. 1998; Hesse and 
Wagner 2000; Sinacore et al. 2000). 
Several commercial serum-free media were developed to support the growth of 
HEK293 cells. Normally, the manufactures recommend to perform a particular protocol 
for their adaptation to these specific media, but it is not always possible to have a 
successful outcome. As shown in results section 3.1 and 3.5, the growth of HEK293s 
cells as single cells or small clumps (less than 20 cells) with doubling times ranging 
from 30 to 36 h, was possible only with some of these commercial media (293 SFM II, 
Ex-Cell 293™ medium and Ex-Cell 293™ modified; see section 2.4.1 for media details) 
and in combinations of some of them (Ex-Cell 293™ modified plus DMEM -Ca2+ + Vit. 
and FreeStyle™ 293 expression medium plus DMEM -Ca2+ + Vit.). These results 
verified, that no universal method has been devised to address the serum-free 
development process.  
Following the first aim of this work, further experiments were performed to find a 
medium totally free of animal proteins or animal-origin components, in which not only 
HEK293s cells were fully adapted, even more facilitate the transient transfection 
processes. This had implicated to avoid the washing step of cells prior to the addition of 
the transfection complex and the changing of the medium after the transfection 
procedure.  
 
Different groups had reported a serum-free formulation to support growth of 
HEK293 cells (Berg et al. 1993; Coté et al. 1998; Durocher et al. 2002; Schlaeger and 
Christensen 1999). However, these media like the commercial ones did not satisfy all 
the prerequisites mentioned above. For example, Schlaeger and Christensen (1990) had 
developed a serum-free medium in which heparin was added to avoid cell aggregation. 
As heparin inhibits DNA uptake in transfection procedure, it has to be removed from 
the medium prior to performing this procedure. Consequently, cells have to be washed 
with a heparin-free medium previous to the addition of the transfection complex.  
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On the other hand, Invitrogen™, life technologies (CA, USA), had developed an 
expression system, using the FreeStyle™293-F cell line, derived from the HEK293 cell 
line (FreeStyle™ 293 Expression System; For large-scale transfection of suspension 293 
cells in a defined, serum-free medium; Catalogue no. K9000-01). In this system, cells 
growing under serum-free conditions were transfected, but the transfection complex was 
prepared in a medium (Opti-MEM® I, see section 2.4.1), which contains less than 1 % 
of FCS. Hence, the system is not completely serum-free.  
In addition, Durocher et al. (2002) had cultivated the HEK293s cells in a serum-free 
medium, but they marked out the requirement of 1 % bovine calf serum (BCS) medium 
supplementation to improve transient transfection mediated by PEI. These authors had 
shown that the presence of serum increases gene delivery and/or transgene expression 
through one mechanism that remains unclear. They used expression vectors containing 
the CMV promoter and they suggested that serum might contribute to augment 
transcriptional activity of this promoter as the CMV immediate early enhancer contains 
multiple binding sites for serum-activated transcription factors (Brightwell et al. 1997). 
However, they obtained only a partial recovery of transgene expression when serum 
was added to the cells 3 h after their transfection in serum-free medium. This suggested 
that, in addition to the potential serum-mediated CMV promoter transcriptional 
activation, other serum component(s) might increase transfection efficacy of DNA:PEI 
complexes (Durocher et al. 2002). However, the results presented here (Section 3.5.3, 
Table 3.5.3a) were contradictory with those showed by Durocher et al. (2002) as are 
discussed below.  
In order to investigate whether the presence of serum improves the transfectability, 
1 % FCS was added to the different serum-free cultures and transfection efficiencies 
lower than 1.5 % were obtained (Table 3.5.3a). These results suggested that the low 
transfectability was due to an inhibition by component(s) of the serum-free medium 
rather than a missing of unknown important component(s) of the FCS. This was verified 
when 60 % higher transfection efficiencies were obtained using the HEK293s cells 
cultivated in a mixture 1:1 of the commercially FreeStyle™ 293 expression medium 
with DMEM -Ca2+ + Vit. medium than using FreeStyle™ 293 expression medium alone 
(see Fig. 3.5.3a). Further investigations should be done to identify the possible 
inhibitory component(s) in order to better understand the serum mechanism in 
transfection mediated by PEI.  
Moreover, transfection efficiencies of 60 – 70 % were reached using cultures with 
24 h conditioned medium, showing that this does not affect the transfection procedure, 
as was postulated by Schlaeger and Christensen (1999). This therefore simplifies 
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process scale-up. These last results were in agreement with those presented by Durocher 
et al. (2002). 
Further results in section 3.6 showed that HEK293s were successfully adapted to 
this new serum-free medium (3.6.1).  
In order to obtain highest transfection efficiencies using lesser amount of DNA, an 
optimum DNA:PEI ratio of 0.5:1.5 (µg:µg) was found (3.6.2). 
 
Under these conditions several transfections were performed with cells from an 
early and a late passage number using pEPO-IRES2-EGFP and pCMV-EGFP-EPO 
plasmids. GFP-positive cells and the rhuEPO concentration present in the cell 
supernatant were determined between 60 and 72 hpt (table 3.7a).  
The results showed lowest transfection efficiencies with the first plasmid, which 
contains a downstream EGFP gene (section 3.3.1). Several authors had shown that, in a 
bicistronic vector, the IRES-dependent second gene expression is significantly lower 
than the cap-dependent first gene expression (Dirks et al. 1993; Hennecke et al. 2001; 
Mizuguchi et al. 2000). Hence, this could be one of the reasons for the differences in the 
GFP expression found between both plasmids. Moreover, the nature of the IRES 
element differs from one plasmid to the other. pEPO-IRES2-EGFP contains the IRES 
site of the ECMV and pCMV-EGFP-EPO that of the poliovirus (Fig. 3.3.1a and Fig. 
3.3.2a). The strength of the internal translation initiation is defined by the nature of the 
IRES element and the cellular context (Hennecke et al. 2001).Therefore different levels 
of gene expression could be expected.  
On the other hand, the results showed that cells from an early passage number 
presented higher transfection efficiencies expressed as GFP-positive cells compared to 
their older counterparts from a late passage number (Table 3.7a). Even more, the 
expression of the recombinant model gene rhuEPO showed the same tendency. Due to 
the complete protein-free medium conditions used, EPO represented between 8 to 10 % 
of the total protein concentration when cells from an early passage number were used, 
and between 2.5 and 3.5 % with cells from a late passage number. This is an additional 
advantage of the chemically defined process for the purification of the protein of 
interest. This can be explained when compared to the transfection performed under 
serum-containing conditions, in which EPO represented 0.02 % of the total protein 
concentration (Table 3.7b). Summarizing serum-free conditions have shown an efficient 
productivity, especially using HEK293s cells from an early passage number. 
The concentration of the rhuEPO under serum-containing condition was higher than 
in serum-free medium. One reason for this difference could be the release of proteases 
into the medium. This process happens during the proliferation phase of the cells as well 
as after their death and following cell lysis. Medium supplemented with serum inhibits 
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proteases, as inhibitors make up 10 % of the total protein content of serum. Therefore, 
in cultures without serum the proteases can have a negative influence upon cell 
proliferation as well as in the desired synthesized product (Murakami 1989; Waldemar 
et al. 1991). 
 
With the results presented here, a new approach in transient transfection system was 
developed, using HEK293s cells cultivated in a medium totally free of animal proteins 
or animal-origin components. Indeed, this is a unique method using this cell line in this 
medium condition (European patent application, Patent no. 03010206.5-2405). 
Recently, Pham et al. (2003) had published the development of a new serum-free 
medium, but with the addition of peptones, that sustains cell growth and PEI-mediated 
transfection of a HEK293/EBNA 1 cell line. 
 
 
Following the second aim of this work, a process characterization towards the further 
optimization of the transient transfection procedure was performed. It was the first time 
that the use of an off-line and invasive method as intracellular nucleotide analysis, and 
the on-line and non-invasive method, the electronic nose, were used to characterize the 
transient transfection procedure using HEK293s cells. The results obtained have shown 
that both methods are suitable and even excellent tools for process optimization as is 
discussed below.  
4.2 Intracellular nucleotide analysis 
Ryll and Wagner (1991 and 1992) demonstrated the application and usefulness of the 
analysis of special intracellular nucleotides for the cultivation of animal cells. 
Nucleotides were found to be a good target as they play a central role in metabolism. 
Especially, the specific combination of these parameters resulted in growth specific 
functions, such as the NTP, U, and NTP/U ratio. Several works (Grammatikos et al. 
1999; Grammatikos et al. 1998; Moore et al. 1997; Ryll et al. 1991a; Ryll et al. 1991b; 
Ryll et al. 1994; Schoenherr et al. 2000) verified the sensitivity of these ratios, and 
extended its application for monitoring, control, and regulation of bioprocess. 
Particularly, the sensitivity of the NTP/U ratio and its ability to report on the 
physiologic status and growth potential made a tool to predict the growth behavior of a 
culture, as was tested for BHK, hybridoma and CHO cells. In the present work, these 
results were further extended to HEK293s cells. 
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The NTP/U ratio 
The NTP/U ratio amplifies the NTP and U ratio by combining their values. For all 
cultivations presented here (3.7.1) and for all batch cultures studied (> 25), this ratio has 
been shown to be a very sensitive parameter, which reported earlier in studies on the 
cell physiological status and the growth potential. Moreover, other investigators 
showed, that this parameter allowed the prediction of the behavior of cells in culture up 
to 2 days before any changes were noted by classic cell number and viability 
measurements (see 3.7.1) (Grammatikos et al. 1999; Ryll and Wagner 1992; Schoenherr 
et al. 2000). In this work it was demonstrated that nucleotide ratios could also be used to 
distinguish between HEK293s cells from early and late passage numbers (3.7.1.1 and 
3.7.1.2) indicating a change in the cellular character during aging of these cells. 
Moreover, nucleotide ratios of transfected HEK293s clearly differed from those in 
untransfected cells and also differed in cells cultured under serum-free and protein-free 
medium conditions compared to the serum-containing media (3.7.1.3). 
Grammatikos et al. (1999) had shown that the absolute value of the NTP/U ratio for 
cells in good physiological state varies with cell type, medium and culture mode. This 
could be verified with HEK293s cells cultivated under different medium conditions. 15 
batch cultivations using serum-free medium and 11 cultures using serum-containing 
medium were performed in this work analyzing the NTP/U ratio. In the first studies, a 
value of 1.0 to 2.3 and in the second ones, 1.0 to 3.3, indicated a good physiological 
state of cells in the exponential growth phase and best growth potential. A 50 % to 100 
% increase was considered as a worsening of the cells conditions and a poorer growth 
potential suggesting the beginning of the reduced exponential growth phase and later, 
the stationary phase. 
     
Early vs. late passage number 
As was shown in the results section (3.7.1.1), HEK293s cells cultivated either in serum-
containing or in serum-free media showed a different behavior depending whether they 
were taken from an early (40 to 77) or a late (89 to 150) passage number. 
Cells from an early passage number growing under serum-containing conditions, 
reached the maximum of the NTP/U ratio first (Fig. 3.7.1.1a; A). In contrast, under 
serum-free conditions, cells from a late passage number were the first to reach this ratio 
(Fig. 3.7.1.1b; A). These maximum NTP/U values were a result of the opposing values 
of the NTP and the U ratio, which have reached the maximum and minimum 
respectively (data not shown). As was demonstrated earlier (Grammatikos et al. 1999; 
Ryll and Wagner 1992) and confirmed for HEK293 cells here, the NTP ratio increased 
during progress of the culture, as a result of an appropriate decrease in the cellular UTP 
and the CTP pool when cells entered the reduced exponential phase. In parallel the U 
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ratio decreased when the culture conditions worsened mainly due to a decrease of the 
UTP pool and an increase of the respective UDP-GNAc pool (the explanation of this 
increasing can be found in a later paragraph of the discussion section).  
These worse conditions and the growth reduction indicated that a limitation of one 
or more essential nutrient compounds had started. During progress of all batch cultures 
performed in this work an elevated NTP/U ratio could be measured (figures section 
3.7.1). Under serum-free conditions, the maximum NTP/U ratio was reached later for 
cells from an early passage number compared to cells from a late passage number (Fig. 
3.7.1.1b; A). This indicated that cells from late passages reached the stationary and/or 
the starvation phase earlier due to a better adaptation to the culture conditions. 
 
Early vs. late passage number – Transfected cells 
The highest transfection efficiencies, expressed as GFP-positive cells, were reached 
with cells that showed the maximum NTP/U ratio in a late phase of the culture (Table 
3.7.1.2a and Fig. 3.7.1.2a; A for serum-containing conditions and, Table 3.7.1.2c and 
Fig. 3.7.1.2b; A for serum-free conditions). For cultures using serum-containing 
conditions, transfected HEK293 cells from late passage numbers reached higher 
transfection efficiencies than cells from early passage numbers (82.07 % compared with 
71.30 %). The inverse behavior was found for the same cells cultured under serum-free 
conditions (cells from an early passage number 73.22 %, compared with 55.62 % from 
cells of late passage number). This tendency was observed in all the transfections 
performed (see Table 3.7a and Table 3.7b). 
Highest transfection efficiencies were obtained when a low cellular UDP-GNAc 
content was measured during the complete batch culture (data not shown). In serum-free 
conditions, transfected cells from an early passage number showed a low percentage of 
UDP-GNAc (9 to 11 %) during the entire culture batch, whilst cells from a late passage 
number, presented values from 10 %, at the beginning of the culture, to 35 % at the end, 
at 168 h. In contrast, cells cultured under serum-containing medium, showed the lowest 
percentage of UDP-activated sugars for cells from a late passage number (from 11 % to 
40 %, at the end of the batch culture), whilst transfected cells from an early passage 
number showed values from 14 % to 55 % at the same time.  
Previous work considered the intracellular UDP-GNAc content as a key regulator of 
cell viability and productivity (Barnabé and Butler 1998; Grammatikos et al. 1998; Ryll 
et al. 1994). The increase of the UDP-GNAc pool can be caused by an elevated 
synthesis or reduced use. The activated N-acetylhexosamines are predominantly used 
for the formation of sugar side chains in glycoproteins and glycolipids (gangliosides). 
Glycoproteins are essential elements of the membranes or secreted molecules, which 
function as messengers within the macroorganims. Ryll et al. (1994) suggested that an 
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elevated intracellular UDP-GNAc pool is a mediator of the loss of cell viability induced 
in cultures by the accumulation or addition of ammonia. Others work groups identified 
ammonia as one of the responsible molecules increasing the UDP-GNAc pool 
(Gawlitzek et al. 1998; Grammatikos et al. 1998; Yang and Butler 2002). Indeed, the 
accumulation of ammonia is well known to inhibit cell growth and to affect protein 
production, thus perturb the glycosylation process (Butler and Spier 1984; Yang and 
Butler 2000; Yang and Butler 2002). Ammonia (as NH3 or NH 4+) is produced by the 
thermal degradation or intracellular deamination of glutamine, which is one of the major 
nutrient sources in cell culture medium (Doyle and Butler 1990; Tritsch and Moore 
1962). Nevertheless, although ammonia has not been measured in this work, a high 
concentration at the end of the batch culture can be assumed.  
Moreover, it was proposed that if the UDP-GNAc pool is kept at low levels during a 
production process, it is conceivable that cell growth is improved and uniform product 
quality is maintained (Grammatikos et al. 1998). In this context, it was shown here, that 
cultures under the influence of a low percentage of UDP-GNAc responded with higher 
transfection efficiencies.  
 
Transfected vs. untransfected cells 
HEK293s cells transfected in either serum-containing or serum-free media showed an 
increase of more than 50 % in the NTP/U ratio 24 h after the addition of the transfection 
complex (Fig. 3.7.1.3a; A and Fig. 3.7.1.3c; A). As well, they presented a decrease of 
more than 50 % in their growth rate (Table 3.7.1.3a and Table 3.7.1.3b). Reductions in 
growth rate have been associated in other studies with an increase in antibody 
production (Barnabé and Butler 1998; Hayter et al. 1992; Milller et al. 1988). Therefore 
this growth rate reduction of transfected HEK293s cells could be related to the 
production phase. The same but untransfected cells, to which only the complex medium 
was added, presented a slow and insignificant decrease in their growth rate of about 10 
– 15 % (Table 3.7.1.3a and Table 3.7.1.3b). Moreover, the characteristic increase in the 
NTP/U ratio of more than 50 % of the basal levels appeared between 24 and 48 h later 
than in transfected cells. 
The sensitivity and applicability of the NTP/U ratio was verified here again by the 
results of this work with HEK293s cells. Nucleotide ratios indicated that the 
physiological state of the cells has changed after the addition of the DNA:PEI complex 
for transfection. These changes in the NTP/U ratio were dominantly caused by a 
decrease in the U ratio (decrease of the UTP and increase of the UDP-GNAc pool; data 
not shown). As mentioned before, the increase of the UDP-GNAc pool can be caused 
by elevated synthesis or reduced use. The increase of the UDP-GNAc pools after 
growth rate reduction did not seem to be the result of a reduced turnover rate alone, 
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because the expression of secreted glycoproteins has been shown active during the 
phase of reduced growth (Al-Rubeai and Emery 1990; Barnabé and Butler 1998; Ryll 
and Wagner 1992). Therefore, in transfected cells this increase of the UDP-activated 
aminohexoses could be related to a high synthesis rate of glycoproteins or glycolipids. 
Furthermore, many studies have shown the importance of the U ratio for earlier 
detection of changes in the cell physiology and the reduction of the growth rate 
(Grammatikos et al. 1999; Moore et al. 1997; Schoenherr et al. 2000). These authors 
discussed the importance of the UTP as key pool in cell growth. Moore et al. (1997) 
showed that a decrease of the UTP pool and an increase of the activated 
aminohexosamine pool correlated with a reduction of the temperature from 37 °C to 30 
°C in arresting CHO cells. Reduction of the culture temperature may cause cell stress. 
In this context, the addition of the transfection complex could be considered as a stress 
situation and therefore could be one of the reasons for the decrease of the UTP and the 
increase of the UDP-GNAc pool in transfected cells in contrast to untransfected cells. 
 
Additionally transfected cells, cultivated either in serum-containing or serum-free 
conditions, showed a less dramatical increase of the NTP/U ratio with a maximum value 
50 % lower compared to untransfected cells. In general, a drastic increase in the UDP-
GNAc pool is responsible for a dramatic decrease in the U ratio and an associated 
dramatic increase in the NTP/U ratio as discussed above. This was correlated with the 
result obtained in this work (section 3.7.1.3), where transfected cultures presented no 
substantial increase of the UDP-activatedhexosamine pool (data not shown) and 
therefore no substantial increase in the NTP/U ratio (Fig. 3.7.1.3a; A and Fig. 3.7.1.3c; 
A), especially in cultures under serum-free medium. One reason could be the use of the 
activated sugars for the formation of glycoproteins. Moreover, as was proposed by 
Grammatikos et al. (1998) (about keeping low levels of the UDP-GNAc pool during a 
production process), one can conclude that the conditions identified during optimization 
of the transfected cultures performed in this work were the most favorable to improve 
productivity.  
 
Transfected cells vs. addition of PEI alone 
When PEI was added to the cultures, a decrease in the cellular growth rate of 
approximately 30 % and 60 % was observed in serum-containing and serum-free media 
conditions, respectively. However, this decrease was not in the same magnitude as for 
DNA:PEI-transfected cells, which showed a decreasing of 55 % (for serum-containing 
medium) and 67 % (for serum-free medium) (Table 3.7.1.4a and 3.7.1.4b). Several 
studies have shown that the DNA:PEI complex added at a concentration for gene 
delivery, did not remarkably affect the cellular metabolism. However, higher amounts 
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of the complex or even free PEI did result in toxicity (Boussif et al. 1995; Godbey et al. 
1999; Kichler et al. 2001). Godbey et al. (1999) postulated that a possible reason for the 
toxic effects of PEI on the cells is due to the membrane permeability, resulting in 
elevated endosomal concentrations of PEI. 
The NTP/U ratio from these PEI-transfected cultures showed a different behavior in 
comparison to DNA:PEI-transfected cells (Fig. 3.7.1.4a; A and Fig. 3.7.1.4b; A). A 50 
% increase of the NTP/U ratio was observed 24 h and 48 h after the addition of PEI in 
cells cultivated under serum-containing and serum-free media, respectively. This 
indicates that PEI has affected the cell physiology. As expected, the incorporation of 
PEI induced cell stress, which could be the reason for the increment of the NTP/U ratio 
(as discussed above). However, the maximum of the NTP/U ratio in PEI-transfected 
cells was 30 and 100 % higher compared to the DNA:PEI-transfected cells, showing 
clearly the difference between DNA:PEI and PEI uptake.  
 
Summarizing, these data showed the intracellular nucleotide ratio as a reliable tool, 
describing the physiological conditions of HEK293s cells. Even more, the NTP/U ratio 
was useful to characterize the transfection procedure using different cellular ages and 
different medium conditions towards an optimal transfection process. In this context, it 
is important to emphasize, that in each example presented in the section 3.7.1 and 
discussed above, the NTP/U ratio was always below to 2.3 – 3.3 before the addition of 
the transfection complex in serum-free as well as in serum-containing media, 
respectively. These low NTP/U values indicated best physiological state for 
transfection.  
Table 3.7b (section 3.7) shows that cells from the same early passage number 42, 
presented a lower percentage of GFP-positive cells as expected using either pEPO-
IRES2-EGFP or pCMV-EGFP-EPO plasmids (44 % and 55 %, respectively) under 
serum-containing conditions. The analysis of the intracellular nucleotides revealed 
NTP/U ratios higher than 3.3 before transfections were performed (data not shown), 
indicating that the cells were in a poor physiological state. These results verified that it 
is important to have cells in best physiological conditions characterized by a high 
growth potential to perform a successful transfection procedure.  
 
The adenylate energy charge (AEC) of cells in all cultivations maintained always at 
high values of more than 0.90 even if cells have entered the starvation phase. Such a 
high AEC seems to be characteristic for continuous mammalian cell lines (Ryll et al. 
1991a; Ryll et al. 1991b) and it cannot be taken as a valid indicator of cell damage 
(Kristensen 1989).  
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The NTP/U plot 
Ryll and Wagner (1992) proposed the plotting of the NTP value as a function of the U 
value, resulting in a curve that reflects the physiological progress of a cell culture during 
the growth cycle of a cell culture process. A particular area of this function, which is 
framed by a rectangle characterizing the upper and the lower limit of a permitted region, 
corresponds to the exponential growth phase and is called log-box. All the other values 
on the left and the right side of the exponential region belong to the lag phase, to the 
reduced exponential growth, or to the starvation phase. The authors postulated that the 
general behavior of the cells is as following: if the cells reduce their growth, the values 
move to the left upper region (increase NTP but decreasing U value). This movement 
can be reversed by a batchwise medium exchange, for example. Upon reaching the 
maximum point in the left upper side, the values move down again (reduced NTP value) 
which indicate a worsening of the cell conditions and a reduces viability. Ryll and 
Wagner (1992) proposed this function for monitoring, control and regulation of 
bioprocesses based on in vitro cell cultures. The advantage of this monitor and control 
system is based on the fact that direct changes of the cell physiology, but not only the 
cell viability, are detected. They suggested its importance for process validation and the 
maintenance of a constant product quality. 
 
Considering these proposals, the NTP/U plot was applied to transfected and 
untransfected HEK293s cells cultured in serum-free and serum-containing media. 
Diagram A and B of figure 4.2a show the NTP/U plot from transfected and 
untransfected HEK293s cells taken from an early and late passage number and cultured 
under serum-containing and serum-free conditions, respectively. The diagrams show a 
media-specific and cell-specific range in which all points are arranged. In both cases, 
when the physiological conditions of the cells alter, the values move from the log-box to 
the left upper side and reach the maximum of the NTP/U ratio (worse cell conditions). 
Subsequently, the points move down again (reduced NTP value) indicating a reduction 
in the cell viability. For untransfected cells cultivated under serum-containing medium 
the points move again to the right down side (increased U value) indicating the 
starvation phase (Fig. 4.2a; A). This increment on the U ratio was mainly due to the 
decrease of the UDP-GNAc pool. At this point, glucose, which is one of the 
components for the formation of the UDP-activated sugars, was completely depleted in 
the medium.  
Comparing both plots, it is possible to identify the different behavior of the 
HEK293s cells cultivated under both media conditions. Even more, in every plot it is 
possible to see that neither transfected and untransfected cells nor cells taken from an 
early or late passage number, show different behavior. 
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Fig. 4.2a: NTP/U-plot for the cultivation and transfection of HEK293s cells taken from an early and 
late passage number and cultured under serum-containing (A) and serum-free medium (B). The 
exponential growth phase is defined as a common region expressed by the rectangle. The arrow to the 
left upper part indicates the movement of the data (increase NTP ratio and decrease U ratio) when the 
cells change their physiology and reach the maximum of the NTP/U ratio (worse cell conditions). 
Upon this maximum, the points move down again (arrow to the down part) indicating the reduced cell 
viability. For untrasnfected cells cultivated under serum-containing medium (A), the points move 
again to the right down side (increase U value) indicating the starvation phase. 
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4.3 BioNose 
In general, bioprocess parameters important for control of the cellular state, such as cell 
number and viability, glucose and lactate concentrations and the pool of intracellular 
nucleotides, are usually monitored off-line with long time intervals between sampling 
and analysis. Additionally, the process is expensive and time-consuming. This off-line 
analysis is mainly due to the fact that on-line sensors often do not fulfill the necessary 
requirements such like reliability, simplicity, sterility, and long-term stability. With 
these limitations, an accurate control of the cellular state in bioprocesses is difficult. 
However, the problem of controlling the status of a cultivation could also be solved by 
sensors that do not directly monitor the above-mentioned environmental parameters but 
that identify important transitions between different cultivation phases which gives 
access to optimal culture conditions (Bachinger and Mandenius 2000b). To assess the 
usefulness of the electronic nose for this purpose, different experiments were performed 
evaluating the BioNose sensor pattern for different phases of the transfection procedure 
using HEK293s cells of different cell age in serum-containing and serum-free media. As 
mentioned in the introduction, this work was part of an EU project. As already 
described by other authors for CHO cells (Bachinger et al. 2000a; Bachinger et al. 
2000c; Bachinger et al. 2002; Mandenius 1999; Mandenius et al. 1998), the use of an 
electronic nose (BioNose) for monitoring mammalian cell cultivation was verified in 
this work for HEK293s cells, to distinguish between different process conditions on the 
one hand and as a tool for process characterization on the other hand. Although the 
sensors signal responses from the BioNose were much weaker than expected (100 times 
lower than expected due to different qualities of the sensors) the usefulness of the 
electronic nose could be demonstrated. 
 
It is important to emphasize that the signal output is the result of the combination of 
many sensor responses without having specific knowledge about the individual sensors´ 
sensitivity. Generally, details on chemical surface reactions for specific analytes are not 
always known, but they are also not needed for accurate function of the electronic nose. 
Consequently, the identification of the different phase in a process by the BioNose is the 
indirect correlation of sensors responses to these analytes and not the direct detection of 
a certain analytes (Bachinger et al. 2000a). 
 
The following phases of the process have been characterized individually and in 
combination: Sterility test, addition of PEI to culture medium, batch cultivation of 
HEK293s cells, addition of PEI to cultured HEK293s cells, transfection of cultured 
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HEK293s cells by the DNA:PEI complex, expression of the recombinant proteins in 
transfected HEK293s cells (3.7.2). 
 
During the sterile test and the batch culture of HEK293s cells cultivated under 
serum-containing conditions were obtained constant sensor responses (3.7.2.1). The 
addition of PEI to the cell culture resulted in a transient increase of the contributing 
MOSFET sensors over a period of 14 – 16 hours (Fig. 3.7.2.1d; A). When the cells were 
transfected by the DNA:PEI complex, especially the same MOSFET sensors responded 
with a transient positive signal over a period of 25 – 27 h which was longer but similar 
to the response of the sensors when only PEI was added (Fig. 3.7.2.1g; A compared to 
Fig. 3.7.2.1d; A). In these cases the score plots revealed a characteristic pattern of the 
culture before and after the addition of PEI alone or DNA:PEI, respectively (Fig. 
3.7.2.1e and Fig. 3.7.2.1h). This result was attributed to the cell physiological uptake of 
PEI / DNA:PEI, corroborated when the addition of the PEI alone to the cell-free culture 
medium showed no response in the sensor signal (Fig. 3.7.2.1j) presenting a 
characteristic process-specific BioNose response pattern for the transient transfection of 
HEK293s cells cultured in serum-containing medium.  
 
The BioNose sensor responses for transient transfection of cells cultivated under 
serum-free conditions using chemically-defined protein-free medium showed the same 
characteristic increase as in serum-containing conditions (Fig. 3.7.2.2b compared to Fig. 
3.7.2.1g). This increase in the sensor response was already observed when the 
bioreactor was inoculated, showing a different behavior of the cells growing under this 
serum-free conditions (Fig. 3.7.2.2b). Moreover, the respective score plots of the 
BioNose for transfection procedures in the different culture conditions even show the 
difference between the undefined (serum-containing medium) and the defined (serum-
free medium) media (Fig. 3.7.2.1h and Fig. 3.7.2.2e; A – B) identifying different 
process conditions. The trajectory of the data signal was more define and clearer for 
transfection processes under serum-free medium compared to serum-containing 
medium. This difference can be assumed by the more complex mixture when serum is 
present.  
 
Bachinger et al (2000a) identified characteristic states of recombinant CHO cells in 
culture and changes in the process operation by individual clusters in the score plot. 
Here, it was also possible to differentiate clusters corresponding to each culture state, 
especially for the procedure under serum-free conditions (Fig. 4.3a; A and B).  
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Fig. 4.3a: Score plot of the complete transfection procedure using the HEK293s cells cultured in 
FS:DMEM + AA serum-free medium. TTran. 040 (A) and TTran. 044 (B). (■): before addition of 
DNA:PEI, (●): between 10 to 15 hours after transfection, (▲): 11 -16 hpt until the end of the culture. 
1 to 6 in A and 1 to 8 in B show the characteristic cluster representing different states of the culture 
process. Every point represents one measurement from the electronic nose at a 20 min interval. 
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During inoculation of the bioreactor and the first day of the batch culture until the 
transfection procedure, the data oscillate in the first cluster (see green squares in the 
figure 4.3a). Additionally, it must be considered that during the cultivation TTran. 044, 
(Fig. 4.3a; B), the BioNose was shut down two times before adding the DNA:PEI 
complex and one more time 17 hours later, producing a distortion in the score plot 
pattern. As described by Bachinger et al. (2000a) and it was corroborated here, the 
sensors are able to track faults related to reactor operation reflecting this in the score 
plot pattern.  
During 10 to 15 hpt, the data move down in a cluster in the right part of the plot (red 
filled circle, cluster no. 2 in Fig. 4.3a; A and no. 4 in Fig. 4.3a; B), which coincided 
with the increase observed in the contributing sensor response (Fig. 3.7.2.2b). Then, the 
data start to shift to the left upper part reaching the top of the plot at 24 – 26 hpt. 
Subsequently, the data make a sharp turn down arranging a new cluster that 
corresponded to a time interval between 25 – 27 hpt and 43 – 46 hpt (blue filled 
triangle, cluster no. 4 in Fig. 4.3a; A and no. 6 in Fig. 4.3a; B). Following the score plot 
data down, another cluster can be identified, which can be attributed to the “production 
phase” and correlates with the determination of the GFP-positive cells measured by 
flow cytometry analysis at 60 hpt [represented by cluster 5 (44.5 % GFP-positive cells) 
and 7 (55.5 % GFP-positive cells) in Fig. 4.3a; A and B, respectively]. Finally (73 to 
196 hpt), by the movement of the data into a new cluster, the stationary and the 
starvation phase was possible to identify in case of the first cultivation (cluster 6, Fig. 
4.3a; A) and the stationary phase in the last cultivation (cluster 8, Fig. 4.3a; B); (see 
section 3.7.2.2 for cell cultivation parameters).  
 
Summarizing, the data show that the BioNose can significantly improve the 
monitoring of a cell cultivation by topically following the progress of the complex 
process. Moreover, electronic noses can distinguish between different process 
conditions without measuring the concentration of specific species. The ideal cultivation 
process with respect to productivity can be found earlier and can be identified more 
reliably. Information generated can easily be implemented for the optimization of 
transient transfection processes. As was described by Bachinger et al. (2000a) to allow 
real-time identification of ideal process states, a mathematical model, like PCA, need to 
be applied onto the sensor signals. A PCA-model can be calculated with the sensor data 
from an ideal cultivation where the corresponding principal components represent ideal 
process states. In subsequent cultivations, the electronic nose signals can be projected in 
real-time onto this “base” PCA-model resulting in a new set of principal components. 
When comparing the plots one can notice if, for example, the production phase from the 
new cultivation is enclosed by boundaries for the region in the plot where the sensor 
157 4.  Discussion 
signals should ideally stay during this new cultivation. If, during a new cultivation, the 
real-time projection of the sensor signals onto the “base” PCA-model does not, a non-
ideal state is indicated and control actions could be effectuated (Bachinger et al. 2000a). 
Even more, Mandenius et al. (1998) described the use of an electronic nose for process 
diagnosis, since they could identify bacterial infection in the course of an ongoing 
cultivation earlier than with alternative methods, such as dissolved oxygen and pH 
probes. 
 
In addition, bioreactor cultivations under serum-free medium (section 3.7.2.2 and 
section 4.3, Fig. 4.3a; TTran. 040 (A) and TTran. 044 (B)) were analyzed using the 
NTP/U ratio. These results showed values higher than 2.3 (5.2 and 3.2) at the beginning 
of the culture (day 1), indicating cells in poor physiological conditions with a low 
growth potential (section 3.7.2.2, Fig. 3.7.2.2d; A and Fig. 3.7.2.2a; A). This was 
consistent with result of the transfection, which was performed at day 2, obtaining a 
lower percentage of GFP-positive cells, 44.5 % and 55.5 % respectively. Additionally 
the presence of cell aggregates before the addition of the transfection complex could 
affected the procedure; hence this is an important prerequisite for a good transfection 
efficiency.  
 It was interesting to observe that in the cell culture showing the lowest NTP/U ratio 
at day 1 (TTran. 044 with NTP/U of 3.2 that indicated better cell conditions compared 
to TTran. 040 with NTP/U ratio of 5.2) the highest transfectability was measured (55.5 
% compared with 44.5 %). Moreover, cells used in both cultivations were derived from 
different passage numbers, 89 (late passage no.) for TTran. 040, and 70 (early passage 
no.) for TTran. 044 (section 3.7.2.2). These results agreed with the points already 
discussed in section 4.2. Cells cultivated under serum-free conditions, derived from an 
early passage no. showed a higher trasnfectability than cells derived from a late passage 
no., although the older cells were better adapted to this medium. 
4.4 Intracellular nucleotide analysis vs. BioNose 
This work showed that the intracellular nucleotide analysis and the electronic nose can 
be used to monitor a bioprocess and to identify different process conditions.  
As already discussed (4.3), on-line monitoring of bioprocess parameters is the 
method of choice when possible. It has several advantages such as the possibility to 
continuously sample data using programmed procedures avoiding time-consuming 
manual sampling. Particularly, one of the dominant advantages of the electronic nose is 
the non-invasive sampling from the bioreactor off-gas line. Thereby the sterile barrier 
can be introduced simply via an off-gas filter, which is implemented in any typical 
industrial bioreactor system. Another advantage of the BioNose is the fact that the 
158 4.  Discussion 
knowledge about the molecular composition of the odor is not needed for identification 
of process parameters. However by combining the electronic nose with the principal 
component analysis it is possible to study a dynamic process. In one plot, a description 
of the process situation can be obtained without having direct information about the 
cellular and physiologic state. 
 
Even though the intracellular nucleotide analysis is not an on-line method, 
nucleotide ratios give direct information about the cell status. Additionally, their 
combination amplifies small changes of the culture giving larger and more easily 
detectable variations. Moreover, they are quite robust and independent on the sampling 
method. Since the parameter is a ratio, it is also independent on the volume used for 
extraction.  
 
Summarizing, the determination of intracellular nucleotides could even help to find 
an ideal cultivation and a suitable PCA-model for on-line process monitoring.  
In addition, using nucleotide ratios pre-culture could be optimized. This is an important 
prerequisite for a successful bioreactor cultivation and thus for a successful large-scale 
transfection procedure.  
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5. Conclusions and future perspectives 
In conclusion, a transient transfection procedure easy to perform, cost-effective, for a 
large-scale application using the mammalian cells HEK293s cultivated in a medium 
totally free of animal proteins or animal-origin components was developed. 
 
The work performed in this thesis contributes to science and technology 
development in transient transfection. Important new goals were achieved in this field: 
 
o Use of minimal amount of DNA. 
o Develop of a new serum-free medium. 
o Omission of the cell wash step prior and after transfection. 
 
In addition, the characterization of the transfection procedure using an off-line 
method such as intracellular nucleotide patterns, and an on-line method such as the 
electronic nose, has showed the applicability of both methods as appropriate and even 
excellent tools for process optimization. 
    
The advantage of obtaining early information on changes in cell physiology that will 
later translate to cell growth worsening, complete arrest or even decreasing viability 
finds many applications in process development. In the absence of NTP/U information, 
one cannot know whether cells are in a good physiological state with high growth 
potential or not. These are essential demands in process development. As was shown in 
this work, cells in sub-optimal physiological state will not respond favorably to stress. 
In this case, this was observed as a low transfection efficiency and as consequence low 
protein expression.  
 
Moreover, information drawn by the NTP/U ratio give access to special cell 
properties e.g. growth retardation during scale-up. Knowledge of the exact time for 
transferring the cells to the next scale is of crucial importance, not only with regard to 
process time reduction but also with regard to efficiently design the respective scale-up 
protocol by avoiding a large number of time-consuming experiments. 
 
In addition, the NTP/U ratio reflected different cell physiological patterns, 
characteristic for the respective process condition. In this context, as mentioned in the 
results section (3.7.1), this ratio had shown to be a useful and reliably tool to distinguish 
between: 
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o  HEK293s cells from early and late passage numbers. 
o Cells cultured under serum-containing conditions from those under 
protein/serum-free medium conditions. 
o Transfected and untransfected cells in culture. 
o DNA:PEI complex uptake (transfection procedure) from PEI uptake alone. 
 
Even more, these results demonstrated that transfectability and productivity of 
transiently transfected HEK293s cells are highly dependent on the characteristic cell 
physiology under every process condition. In this context, the nucleotide ratio plays an 
essential role, more than the most common parameters such as cell number and 
viability, or the determination of glucose, lactate, LDH or amino acids in the culture 
supernatant or even the cell passage number. 
 
NTP/U profiles could be used to find optimum process state in a series of production 
runs with regard to the best cell physiology status and the optimum time and conditions 
for transient transfection. 
 
The use of the BioNose as a tool for process characterization, cell culture monitoring 
and optimization was demonstrated. Moreover, a characteristic process-specific 
BioNose pattern for the transient transfection of HEK293s was found. In addition, the 
data obtained here, can be used to generate a database for optimization of transfection 
processes based on cultured HEK293s cells. However, a further improvement of the 
sensors sensitivity is a prerequisite to provide a reliable robustness to this continues 
non-invasive real-time monitoring method. 
 
 
Additional experiments are required to further improve the process: 
 
o Further optimization of the transient transfection to larger scales. 
o Extension of the results obtaining so far to all conceivable scales. 
o Expansion of the results to different mammalian cell types. 
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7. Appendix 
7.1 Media composition 
 
DMEM -Ca2+ 
+ Vit. + Pl. + 5 % 
FCS 
DMEM -Ca2+ + 
Vit. 
Components Concentration  
x x MgSO4 × 7H2O 200.0 mg L-1 
x x KCl 400.0 mg L-1 
x x NaHCO3 3700.0 mg L-1 
x x NaCl 6400.0 mg L-1 
x x NaH2PO4 109.0 mg L-1 
x x L-Arginine × HCl 168.6 mg L-1 
x x L-Cystine × 2HCl 62.6 mg L-1 
x x Glycine 30.0 mg L-1 
x x L-Histidine × 
HCl·H2O 
42.0 mg L-1 
x x L-Isoleucine 131.0 mg L-1 
x x L-Leucine 131.0 mg L-1 
x x L-Lysine × HCl 219.0 mg L-1 
x x L-Methionine 60.0 mg L-1 
x x L-Phenylalanine 66.0 mg L-1 
x x L-Serine 84.0 mg L-1 
x x L-Threonine 95.0 mg L-1 
x x L-Tryptophane 16.0 mg L-1 
x x L-Tyrosine 71.4 mg L-1 
x x L-Valine 94.0 mg L-1 
x x D-Glucose × H2O 4950.0 mg L-1 
x x L-Glutamine 731.0 mg L-1 
x x Fe(NO3)3 × 9H2O 0.1 mg L-1 
x x Phenol red 1.5×10-3% (V V-1) 
x x MEM vitamins 
solution(100 ×) 
4.0 %(V V-1) 
x - Pluronic F-68, 
solution 10 % 
0.1 % (V V-1) 
x - FCS 5.0 % (V V-1) 
 
 
 
 
 
 
 
 
Table A1: DMEM -Ca2+ + Vit. + Pl. + 5% FCS and DMEM -Ca2+ + Vit. chemical composition 
media. 
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H-SFM + Pl. H-SFM + Pl. + 
Lip. + EDTA 
Components Concentration 
x x Pluronic F-68, solution 
10 % 
0.1 % (V V-1) 
- x Lipid medium 
supplement (0.1 %) 
1.0 mL L-1 
- x EDTA (Stock sol. 1.6 g 
L-1) 
1.4 mL L-1 
 
Table A2: Description of H-SFM medium supplemented either with Pl., Lip. or EDTA.  
CURRICULUM VITAE 
PERSONAL DATA 
NAME: Maria de los Milagros Bassani Molinas 
DATE OF BIRTH: 28-10-70 
PLACE OF BIRTH: Santa Fe - Argentine 
NACIONALITY: Argentine- Italian 
MARRITAL STATUS:  Married CHILDREN: one  
LANGUAGE:  Spanish – English – German 
 
EDUCATION 
1977 – 1983 Primary school, “Instituto San José Adoratrices”, Santa Fe, Argentine. 
1984 – 1988 Secundary school (Bachelor), “Instituto San José Adoratrices”, Santa Fe, 
Argentine 
1989 – 1996 Diploma as Biochemist, Facultad de Bioquímica y Ciencias Biológicas, 
Universidad Nacional del Litoral, Santa Fe, Argentine. 
 
RESEARCH AND PROFESSIONAL EXPERIENCE 
March 1994 / March 1995 
Student research (Expte.53.936-B/94), General Analytical Chemistry Department, 
Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa 
Fe, Argentine. “Determination of physical-chemistry variables in natural fruit juices”, 
directed by Dr. Victor E. Mantovani 
April 1995 / April 1997 
Student research (Expdte. 57743-K/96), Laboratory of Endocrinology and Hormone-
dependent tumors, Human Physiology Department, Facultad de Bioquímica y Ciencias 
Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentine. “Factors that improve 
the reproductive efficiency: Mechanism of uterus neck dilation during the delivery in a 
sheep”, directed by Dr. Enrique Luque.       
August 1996 
Guest Scientist in Cell Biology Laboratory, Pathology Department, Laboratório de 
Biologia Celular da Faculdade de Medicina da Universidade de Sao Paulo, Brazil. 
February 1997 / May 1997 
Graduate training in Cell Culture Techniques in the Institute of Biologic Technology 
(INTEBIO), supervised by Dra. Marina Etcheverrigary and directed by Dr. Ricardo 
Kratje. Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, 
Santa Fe, Argentine. 
February 1998 / July 1998 
Graduate training in the Cell Culture Section at the Immunogenetics Laboratory, Hospital 
Universitario José de San Martín , Facultad de Medicina, Universidad de Buenos Aries, 
Buenos Aires, Argentine. Directed by Prof. Dr. Leonardo Fainbom. 
 
 
 
  
August 1998/ March 1999 
Graduate training in Molecular Neurobiology; Mycrobiology, Immunology and 
Biotechnology Department, Genetic and Biology Molecular, Facultad de Farmacia y 
Bioquímicos, Graduate School, Universidad de Buenos Aires, Buenos Aires, Argentine. 
April 1999 / December 2000 
Fellowship in Neuroimmunology directed by Dr. Jorge Correale. Research and Teach 
Department, Institute of Neurology Research “Dr. Raúl Carrea” (FLENI), Buenos Aires, 
Argentine. 
January 2001 / December 2004 
Doctoral student at the Cell Culture Technology Department (ZKT), German Research 
Center of Biotechnology (GBF), Braunschweig, Germany. Thesis supervised by Prof. Dr. 
Roland Wagner. 
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SCIENTIFIC COURSES, MEETINGS AND CONGRESS 
1. “Research Projects (Art and Technique of its formulation). Facultad de Bioquímica y Ciencias 
Biológicas, Universidad Nacional del Litoral. Santa Fe, Argentine. 14 th May, 1994. 
2. “Animals laboratory: general and special aspects application in the research working 
andtechnology development in Biology Sciences”. LETH (Laboratorio de Endocrinología 
y Tumores Hormonodependientes). Human Physiology Department. Facultad de 
Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral.  Santa Fe, 
Argentine. September - October 1995. 
3. “High Performance Liquid Chromatography with application in food analysis”  Instituto de 
Desarrollo Tecnológico para la Industria Química (INTEC), Universidad Nacional del 
Litoral, Consejo Nacional de Investigaciones Científicas y Técnicas., Santa Fe, Argentine, 
14 th March - 25 th April, 1997. 
4. “First Workshop and Latinoamerican Conference of Autoimmunity”. Buenos Aires, 
Argentine, 21 - 23 April, 1997. 
5. “Practice and theory: Second course about recently advance in Immunogenetics and 
Histocompatibility”. Sociedad Argentina de Inmunología (SAI); The International Union 
of Immunological Societies (IUIS);, The American Society for Histocompatibility and 
Immunogenetics (ASHI); Maestría en Biotecnología, Universidad de Buenos Aires 
(UBA); The American Board of Histocompatibility and Immunogenetics (ABHI); Buenos 
Aires, Argentine; 11 - 20 August, 1997. 
6. “Immunology and Immunopathology”. Facultad de Ciencias Médicas, Universidad Nacional 
de Rosario, Argentine. (72 hs) May - October, 1997. 
7. “Analysis of DNA in biological samples (Estudios de Filiación e Identidad)”. Fundación 
Argentina de Investigaciones Biomoleculares (FIBIO). Buenos Aires, Argneine. 18 - 22 
May, 1998. 
8. “Actualization in Medical Molecular Biology”. Instituto de Investigaciones Bioquímicas, 
Fundación Campomar. Buenos Aires, Argentine. 3 - 31 August, 1998. 
9. “Molecular Neurobiology”. Facultad de Farmacia y Bioquímica, Escuela de Graduados. 
Universidad de Buenos Aires, Argentine. May - June, 1998. 
10. “Immune System Physiology”. Facultad de Ciencias Exactas y Naturales, Universidad de 
Buenos Aires, Argentine. October, 1998. 
 
  
11. “Cytoquines and adhesion molecules in inflammation and autoimmunity”. Facultad de 
Ciencias Exactas y Naturales,  Universidad de Buenos Aires, Argentine. May - June, 
1999. 
12. “Techniques in Biochemistry and Molecular Biology”, Instituto de Investigaciones Dr. JF 
Leloir (Fundación Campomar), Buenos Aires, Argentine. August - December, 1999. 
13. “Research Methodology ”. Academia Nacional de Medicina de Buenos Aires. Instituto de 
Investigaciones Hematológicas “Mariano Castex”. Buenos Aires, Argentine. October, 
2000. 
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